USE OF PICOLINAMIDES AS FUNGICIDES

Abstract

This disclosure relates to picolinamides of Formula I and their use as fungicides.

##STR00001##

Claims

1. A composition for the control of a fungal pathogen including mixtures of at least one of the compounds of Formula 1 ##STR00336## wherein X is hydrogen or C(O)R.sub.5; Y is hydrogen, C(O)R.sub.5, or Q; Q is ##STR00337## R.sub.1 and R.sub.11 are independently chosen from hydrogen or alkyl, optionally substituted with 0, 1 or multiple R.sub.8; Alternatively, R.sub.1 and R.sub.11 may be taken together to form a 3-6 membered saturated or partially saturated carbocycle or heterocycle, optionally substituted with 0, 1 or multiple R.sub.8; R.sub.2 and R.sub.12 are independently chosen from hydrogen or methyl; R.sub.3 is chosen from aryl or heteroaryl, each optionally substituted with 0, 1 or multiple R.sub.8; R.sub.4 is chosen from alkyl, aryl, or acyl, each optionally substituted with 0, 1 or multiple R.sub.8; R.sub.5 is chosen from alkoxy or benzyloxy, each optionally substituted with 0, 1, or multiple R.sub.8; R.sub.6 is chosen from hydrogen, alkoxy, or halo, each optionally substituted with 0, 1, or multiple R.sub.8; R.sub.7 is chosen from hydrogen, —C(O)R.sub.9, or —CH.sub.2OC(O)R.sub.9; R.sub.8 is chosen from hydrogen, alkyl, aryl, acyl, halo, alkenyl, alkoxy, or heterocyclyl, each optionally substituted with 0, 1, or multiple R.sub.10; R.sub.9 is chosen from alkyl, alkoxy, or aryl, each optionally substituted with 0, 1, or multiple R.sub.8; and R.sub.10 is chosen from hydrogen, alkyl, aryl, acyl, halo, alkenyl, alkoxy, or heterocyclyl.

2. A composition according to claim 1, wherein X is hydrogen and Y is Q.

3. A composition according to claim 2, wherein R.sub.6 is alkoxy.

4. A composition according to claim 3, wherein R.sub.7 is hydrogen.

5. A composition according to claim 4, wherein R.sub.1 and R.sub.11 are independently chosen from hydrogen or alkyl.

6. (canceled)

7. A composition according to claim 4, wherein R.sub.3 is aryl, optionally substituted with 0, 1 or multiple R.sub.8.

8. A composition according to claim 4, wherein R.sub.4 is chosen from alkyl or aryl, each optionally substituted with 0, 1 or multiple R.sub.8.

9. A composition according to claim 4, wherein R.sub.1 and R.sub.11 are independently chosen from hydrogen or alkyl, optionally substituted with 0, 1 or multiple R.sub.8, and R.sub.4 is chosen from alkyl or aryl, each optionally substituted with 0, 1 or multiple R.sub.8.

10. A composition according to claim 3, wherein R.sub.7 is chosen from —C(O)R.sub.9, or —CH.sub.2OC(O)R.sub.9.

11. A composition according to claim 10, wherein R.sub.9 is alkyl, optionally substituted with 0, 1 or multiple R.sub.8.

12. A composition according to claim 11, wherein R.sub.1 and R.sub.11 are independently chosen from hydrogen or alkyl.

13. (canceled)

14. A composition according to claim 11, wherein R.sub.3 is aryl, optionally substituted with 0, 1 or multiple R.sub.8.

15. A composition according to claim 11, wherein R.sub.4 is chosen from alkyl or aryl, each optionally substituted with 0, 1 or multiple R.sub.8.

16. A composition according to claim 11, wherein R.sub.1 and R.sub.11 are independently chosen from hydrogen or alkyl, R.sub.3 is aryl, optionally substituted with 0, 1 or multiple R.sub.8, and R.sub.4 is chosen from alkyl or aryl, each optionally substituted with 0, 1 or multiple R.sub.8.

17. A composition according to claim 16, wherein R.sub.9 is chosen from —CH.sub.3, —CH.sub.2OCH.sub.2CH.sub.3, —CH.sub.2CH.sub.2OCH.sub.3, —CH(CH.sub.3).sub.2, —CH.sub.2CH.sub.2CH.sub.2CH.sub.3, or -cyclopropyl.

18. A composition for the control of a fungal pathogen including at least one of the compositions of claim 9 and a phytologically acceptable carrier material.

19. A composition for the control of a fungal pathogen including at least one of the compositions of claim 16 and a phytologically acceptable carrier material.

20. (canceled)

21. A composition for the control of a fungal pathogen including mixtures of at least one of the compositions of claim 9 and another pesticide including fungicides, insecticides, nematocides, miticides, arthropodicides, bactericides and combinations thereof.

22. A composition for the control of a fungal pathogen including mixtures of at least one of the compositions of claim 16 and another pesticide including fungicides, insecticides, nematocides, miticides, arthropodicides, bactericides and combinations thereof.

23. (canceled)

24. (canceled)

25. (canceled)

26. (canceled)

27. (canceled)

28. A method for the control and prevention of fungal attack on a plant, the method including the step of: Applying a fungicidally effective amount of at least one of the compositions of claim 9 to at least one of the plant, an area adjacent to the plant, soil adapted to support growth of the plant, a root of the plant, and foliage of the plant.

29. A method for the control and prevention of fungal attack on a plant, the method including the step of: Applying a fungicidally effective amount of at least one of the compositions of claim 16 to at least one of the plant, an area adjacent to the plant, soil adapted to support growth of the plant, a root of the plant, and foliage of the plant.

30. (canceled)

31. (canceled)

32. (canceled)

Description

DETAILED DESCRIPTION

[0035] The compounds of the present disclosure may be applied by any of a variety of known techniques, either as the compounds or as formulations comprising the compounds. For example, the compounds may be applied to the roots or foliage of plants for the control of various fungi, without damaging the commercial value of the plants. The materials may be applied in the form of any of the generally used formulation types, for example, as solutions, dusts, wettable powders, flowable concentrate, or emulsifiable concentrates.

[0036] Preferably, the compounds of the present disclosure are applied in the form of a formulation, comprising one or more of the compounds of Formula I with a phytologically acceptable carrier. Concentrated formulations may be dispersed in water, or other liquids, for application, or formulations may be dust-like or granular, which may then be applied without further treatment. The formulations can be prepared according to procedures that are conventional in the agricultural chemical art.

[0037] The present disclosure contemplates all vehicles by which one or more of the compounds may be formulated for delivery and used as a fungicide. Typically, formulations are applied as aqueous suspensions or emulsions. Such suspensions or emulsions may be produced from water-soluble, water-suspendible, or emulsifiable formulations which are solids, usually known as wettable powders; or liquids, usually known as emulsifiable concentrates, aqueous suspensions, or suspension concentrates. As will be readily appreciated, any material to which these compounds may be added may be used, provided it yields the desired utility without significant interference with the activity of these compounds as antifungal agents.

[0038] Wettable powders, which may be compacted to form water-dispersible granules, comprise an intimate mixture of one or more of the compounds of Formula I, an inert carrier and surfactants. The concentration of the compound in the wettable powder may be from about 10 percent to about 90 percent by weight based on the total weight of the wettable powder, more preferably about 25 weight percent to about 75 weight percent. In the preparation of wettable powder formulations, the compounds may be compounded with any finely divided solid, such as prophyllite, talc, chalk, gypsum, Fuller's earth, bentonite, attapulgite, starch, casein, gluten, montmorillonite clays, diatomaceous earths, purified silicates or the like. In such operations, the finely divided carrier and surfactants are typically blended with the compound(s) and milled.

[0039] Emulsifiable concentrates of the compounds of Formula I may comprise a convenient concentration, such as from about 1 weight percent to about 50 weight percent of the compound, in a suitable liquid, based on the total weight of the concentrate. The compounds may be dissolved in an inert carrier, which is either a water-miscible solvent or a mixture of water-immiscible organic solvents, and emulsifiers. The concentrates may be diluted with water and oil to form spray mixtures in the form of oil-in-water emulsions. Useful organic solvents include aromatics, especially the high-boiling naphthalenic and olefinic portions of petroleum such as heavy aromatic naphtha. Other organic solvents may also be used, for example, terpenic solvents, including rosin derivatives, aliphatic ketones, such as cyclohexanone, and complex alcohols, such as 2-ethoxyethanol.

[0040] Emulsifiers which may be advantageously employed herein may be readily determined by those skilled in the art and include various nonionic, anionic, cationic and amphoteric emulsifiers, or a blend of two or more emulsifiers. Examples of nonionic emulsifiers useful in preparing the emulsifiable concentrates include the polyalkylene glycol ethers and condensation products of alkyl and aryl phenols, aliphatic alcohols, aliphatic amines or fatty acids with ethylene oxide, propylene oxides such as the ethoxylated alkyl phenols and carboxylic esters solubilized with the polyol or polyoxyalkylene. Cationic emulsifiers include quaternary ammonium compounds and fatty amine salts. Anionic emulsifiers include the oil-soluble salts (e.g., calcium) of alkylaryl sulphonic acids, oil-soluble salts or sulfated polyglycol ethers and appropriate salts of phosphated polyglycol ether.

[0041] Representative organic liquids which may be employed in preparing the emulsifiable concentrates of the compounds of the present disclosure are the aromatic liquids such as xylene, propyl benzene fractions; or mixed naphthalene fractions, mineral oils, substituted aromatic organic liquids such as dioctyl phthalate; kerosene; dialkyl amides of various fatty acids, particularly the dimethyl amides of fatty glycols and glycol derivatives such as the n-butyl ether, ethyl ether or methyl ether of diethylene glycol, the methyl ether of triethylene glycol, petroleum fractions or hydrocarbons such as mineral oil, aromatic solvents, paraffinic oils, and the like; vegetable oils such as soy bean oil, rape seed oil, olive oil, castor oil, sunflower seed oil, coconut oil, corn oil, cotton seed oil, linseed oil, palm oil, peanut oil, safflower oil, sesame oil, tung oil and the like; esters of the above vegetable oils; and the like. Mixtures of two or more organic liquids may also be employed in the preparation of the emulsifiable concentrate. Organic liquids include xylene, and propyl benzene fractions, with xylene being most preferred in some cases. Surface-active dispersing agents are typically employed in liquid formulations and in an amount of from 0.1 to 20 percent by weight based on the combined weight of the dispersing agent with one or more of the compounds. The formulations can also contain other compatible additives, for example, plant growth regulators and other biologically active compounds used in agriculture.

[0042] Aqueous suspensions comprise suspensions of one or more water-insoluble compounds of Formula I, dispersed in an aqueous vehicle at a concentration in the range from about 1 to about 50 weight percent, based on the total weight of the aqueous suspension. Suspensions are prepared by finely grinding one or more of the compounds, and vigorously mixing the ground material into a vehicle comprised of water and surfactants chosen from the same types discussed above. Other components, such as inorganic salts and synthetic or natural gums, may also be added to increase the density and viscosity of the aqueous vehicle.

[0043] The compounds of Formula I can also be applied as granular formulations, which are particularly useful for applications to the soil. Granular formulations generally contain from about 0.5 to about 10 weight percent, based on the total weight of the granular formulation of the compound(s), dispersed in an inert carrier which consists entirely or in large part of coarsely divided inert material such as attapulgite, bentonite, diatomite, clay or a similar inexpensive substance. Such formulations are usually prepared by dissolving the compounds in a suitable solvent and applying it to a granular carrier which has been preformed to the appropriate particle size, in the range of from about 0.5 to about 3 mm. A suitable solvent is a solvent in which the compound is substantially or completely soluble. Such formulations may also be prepared by making a dough or paste of the carrier and the compound and solvent, and crushing and drying to obtain the desired granular particle.

[0044] Dusts containing the compounds of Formula I may be prepared by intimately mixing one or more of the compounds in powdered form with a suitable dusty agricultural carrier, such as, for example, kaolin clay, ground volcanic rock, and the like. Dusts can suitably contain from about 1 to about 10 weight percent of the compounds, based on the total weight of the dust.

[0045] The formulations may additionally contain adjuvant surfactants to enhance deposition, wetting, and penetration of the compounds onto the target crop and organism. These adjuvant surfactants may optionally be employed as a component of the formulation or as a tank mix. The amount of adjuvant surfactant will typically vary from 0.01 to 1.0 percent by volume, based on a spray-volume of water, preferably 0.05 to 0.5 volume percent. Suitable adjuvant surfactants include, but are not limited to ethoxylated nonyl phenols, ethoxylated synthetic or natural alcohols, salts of the esters or sulphosuccinic acids, ethoxylated organosilicones, ethoxylated fatty amines, blends of surfactants with mineral or vegetable oils, crop oil concentrate (mineral oil (85%)+emulsifiers (15%)); nonylphenol ethoxylate; benzylcocoalkyldimethyl quaternary ammonium salt; blend of petroleum hydrocarbon, alkyl esters, organic acid, and anionic surfactant; C.sub.9-C.sub.11 alkylpolyglycoside; phosphated alcohol ethoxylate; natural primary alcohol (C.sub.12-C.sub.16) ethoxylate; di-sec-butylphenol EO-PO block copolymer; polysiloxane-methyl cap; nonylphenol ethoxylate+urea ammonium nitrate; emulsified methylated seed oil; tridecyl alcohol (synthetic) ethoxylate (8EO); tallow amine ethoxylate (15 EO); PEG(400) dioleate-99. The formulations may also include oil-in-water emulsions such as those disclosed in U.S. patent application Ser. No. 11/495,228, the disclosure of which is expressly incorporated by reference herein.

[0046] The formulations may optionally include combinations that contain other pesticidal compounds. Such additional pesticidal compounds may be fungicides, insecticides, herbicides, nematocides, miticides, arthropodicides, bactericides or combinations thereof that are compatible with the compounds of the present disclosure in the medium selected for application, and not antagonistic to the activity of the present compounds. Accordingly, in such embodiments, the other pesticidal compound is employed as a supplemental toxicant for the same or for a different pesticidal use. The compounds of Formula I and the pesticidal compound in the combination can generally be present in a weight ratio of from 1:100 to 100:1.

[0047] The compounds of the present disclosure may also be combined with other fungicides to form fungicidal mixtures and synergistic mixtures thereof. The fungicidal compounds of the present disclosure are often applied in conjunction with one or more other fungicides to control a wider variety of undesirable diseases. When used in conjunction with other fungicide(s), the presently claimed compounds may be formulated with the other fungicide(s), tank-mixed with the other fungicide(s) or applied sequentially with the other fungicide(s). Such other fungicides may include 2-(thiocyanatomethylthio)-benzothiazole, 2-phenylphenol, 8-hydroxyquinoline sulfate, ametoctradin, amisulbrom, antimycin, Ampelomyces quisqualis, azaconazole, azoxystrobin, Bacillus subtilis, Bacillus subtilis strain QST713, benalaxyl, benomyl, benthiavalicarb-isopropyl, benzovindiflupyr benzylaminobenzene-sulfonate (BABS) salt, bicarbonates, biphenyl, bismerthiazol, bitertanol, bixafen, blasticidin-S, borax, Bordeaux mixture, boscalid, bromuconazole, bupirimate, calcium polysulfide, captafol, captan, carbendazim, carboxin, carpropamid, carvone, chlazafenone, chloroneb, chlorothalonil, chlozolinate, Coniothyrium minitans, copper hydroxide, copper octanoate, copper oxychloride, copper sulfate, copper sulfate (tribasic), cuprous oxide, cyazofamid, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, dazomet, debacarb, diammonium ethylenebis-(dithiocarbamate), dichlofluanid, dichlorophen, diclocymet, diclomezine, dichloran, diethofencarb, difenoconazole, difenzoquat ion, diflumetorim, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinobuton, dinocap, diphenylamine, dithianon, dodemorph, dodemorph acetate, dodine, dodine free base, edifenphos, enestrobin, enestroburin, epoxiconazole, ethaboxam, ethoxyquin, etridiazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fenpyrazamine, fentin, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumorph, fluopicolide, fluopyram, fluoroimide, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, formaldehyde, fosetyl, fosetyl-aluminium, fuberidazole, furalaxyl, furametpyr, guazatine, guazatine acetates, GY-81, hexachlorobenzene, hexaconazole, hymexazol, imazalil, imazalil sulfate, imibenconazole, iminoctadine, iminoctadine triacetate, iminoctadine tris(albesilate), iodocarb, ipconazole, ipfenpyrazolone, iprobenfos, iprodione, iprovalicarb, isoprothiolane, isopyrazam, isotianil, kasugamycin, kasugamycin hydrochloride hydrate, kresoxim-methyl, laminarin, mancopper, mancozeb, mandipropamid, maneb, mefenoxam, mepanipyrim, mepronil, meptyl-dinocap, mercuric chloride, mercuric oxide, mercurous chloride, metalaxyl, metalaxyl-M, metam, metam-ammonium, metam-potassium, metam-sodium, metconazole, methasulfocarb, methyl iodide, methyl isothiocyanate, metiram, metominostrobin, metrafenone, mildiomycin, myclobutanil, nabam, nitrothal-isopropyl, nuarimol, octhilinone, ofurace, oleic acid (fatty acids), orysastrobin, oxadixyl, oxine-copper, oxpoconazole fumarate, oxycarboxin, pefurazoate, penconazole, pencycuron, penflufen, pentachlorophenol, pentachlorophenyl laurate, penthiopyrad, phenylmercury acetate, phosphonic acid, phthalide, picoxystrobin, polyoxin B, polyoxins, polyoxorim, potassium bicarbonate, potassium hydroxyquinoline sulfate, probenazole, prochloraz, procymidone, propamocarb, propamocarb hydrochloride, propiconazole, propineb, proquinazid, prothioconazole, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyributicarb, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, quinoclamine, quinoxyfen, quintozene, Reynoutria sachalinensis extract, sedaxane, silthiofam, simeconazole, sodium 2-phenylphenoxide, sodium bicarbonate, sodium pentachlorophenoxide, spiroxamine, sulfur, SYP-Z048, tar oils, tebuconazole, tebufloquin, tecnazene, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triazoxide, tricyclazole, tridemorph, trifloxystrobin, triflumizole, triforine, triticonazole, validamycin, valifenalate, valiphenal, vinclozolin, zineb, ziram, zoxamide, Candida oleophila, Fusarium oxysporum, Gliocladium spp., Phlebiopsis gigantea, Streptomyces griseoviridis, Trichoderma spp., (RS)—N-(3,5-dichlorophenyl)-2-(methoxymethyl)-succinimide, 1,2-dichloropropane, 1,3-dichloro-1,1,3,3-tetrafluoroacetone hydrate, 1-chloro-2,4-dinitronaphthalene, 1-chloro-2-nitropropane, 2-(2-heptadecyl-2-imidazolin-1-yl)ethanol, 2,3-dihydro-5-phenyl-1,4-dithi-ine 1,1,4,4-tetraoxide, 2-methoxyethylmercury acetate, 2-methoxyethylmercury chloride, 2-methoxyethylmercury silicate, 3-(4-chlorophenyl)-5-methylrhodanine, 4-(2-nitroprop-1-enyl)phenyl thiocyanateme, ampropylfos, anilazine, azithiram, barium polysulfide, Bayer 32394, benodanil, benquinox, bentaluron, benzamacril; benzamacril-isobutyl, benzamorf, binapacryl, bis(methylmercury) sulfate, bis(tributyltin) oxide, buthiobate, cadmium calcium copper zinc chromate sulfate, carbamorph, CECA, chlobenthiazone, chloraniformethan, chlorfenazole, chlorquinox, climbazole, copper bis(3-phenylsalicylate), copper zinc chromate, cufraneb, cupric hydrazinium sulfate, cuprobam, cyclafuramid, cypendazole, cyprofuram, decafentin, dichlone, dichlozoline, diclobutrazol, dimethirimol, dinocton, dinosulfon, dinoterbon, dipyrithione, ditalimfos, dodicin, drazoxolon, EBP, ESBP, etaconazole, etem, ethirim, fenaminosulf, fenapanil, fenitropan, fluotrimazole, furcarbanil, furconazole, furconazole-cis, furmecyclox, furophanate, glyodine, griseofulvin, halacrinate, Hercules 3944, hexylthiofos, ICIA0858, isopamphos, isovaledione, mebenil, mecarbinzid, metazoxolon, methfuroxam, methylmercury dicyandiamide, metsulfovax, milneb, mucochloric anhydride, myclozolin, N-3,5-dichlorophenyl-succinimide, N-3-nitrophenylitaconimide, natamycin, N-ethylmercurio-4-toluenesulfonanilide, nickel bis(dimethyldithiocarbamate), OCH, phenylmercury dimethyldithiocarbamate, phenylmercury nitrate, phosdiphen, prothiocarb; prothiocarb hydrochloride, pyracarbolid, pyridinitril, pyroxychlor, pyroxyfur, quinacetol; quinacetol sulfate, quinazamid, quinconazole, rabenzazole, salicylanilide, SSF-109, sultropen, tecoram, thiadifluor, thicyofen, thiochlorfenphim, thiophanate, thioquinox, tioxymid, triamiphos, triarimol, triazbutil, trichlamide, urbacid, zarilamid, and any combinations thereof.

[0048] Additionally, the compounds described herein may be combined with other pesticides, including insecticides, nematocides, miticides, arthropodicides, bactericides or combinations thereof that are compatible with the compounds of the present disclosure in the medium selected for application, and not antagonistic to the activity of the present compounds to form pesticidal mixtures and synergistic mixtures thereof. The fungicidal compounds of the present disclosure may be applied in conjunction with one or more other pesticides to control a wider variety of undesirable pests. When used in conjunction with other pesticides, the presently claimed compounds may be formulated with the other pesticide(s), tank-mixed with the other pesticide(s) or applied sequentially with the other pesticide(s). Typical insecticides include, but are not limited to: 1,2-dichloropropane, abamectin, acephate, acetamiprid, acethion, acetoprole, acrinathrin, acrylonitrile, alanycarb, aldicarb, aldoxycarb, aldrin, allethrin, allosamidin, allyxycarb, alpha-cypermethrin, alpha-ecdysone, alpha-endosulfan, amidithion, aminocarb, amiton, amiton oxalate, amitraz, anabasine, athidathion, azadirachtin, azamethiphos, azinphos-ethyl, azinphos-methyl, azothoate, barium hexafluorosilicate, barthrin, bendiocarb, benfuracarb, bensultap, beta-cyfluthrin, beta-cypermethrin, bifenthrin, bioallethrin, bioethanomethrin, biopermethrin, bistrifluron, borax, boric acid, bromfenvinfos, bromocyclen, bromo-DDT, bromophos, bromophos-ethyl, bufencarb, buprofezin, butacarb, butathiofos, butocarboxim, butonate, butoxycarboxim, cadusafos, calcium arsenate, calcium polysulfide, camphechlor, carbanolate, carbaryl, carbofuran, carbon disulfide, carbon tetrachloride, carbophenothion, carbosulfan, cartap, cartap hydrochloride, chlorantraniliprole, chlorbicyclen, chlordane, chlordecone, chlordimeform, chlordimeform hydrochloride, chlorethoxyfos, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chloroform, chloropicrin, chlorphoxim, chlorprazophos, chlorpyrifos, chlorpyrifos-methyl, chlorthiophos, chromafenozide, cinerin I, cinerin II, cinerins, cismethrin, cloethocarb, closantel, clothianidin, copper acetoarsenite, copper arsenate, copper naphthenate, copper oleate, coumaphos, coumithoate, crotamiton, crotoxyphos, crufomate, cryolite, cyanofenphos, cyanophos, cyanthoate, cyantraniliprole, cyclethrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin, cyphenothrin, cyromazine, cythioate, DDT, decarbofuran, deltamethrin, demephion, demephion-O, demephion-S, demeton, demeton-methyl, demeton-O, demeton-O-methyl, demeton-S, demeton-S-methyl, demeton-S-methylsulphon, diafenthiuron, dialifos, diatomaceous earth, diazinon, dicapthon, dichlofenthion, dichlorvos, dicresyl, dicrotophos, dicyclanil, dieldrin, diflubenzuron, dilor, dimefluthrin, dimefox, dimetan, dimethoate, dimethrin, dimethylvinphos, dimetilan, dinex, dinex-diclexine, dinoprop, dinosam, dinotefuran, diofenolan, dioxabenzofos, dioxacarb, dioxathion, disulfoton, dithicrofos, d-limonene, DNOC, DNOC-ammonium, DNOC-potassium, DNOC-sodium, doramectin, ecdysterone, emamectin, emamectin benzoate, EMPC, empenthrin, endosulfan, endothion, endrin, EPN, epofenonane, eprinomectin, esdepallethrine, esfenvalerate, etaphos, ethiofencarb, ethion, ethiprole, ethoate-methyl, ethoprophos, ethyl formate, ethyl-DDD, ethylene dibromide, ethylene dichloride, ethylene oxide, etofenprox, etrimfos, EXD, famphur, fenamiphos, fenazaflor, fenchlorphos, fenethacarb, fenfluthrin, fenitrothion, fenobucarb, fenoxacrim, fenoxycarb, fenpirithrin, fenpropathrin, fensulfothion, fenthion, fenthion-ethyl, fenvalerate, fipronil, flonicamid, flubendiamide, flucofuron, flucycloxuron, flucythrinate, flufenerim, flufenoxuron, flufenprox, fluvalinate, fonofos, formetanate, formetanate hydrochloride, formothion, formparanate, formparanate hydrochloride, fosmethilan, fospirate, fosthietan, furathiocarb, furethrin, gamma-cyhalothrin, gamma-HCH, halfenprox, halofenozide, HCH, HEOD, heptachlor, heptenophos, heterophos, hexaflumuron, HHDN, hydramethylnon, hydrogen cyanide, hydroprene, hyquincarb, imidacloprid, imiprothrin, indoxacarb, iodomethane, IPSP, isazofos, isobenzan, isocarbophos, isodrin, isofenphos, isofenphos-methyl, isoprocarb, isoprothiolane, isothioate, isoxathion, ivermectin, jasmolin I, jasmolin II, jodfenphos, juvenile hormone I, juvenile hormone II, juvenile hormone III, kelevan, kinoprene, lambda-cyhalothrin, lead arsenate, lepimectin, leptophos, lindane, lirimfos, lufenuron, lythidathion, malathion, malonoben, mazidox, mecarbam, mecarphon, menazon, mephosfolan, mercurous chloride, mesulfenfos, metaflumizone, methacrifos, methamidophos, methidathion, methiocarb, methocrotophos, methomyl, methoprene, methoxychlor, methoxyfenozide, methyl bromide, methyl isothiocyanate, methylchloroform, methylene chloride, metofluthrin, metolcarb, metoxadiazone, mevinphos, mexacarbate, milbemectin, milbemycin oxime, mipafox, mirex, molosultap, monocrotophos, monomehypo, monosultap, morphothion, moxidectin, naftalofos, naled, naphthalene, nicotine, nifluridide, nitenpyram, nithiazine, nitrilacarb, novaluron, noviflumuron, omethoate, oxamyl, oxydemeton-methyl, oxydeprofos, oxydisulfoton, para-dichlorobenzene, parathion, parathion-methyl, penfluron, pentachlorophenol, permethrin, phenkapton, phenothrin, phenthoate, phorate, phosalone, phosfolan, phosmet, phosnichlor, phosphamidon, phosphine, phoxim, phoxim-methyl, pirimetaphos, pirimicarb, pirimiphos-ethyl, pirimiphos-methyl, potassium arsenite, potassium thiocyanate, pp′-DDT, prallethrin, precocene I, precocene II, precocene III, primidophos, profenofos, profluralin, promacyl, promecarb, propaphos, propetamphos, propoxur, prothidathion, prothiofos, prothoate, protrifenbute, pyraclofos, pyrafluprole, pyrazophos, pyresmethrin, pyrethrin I, pyrethrin II, pyrethrins, pyridaben, pyridalyl, pyridaphenthion, pyrifluquinazon, pyrimidifen, pyrimitate, pyriprole, pyriproxyfen, quassia, quinalphos, quinalphos-methyl, quinothion, rafoxanide, resmethrin, rotenone, ryania, sabadilla, schradan, selamectin, silafluofen, silica gel, sodium arsenite, sodium fluoride, sodium hexafluorosilicate, sodium thiocyanate, sophamide, spinetoram, spinosad, spiromesifen, spirotetramat, sulcofuron, sulcofuron-sodium, sulfluramid, sulfotep, sulfoxaflor, sulfuryl fluoride, sulprofos, tau-fluvalinate, tazimcarb, TDE, tebufenozide, tebufenpyrad, tebupirimfos, teflubenzuron, tefluthrin, temephos, TEPP, terallethrin, terbufos, tetrachloroethane, tetrachlorvinphos, tetramethrin, tetramethylfluthrin, theta-cypermethrin, thiacloprid, thiamethoxam, thicrofos, thiocarboxime, thiocyclam, thiocyclam oxalate, thiodicarb, thiofanox, thiometon, thiosultap, thiosultap-disodium, thiosultap-monosodium, thuringiensin, tolfenpyrad, tralomethrin, transfluthrin, transpermethrin, triarathene, triazamate, triazophos, trichlorfon, trichlormetaphos-3, trichloronat, trifenofos, triflumuron, trimethacarb, triprene, vamidothion, vaniliprole, XMC, xylylcarb, zeta-cypermethrin, zolaprofos, and any combinations thereof.

[0049] Additionally, the compounds described herein may be combined with herbicides that are compatible with the compounds of the present disclosure in the medium selected for application, and not antagonistic to the activity of the present compounds to form pesticidal mixtures and synergistic mixtures thereof. The fungicidal compounds of the present disclosure may be applied in conjunction with one or more herbicides to control a wide variety of undesirable plants. When used in conjunction with herbicides, the presently claimed compounds may be formulated with the herbicide(s), tank-mixed with the herbicide(s) or applied sequentially with the herbicide(s). Typical herbicides include, but are not limited to: 4-CPA; 4-CPB; 4-CPP; 2,4-D; 3,4-DA; 2,4-DB; 3,4-DB; 2,4-DEB; 2,4-DEP; 3,4-DP; 2,3,6-TBA; 2,4,5-T; 2,4,5-TB; acetochlor, acifluorfen, aclonifen, acrolein, alachlor, allidochlor, alloxydim, allyl alcohol, alorac, ametridione, ametryn, amibuzin, amicarbazone, amidosulfuron, aminocyclopyrachlor, aminopyralid, amiprofos-methyl, amitrole, ammonium sulfamate, anilofos, anisuron, asulam, atraton, atrazine, azafenidin, azimsulfuron, aziprotryne, barban, BCPC, beflubutamid, benazolin, bencarbazone, benfluralin, benfuresate, bensulfuron, bensulide, bentazone, benzadox, benzfendizone, benzipram, benzobicyclon, benzofenap, benzofluor, benzoylprop, benzthiazuron, bicyclopyrone, bifenox, bilanafos, bispyribac, borax, bromacil, bromobonil, bromobutide, bromofenoxim, bromoxynil, brompyrazon, butachlor, butafenacil, butamifos, butenachlor, buthidazole, buthiuron, butralin, butroxydim, buturon, butylate, cacodylic acid, cafenstrole, calcium chlorate, calcium cyanamide, cambendichlor, carbasulam, carbetamide, carboxazole chlorprocarb, carfentrazone, CDEA, CEPC, chlomethoxyfen, chloramben, chloranocryl, chlorazifop, chlorazine, chlorbromuron, chlorbufam, chloreturon, chlorfenac, chlorfenprop, chlorflurazole, chlorflurenol, chloridazon, chlorimuron, chlornitrofen, chloropon, chlorotoluron, chloroxuron, chloroxynil, chlorpropham, chlorsulfuron, chlorthal, chlorthiamid, cinidon-ethyl, cinmethylin, cinosulfuron, cisanilide, clethodim, cliodinate, clodinafop, clofop, clomazone, clomeprop, cloprop, cloproxydim, clopyralid, cloransulam, CMA, copper sulfate, CPMF, CPPC, credazine, cresol, cumyluron, cyanatryn, cyanazine, cycloate, cyclosulfamuron, cycloxydim, cycluron, cyhalofop, cyperquat, cyprazine, cyprazole, cypromid, daimuron, dalapon, dazomet, delachlor, desmedipham, desmetryn, di-allate, dicamba, dichlobenil, dichloralurea, dichlormate, dichlorprop, dichlorprop-P, diclofop, diclosulam, diethamquat, diethatyl, difenopenten, difenoxuron, difenzoquat, diflufenican, diflufenzopyr, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimexano, dimidazon, dinitramine, dinofenate, dinoprop, dinosam, dinoseb, dinoterb, diphenamid, dipropetryn, diquat, disul, dithiopyr, diuron, DMPA, DNOC, DSMA, EBEP, eglinazine, endothal, epronaz, EPTC, erbon, esprocarb, ethalfluralin, ethametsulfuron, ethidimuron, ethiolate, ethofumesate, ethoxyfen, ethoxysulfuron, etinofen, etnipromid, etobenzanid, EXD, fenasulam, fenoprop, fenoxaprop, fenoxaprop-P, fenoxasulfone, fenteracol, fenthiaprop, fentrazamide, fenuron, ferrous sulfate, flamprop, flamprop-M, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazolate, flucarbazone, flucetosulfuron, fluchloralin, flufenacet, flufenican, flufenpyr, flumetsulam, flumezin, flumiclorac, flumioxazin, flumipropyn, fluometuron, fluorodifen, fluoroglycofen, fluoromidine, fluoronitrofen, fluothiuron, flupoxam, flupropacil, flupropanate, flupyrsulfuron, fluridone, flurochloridone, fluroxypyr, flurtamone, fluthiacet, fomesafen, foramsulfuron, fosamine, furyloxyfen, glufosinate, glufosinate-P, glyphosate, halauxifen, halosafen, halosulfuron, haloxydine, haloxyfop, haloxyfop-P, hexachloroacetone, hexaflurate, hexazinone, imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr, imazosulfuron, indanofan, indaziflam, iodobonil, iodomethane, iodosulfuron, ioxynil, ipazine, ipfencarbazone, iprymidam, isocarbamid, isocil, isomethiozin, isonoruron, isopolinate, isopropalin, isoproturon, isouron, isoxaben, isoxachlortole, isoxaflutole, isoxapyrifop, karbutilate, ketospiradox, lactofen, lenacil, linuron, MAA, MAMA, MCPA, MCPA-thioethyl, MCPB, mecoprop, mecoprop-P, medinoterb, mefenacet, mefluidide, mesoprazine, mesosulfuron, mesotrione, metam, metamifop, metamitron, metazachlor, metazosulfuron, metflurazon, methabenzthiazuron, methalpropalin, methazole, methiobencarb, methiozolin, methiuron, methometon, methoprotryne, methyl bromide, methyl isothiocyanate, methyldymron, metobenzuron, metobromuron, metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, molinate, monalide, monisouron, monochloroacetic acid, monolinuron, monuron, morfamquat, MSMA, naproanilide, napropamide, naptalam, neburon, nicosulfuron, nipyraclofen, nitralin, nitrofen, nitrofluorfen, norflurazon, noruron, OCH, orbencarb, ortho-dichlorobenzene, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxapyrazon, oxasulfuron, oxaziclomefone, oxyfluorfen, parafluron, paraquat, pebulate, pelargonic acid, pendimethalin, penoxsulam, pentachlorophenol, pentanochlor, pentoxazone, perfluidone, pethoxamid, phenisopham, phenmedipham, phenmedipham-ethyl, phenobenzuron, phenylmercury acetate, picloram, picolinafen, pinoxaden, piperophos, potassium arsenite, potassium azide, potassium cyanate, pretilachlor, primisulfuron, procyazine, prodiamine, profluazol, profluralin, profoxydim, proglinazine, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propyrisulfuron, propyzamide, prosulfalin, prosulfocarb, prosulfuron, proxan, prynachlor, pydanon, pyraclonil, pyraflufen, pyrasulfotole, pyrazolynate, pyrazosulfuron, pyrazoxyfen, pyribenzoxim, pyributicarb, pyriclor, pyridafol, pyridate, pyriftalid, pyriminobac, pyrimisulfan, pyrithiobac, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quinonamid, quizalofop, quizalofop-P, rhodethanil, rimsulfuron, saflufenacil, S-metolachlor, sebuthylazine, secbumeton, sethoxydim, siduron, simazine, simeton, simetryn, SMA, sodium arsenite, sodium azide, sodium chlorate, sulcotrione, sulfallate, sulfentrazone, sulfometuron, sulfosulfuron, sulfuric acid, sulglycapin, swep, TCA, tebutam, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbuchlor, terbumeton, terbuthylazine, terbutryn, tetrafluron, thenylchlor, thiazafluron, thiazopyr, thidiazimin, thidiazuron, thiencarbazone-methyl, thifensulfuron, thiobencarb, tiocarbazil, tioclorim, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam, tribenuron, tricamba, triclopyr, tridiphane, trietazine, trifloxysulfuron, trifluralin, triflusulfuron, trifop, trifopsime, trihydroxytriazine, trimeturon, tripropindan, tritac, tritosulfuron, vernolate, and xylachlor.

[0050] Another embodiment of the present disclosure is a method for the control or prevention of fungal attack. This method comprises applying to the soil, plant, roots, foliage, or locus of the fungus, or to a locus in which the infestation is to be prevented (for example applying to cereal or grape plants), a fungicidally effective amount of one or more of the compounds of Formula I. The compounds are suitable for treatment of various plants at fungicidal levels, while exhibiting low phytotoxicity. The compounds may be useful both in a protectant and/or an eradicant fashion.

[0051] The compounds have been found to have significant fungicidal effect particularly for agricultural use. Many of the compounds are particularly effective for use with agricultural crops and horticultural plants.

[0052] It will be understood by those skilled in the art that the efficacy of the compound for the foregoing fungi establishes the general utility of the compounds as fungicides.

[0053] The compounds have broad ranges of activity against fungal pathogens. Exemplary pathogens may include, but are not limited to, causing agent of wheat leaf blotch (Zymoseptoria tritici), wheat brown rust (Puccinia triticina), wheat stripe rust (Puccinia striiformis), scab of apple (Venturia inaequalis), powdery mildew of grapevine (Uncinula necator), barley scald (Rhynchosporium secalis), blast of rice (Pyricularia oryzae), rust of soybean (Phakopsora pachyrhizi), glume blotch of wheat (Leptosphaeria nodorum), powdery mildew of wheat (Blumeria gramninis f. sp. tritici), powdery mildew of barley (Blumeria gramninis f. sp. hordei), powdery mildew of cucurbits (Erysiphe cichoracearum), anthracnose of cucurbits (Colletotrichum lagenarium), leaf spot of beet (Cercospora beticola), early blight of tomato (Alternaria solani), and spot blotch of barley (Cochliobolus sativus). The exact amount of the active material to be applied is dependent not only on the specific active material being applied, but also on the particular action desired, the fungal species to be controlled, and the stage of growth thereof, as well as the part of the plant or other product to be contacted with the compound. Thus, all the compounds, and formulations containing the same, may not be equally effective at similar concentrations or against the same fungal species.

[0054] The compounds are effective in use with plants in a disease-inhibiting and phytologically acceptable amount. The term “disease-inhibiting and phytologically acceptable amount” refers to an amount of a compound that kills or inhibits the plant disease for which control is desired, but is not significantly toxic to the plant. This amount will generally be from about 0.1 to about 1000 ppm (parts per million), with 1 to 500 ppm being preferred. The exact concentration of compound required varies with the fungal disease to be controlled, the type of formulation employed, the method of application, the particular plant species, climate conditions, and the like. A suitable application rate is typically in the range from about 0.10 to about 4 pounds/acre (about 0.01 to 0.45 grams per square meter, g/m.sup.2).

[0055] Any range or desired value given herein may be extended or altered without losing the effects sought, as is apparent to the skilled person for an understanding of the teachings herein.

[0056] The compounds of Formula I may be made using well-known chemical procedures. Intermediates not specifically mentioned in this disclosure are either commercially available, may be made by routes disclosed in the chemical literature, or may be readily synthesized from commercial starting materials utilizing standard procedures.

General Schemes

[0057] The following schemes illustrate approaches to generating picolinamide compounds of Formula (I). The following descriptions and examples are provided for illustrative purposes and should not be construed as limiting in terms of substituents or substitution patterns.

[0058] Compounds of Formulae 1.1, 1.2, 1.3, and 1.4, wherein R.sub.3 is as originally defined, can be prepared by the methods shown in Scheme 1, steps a-c. Compounds of Formula 1.0, wherein Z is ethoxy (—OCH.sub.2CH.sub.3, OEt) or pyrrolidine and P.G. is Bn or PMB, can be treated with a mixture of an organometallic nucleophile, such as phenylmagnesium bromide or phenyllithium, and a reducing agent, such as lithium borohydride (LiBH.sub.4), in a polar, aprotic solvent such as tetrahydrofuran (THF) or diethyl ether (Et.sub.2O) at a reduced temperature of about −78° C. to about 0° C. to afford compounds of Formula 1.1, wherein R.sub.3 is as previously defined, as shown in step a. Alternatively, the compound of Formula 1.0, wherein Z is OEt and P.G. is Bn or PMB, can be converted to the aldehyde of Formula 1.2 by treating with a catalyst, such as chlorobis(cyclooctene)iridium(I) dimer (Ir.sub.2(coe).sub.4Cl.sub.2), and a reducing agent, such as diethylsilane (Et.sub.2SiH.sub.2), in a halogenated solvent such as dichloromethane (CH.sub.2Cl.sub.2), as described by Cheng, C.; Brookhart, M. Angew. Chem. Int. Ed. 2012, 51, 9422-9424 and shown in step b. Compounds of Formulas 1.3 and 1.4, wherein R.sub.3 is as previously defined, can be obtained by treating the aldehyde of Formula 1.2 with a carbon nucleophile, such as phenyl magnesium bromide, in a polar aprotic solvent, such as THF, at a reduced temperature of about −78° C. to about 23° C., as depicted in step c.

##STR00004##

[0059] Compounds of Formulas 2.1, 2.2 and 2.3, wherein R.sub.3 is as originally defined, can be obtained using the methods outlined in Scheme 2, steps a-d. Compounds of Formula 2.1, wherein R.sub.3 is as previously defined and R.sub.4 is aryl, can be prepared by treating solutions of compounds of Formula 2.0, wherein R.sub.3 is as originally defined, in a solvent such as toluene, with an organometallic species, such as bis(acetato-O)triphenyl-bismuth(V) (Ph.sub.3Bi(OAc).sub.2), in the presence of a catalyst, such as copper(II) acetate (Cu(OAc).sub.2), at an elevated temperature of about 50° C., as shown in step a. Alternatively, arylated products of Formula 2.1, wherein R.sub.3 is as previously defined, can be prepared by treating compounds of Formula 2.0, wherein R.sub.3 is as previously defined, with an aryl fluoride, such as 1,3-difluorobenzene, and an alkoxide base, such as potassium tert-butoxide (KOt-Bu) or sodium hydride (NaH), in a polar aprotic solvent, such as N,N-dimethyl formamide (DMF) or dimethyl sulfoxide (DMSO), at an elevated temperature of about 50° C. to about 70° C., as shown in step b. Compounds of Formula 2.2, wherein R.sub.3 is as previously defined and R.sub.4 is alkyl, can be prepared from compounds of Formula 2.0, wherein R.sub.3 is as previously defined, by treating with a base, such as KOt-Bu or NaH, and an electrophile, such as an alkyl halide such as (bromomethyl)cyclopropane, in a polar aprotic solvent such as DMF, at an elevated temperature of about 50° C., as shown in step c. Compounds of Formula 2.3, wherein R.sub.3 is as previously defined and R.sub.4 is acyl, can be prepared from compounds of Formula 2.0, by treating with an acyl electrophile, such as an acyl chloride, in a pyridine solvent at ambient temperature as shown in step d.

##STR00005##

[0060] Compounds of Formula 3.2, wherein R.sub.4 and R.sub.8 are as originally defined, can be prepared according to the methods outlined in Scheme 3, steps a-c. Compounds of Formula 3.0, wherein R.sub.4 is as originally defined, can be subjected to a palladium catalyst, such as tetrakis(triphenylphosphine)palladium(0) (Pd(PPh.sub.3).sub.4), and a secondary amine, such as morpholine, in a polar aprotic solvent, such as THF, at a temperature of about 23° C. to afford compounds of Formula 3.1, wherein R.sub.4 is as originally defined, as shown in step a. Compounds of Formula 3.2, wherein R.sub.4 is as originally defined and R.sub.8 is alkyl, can be prepared from compounds of Formula 3.1, wherein R.sub.4 is as originally defined, by treatment with a base, such as potassium carbonate (K.sub.2CO.sub.3), and an alkyl bromide, such as (bromomethyl)cyclohexane, in a polar aprotic solvent, such as acetone, at a temperature of about 25° C. to about 50° C., as shown in step b. Additionally, compounds of Formula 3.2, wherein R.sub.4 is as originally defined and R.sub.8 is aryl, can be prepared from alcohols of Formula 3.1, wherein R.sub.4 is as previously defined, by treatment with a copper catalyst, such as Cu(OAc).sub.2, an aryl boronic acid, such as phenyl boronic acid, and a tertiary amine, such as triethylamine (NEt.sub.3), in a halogenated solvent, such as CH.sub.2Cl.sub.2, in the presence of 4 Å molecular sieves at a temperature of approximately 23° C., as described by Nie, Z.; Perretta, C.; Lu, J.; Su, Y.; Margosiak, S.; Gajiwala, K. S.; Cortez, J.; Nikulin, V.; Yager, K. M.; Appelt, K.; Chu, S. J. Med. Chem., 2005, 48 (5), pp 1596-1609, and shown in step c.

##STR00006##

[0061] Compounds of Formula 4.2, wherein R.sub.3 and R.sub.4 are as originally defined, can be prepared according to the methods outlined in Scheme 4, steps a-c. Compounds of Formula 4.2, wherein R.sub.3 and R.sub.4 are as previously defined but not alkenyl, can be prepared by treating compounds of Formula 4.0, wherein R.sub.3 and R.sub.4 are originally defined, with a catalyst, such as palladium on carbon (Pd/C), in the presence of hydrogen gas (H.sub.2) in a polar solvent, such as ethyl acetate (EtOAc) or MeOH, or with an alternate source of hydrogen, such as cyclohexene, in a polar solvent such as EtOH, as shown in step a. Additionally, compounds of Formula 4.0, wherein R.sub.3 is as previously defined and R.sub.4 is an aryl chloride, can be subjected to modified hydrogenolysis conditions, by exposing an EtOH solution of the aryl chloride to H.sub.2 in the presence of Pd/C and NEt.sub.3 to afford compounds of Formula 4.2, wherein R.sub.3 and R.sub.4 are as originally defined, but not alkenyl or chloro, as shown in step b. Compounds of Formula 4.2, wherein R.sub.3 and R.sub.4 are as originally defined, can be obtained by treating compounds of Formula 4.1, wherein R.sub.3 and R.sub.4 are as originally defined, with an oxidant, such as 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), in a solvent mixture, such as aqueous CH.sub.2Cl.sub.2, as indicated in step c.

##STR00007##

[0062] Compounds of Formula 5.2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12, are as originally defined, can be prepared according to the method outlined in Scheme 5, step a. Alcohols of Formula 5.0, wherein R.sub.2, R.sub.3, R.sub.4, and R.sub.12, are as originally defined, can be treated with compounds of Formula 5.1, wherein R.sub.1 and R.sub.11 are as originally defined, a coupling reagent, such as 3-(ethyliminomethyleneamino)-N,N-dimethylpropan-1-amine hydrochloride (EDC) or a polymer-supported carbodiimide (PS-CDI), and a catalyst, such as N,N-dimethylpyridin-4-amine (DMAP), in a halogenated solvent, such as CH.sub.2Cl.sub.2, to afford compounds of Formula 5.2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12 are as previously defined, as shown in step a.

##STR00008##

[0063] Compounds of Formula 6.4, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.11, and R.sub.12 are as originally defined, can be prepared according to the methods outlined in Scheme 6, steps a-d. Compounds of Formula 6.0, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12 are as originally defined, but not alkenyl, can be treated with an acid, such as a 4 N solution of HCl in dioxane, in a halogenated solvent such as CH.sub.2Cl.sub.2 to afford compounds of Formula 6.1, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12, are as originally defined, but not alkenyl, as shown in step a. Compounds of Formula 6.2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12 are as originally defined, can be prepared by treating compounds of Formula 6.0, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12 are as originally defined, with an acid, such as 2,2,2-trifluoroacetic acid, in a halogenated solvent such as CH.sub.2Cl.sub.2, as shown in step b. Compounds of Formulas 6.1 and 6.2, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.11, and R.sub.12 are as originally defined, can be treated with compounds of Formula 6.3, wherein R.sub.6 is as originally defined, in the presence of a base, such as diisopropylethylamine, and a peptide coupling reagent, such as benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) or O-(7-azabenzo-triazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU), in an halogenated solvent such as CH.sub.2Cl.sub.2, to afford compounds of Formula 6.4, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.11, and R.sub.12 are as previously defined, as shown in step c.

##STR00009##

[0064] Compounds of Formula 7.1, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.6, R.sub.11, and R.sub.12 are as originally defined, but not alkenyl, and R.sub.8 is as originally defined, but not alkenyl or chloro, can be prepared according to the method outlined in Scheme 7, step a. Compounds of Formula 7.0, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.6, R.sub.8, R.sub.11, and R.sub.12 are as originally defined, can be subjected to the hydrogenation conditions described in Scheme 4, step b to afford compounds of Formula 7.1, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.6, R.sub.8, R.sub.11, and R.sub.12 are as previously defined, as depicted in step a.

##STR00010##

[0065] Compounds of Formula 8.1, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.7, R.sub.11, and R.sub.12 are as originally defined, can be prepared according to the method outlined in Scheme 8, steps a or b. Compounds of Formula 8.0, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.11, and R.sub.12 are as previously defined, can be treated with an appropriate alkyl halide with or without a reagent such as sodium iodide (NaI) and an alkali carbonate base, such as Na.sub.2CO.sub.3 or potassium carbonate (K.sub.2CO.sub.3), in a solvent such as acetone, as shown in step a. Or, alternatively, by treatment with an acyl halide or anhydride in the presence of an amine base, such as pyridine, NEt.sub.3, DMAP, or mixtures thereof, in an aprotic solvent, such as CH.sub.2Cl.sub.2, to afford compounds of Formula 8.1, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.6, R.sub.7, R.sub.11, and R.sub.12 are as previously defined, as shown in step b.

##STR00011##

[0066] Compounds of Formula 9.1 and 9.2, wherein R.sub.1, R.sub.2, R.sub.4, R.sub.6, R.sub.11, and R.sub.12 are as originally defined, but not alkenyl, and R.sub.8 is as originally defined, but not allyloxy or alkenyl, can be prepared according to the method outlined in Scheme 9, step a. Compounds of Formula 9.0, wherein R.sub.1, R.sub.2, R.sub.4, R.sub.6, R.sub.8, R.sub.11, and R.sub.12 are as originally defined, can be treated with a ruthenium catalyst, such as ruthenium trichloride n-hydrate, and a hydride source, such as sodium borohydride (NaBH.sub.4), in a polar aprotic solvent, such as THF, in the presence of water, at a temperature of about 0° C. to afford compounds of Formula 9.1 and 9.2, as described by Sharma, P. K.; Kumar, S.; Kumar, P.; Nielson, P. Tet. Lett. 2012, 48, 8704-8708 and shown in step a.

##STR00012##

[0067] Compounds of Formula 10.3, wherein R.sub.2, R.sub.3, R.sub.4 and R.sub.12 are as originally defined, can be prepared according to the methods outlined in Scheme 10, steps a-c. Compounds of Formula 10.0, wherein R.sub.3 is as originally defined, can be transformed into a Grignard reagent by being subjected to magnesium metal in the presence of a lithium salt, such as lithium chloride (LiCl) in a polar aprotic solvent, such as THF, at an elevated temperature of about 70° C. The subsequent Grignard reagent can then be subjected to an iron catalyst, such as tris(acetylacetonato) iron(III) (Fe(acac).sub.3), and an alkyl chloride, such as allyl chloride, in a polar aprotic solvent, such as THF, at an elevated temperature of about 70° C. to afford compounds of Formula 10.1, wherein R.sub.2, R.sub.3, R.sub.12 are as originally defined, as described by Mayer, M.; Welther, A.; von Wangelin, A. J. ChemCatChem, 2011, 3, pp 1567-1571, and as shown in step a. Compounds of Formula 10.2, wherein R.sub.2, R.sub.3, and R.sub.12 are as originally defined, can be prepared from compounds of Formula 10.1, wherein R.sub.2, R.sub.3, and R.sub.12 are as originally defined, by treatment with an ammonium salt such as tetra n-butylammonium hydrogen sulfate, an epoxidation catalyst, such as 1,2:4,5-Bis-O-(isopropylidene)-β-L-erythro-2,3-hexodiulo-2,6-pyranose (Shi epoxidation catalyst enantiomer), a buffer solution, such as 0.05 M Na.sub.2B.sub.4O.sub.7-10H.sub.2O in 4×10.sup.−4 M aqueous Na.sub.2(EDTA), in a polar aprotic solvent, such as acetonitrile, at a temperature of about 0° C. Followed by slow addition of an oxidant such as Oxone in a solution of Na.sub.2(EDTA) and simultaneous slow addition of a solution of a base such as K.sub.2CO.sub.3 in water as described by Wang, Z.-X.; Tu, Y.; Frohn, M.; Zhang, J.-R.; Shi, Y. J. Am. Chem. Soc, 1997, 119, pp 11224-11235, and as shown in step b. Additionally, compounds of Formula 10.3, wherein R.sub.2, R.sub.3, R.sub.4 and R.sub.12 are as originally defined, can be prepared from epoxides of Formula 10.2, wherein R.sub.2, R.sub.3, R.sub.12 are as previously defined, by treatment with an acid, such as sulfuric acid (H.sub.2SO.sub.4) in a mixture of an alcohol substituted with R.sub.4 wherein R.sub.4 is as previously defined, such as cyclopropanol, at a reduced temperature of about 0° C., as described by Aggarwal, V. K; Bae, I; Lee, H.-Y. Tetrahedron, 2006, 60 (43), pp 9725-9733, and shown in step c.

##STR00013##

EXAMPLES

Example 1A: Preparation of (1R,2S)-1-(4-fluorophenyl)-2-((4-methoxybenzyl)oxy)propan-1-ol

[0068] ##STR00014##

[0069] To a solution of (4-fluorophenyl)magnesium bromide (7.08 mL, 5.67 mmol) and lithium borohydride (LiBH.sub.4) (2.83 mL, 5.67 mmol, 2.0 molar (M) in THF) in anhydrous Et.sub.2O (11.45 mL) at −15° C. was added (S)-ethyl 2-((4-methoxybenzyl)oxy)propanoate (1.35 g, 5.67 mmol) as a 1M solution in anhydrous Et.sub.2O (5.67 mL) via addition funnel over approximately a 40 minute (min) period at a rate that maintained an internal temperature between −7 and −15° C. The reaction vessel was allowed to slowly warm to room temperature (rt) overnight. The reaction mixture was cooled to 0° C. and quenched via slow addition of saturated aqueous ammonium chloride (NH.sub.4Cl, 25 mL) followed by water (H.sub.2O, 25 mL). The mixture was transferred to a separatory funnel, and the aqueous (aq.) phase was extracted with Et.sub.2O (3×50 mL). The combined organic phases were dried over magnesium sulfate (MgSO.sub.4), filtered, and concentrated. The resulting residue was purified by flash column chromatography (silica gel (SiO.sub.2), 5-25% acetone in hexanes) to afford the title compound (214 mg, 13%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.33-7.27 (m, 2H), 7.25-7.21 (m, 2H), 7.05-6.98 (m, 2H), 6.91-6.86 (m, 2H), 4.85 (t, J=3.3 Hz, 1H), 4.57 (d, J=11.4 Hz, 1H), 4.46 (d, J=11.4 Hz, 1H), 3.81 (s, 3H), 3.69 (qd, J=6.3, 4.0 Hz, 1H), 2.53 (d, J=2.9 Hz, 1H), 1.02 (d, J=6.3 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −115.49 (s); ESIMS m/z 603 ([2M+Na].sup.+).

Example 1B: Preparation of (S)-2-((4-methoxybenzyl)oxy)propanal

[0070] ##STR00015##

[0071] To a solution of (S)-ethyl 2-((4-methoxybenzyl)oxy)propanoate (5.00 g, 21.0 mmol) in CH.sub.2Cl.sub.2 (30 mL) at 0° C. was added chlorobis(cyclooctene)iridium(I) dimer (Ir.sub.2Cl.sub.2(coe).sub.4); 94.0 milligrams (mg), 0.105 mmol) followed by diethylsilane (Et.sub.2SiH.sub.2; 4.08 mL, 31.5 mmol) over 10 min. The mixture was stirred at 0° C. for 30 min, then was warmed to rt and stirred for 3 h. The reaction mixture was cooled to 0° C. and quenched by adding 1 normal (N) aq. hydrogen chloride (HCl; 12 mL). The resulting solution was warmed to rt and stirred for 15 min. The phases were separated, and the aq. phase was extracted with CH.sub.2Cl.sub.2 (3×30 mL). The combined organic phases were washed with brine, dried over sodium sulfate (Na.sub.2SO.sub.4), filtered, evaporated, and purified by flash column chromatography (SiO.sub.2, 2.fwdarw.50% acetone in hexanes) to afford the title compound (4.27 g, 100%) as a yellow oil: IR (Thin Film) 2934, 2837, 2865, 1731, 1512 cm.sup.−1; .sup.1H NMR (300 MHz, CDCl.sub.3) δ 9.64 (d, J=1.9 Hz, 1H), 7.35-7.21 (m, 2H), 6.95-6.79 (m, 2H), 4.63-4.40 (m, 2H), 3.94-3.76 (m, 1H), 3.81 (s, 3H), 1.31 (d, J=6.9 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 203.58, 159.54, 129.65, 129.37, 113.98, 79.14, 71.75, 55.30, 15.34.

Example 1C: Preparation of (1S,2S)-2-((4-methoxybenzyl)oxy)-1-phenylpropan-1-ol

[0072] ##STR00016##

[0073] To a solution of (S)-2-((4-methoxybenzyl)oxy)propanal (3.38 g, 17.4 mmol) in Et.sub.2O (58 mL) at −78° C. was added phenylmagnesium bromide (34.8 mL, 34.8 mmol, 1 M in THF) dropwise. The reaction mixture was stirred and allowed to warm to rt overnight. The reaction was quenched by addition of sat. aq. ammonium chloride (NH.sub.4Cl). The mixture was partitioned between H.sub.2O and EtOAc, the phases were separated, and the aqueous phase was extracted with EtOAc (2×). The combined organic phases were washed with brine, dried over Na.sub.2SO.sub.4, filtered and concentrated. Purification via flash column chromatography (SiO.sub.2, 2.fwdarw.50% acetone in hexanes) afforded an inseparable mixture of diastereomers (d.r. 3:1 SS:RS) of the title compound (3.29 g, 66%) as a yellow oil: .sup.1H NMR (400 MHz, CDCl.sub.3; major) δ 7.37-7.25 (m, 7H), 6.89 (d, J=8.6 Hz, 2H), 4.62 (d, J=11.0 Hz, 1H), 4.44 (dd, J=7.8, 2.1 Hz, 1H), 4.41 (d, J=11.0 Hz, 1H), 3.82 (s, 3H), 3.60 (dq, J=7.8, 6.2 Hz, 1H), 3.21 (d, J=2.1 Hz, 1H), 1.05 (d, J=6.2 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 159.34, 140.56, 130.21, 129.46, 128.31, 127.25, 126.31, 113.93, 79.66, 78.32, 70.92, 55.30, 15.56; ESIMS m/z 295 ([M+Na].sup.+).

Example 1D: Preparation of (1S,2S)-2-((4-methoxybenzyl)oxy)-1-(thiophen-2-yl)propan-1-ol and (1R,2S)-2-((4-methoxybenzyl)oxy)-1-(thiophen-2-yl)propan-1-ol

[0074] ##STR00017##

[0075] To a solution of thiophen-2-yllithium (4.00 mL, 4.00 mmol, 1 M in THF) and lithium borohydride (LiBH.sub.4; 1.30 mL, 2.60 mmol, 2 M in THF) in THF (10 mL) at −10° C. was added neat (S)-2-((4-methoxybenzyl)oxy)-1-(pyrrolidin-1-yl)propan-1-one (0.527 g, 2.00 mmol) (for preparation see: Pellicena, M.; Solsona, J. G.; Romea, P.; Urpi, F. Tetrahedron 2012, 68, 10338.) dropwise via syringe pump addition over approximately a 1 h period, at a rate which maintained the internal temperature below −5° C. The reaction vessel was allowed to slowly warm to rt overnight. The reaction mixture was quenched by addition of sat. aq. NH.sub.4Cl. The aqueous phase was extracted with Et.sub.2O (3×). The combined organic phases were washed with brine, dried over Na.sub.2SO.sub.4, filtered, and concentrated. Purification via flash column chromatography (SiO.sub.2, 2.fwdarw.10% acetone in hexanes) afforded the title compounds (0.231 g, 41% and 0.175 g, 31%, respectively) as colorless oils: major: .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.32-7.21 (m, 3H), 7.05-6.93 (m, 2H), 6.94-6.83 (m, 2H), 5.03 (t, J=4.2 Hz, 1H), 4.61 (d, J=11.4 Hz, 1H), 4.48 (d, J=11.3 Hz, 1H), 3.81 (s, 3H), 3.88-3.73 (m, 1H), 2.59 (d, J=4.4 Hz, 1H), 1.13 (d, J=6.3 Hz, 3H); ESIMS m/z 579 ([2M+Na].sup.+); minor: .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.34-7.22 (m, 3H), 7.06-6.92 (m, 2H), 6.95-6.84 (m, 2H), 4.73 (dd, J=7.3, 2.7 Hz, 1H), 4.63 (d, J=10.9 Hz, 1H), 4.44 (d, J=11.0 Hz, 1H), 3.82 (s, 3H), 3.67 (dq, J=7.3, 6.2 Hz, 1H), 3.29 (d, J=2.8 Hz, 1H), 1.14 (d, J=6.1 Hz, 3H); ESIMS m/z 579 ([2M+Na].sup.+).

Example 1E: Preparation of (1R,2S)-1-(4-fluoro-2-methoxyphenyl)-2-((4-methoxybenzyl)oxy)propan-1-ol

[0076] ##STR00018##

[0077] To a reaction flask was added 1-bromo-4-fluoro-2-methoxybenzene (0.4 g, 1.951 mmol) and dry diethyl ether (9.75 ml). The flask was sealed, evacuated and backfilled with nitrogen, and cooled to −78° C. Then, n-BuLi (2.5 M in hexanes, 0.780 ml, 1.951 mmol) was added to the reaction, and the reaction mixture was stirred at −78° C. for 1 h. LiBH.sub.4 (2.0M in THF, 0.975 ml, 1.951 mmol) was added, followed by dropwise addition of (S)-ethyl 2-((4-methoxybenzyl)oxy)propanoate (0.465 g, 1.951 mmol) as a 0.5 M solution in dry diethyl ether. The reaction was allowed to gradually warm to rt as the cooling bath expired overnight. The reaction was quenched by careful addition of 2 mL sat. aq. NH.sub.4Cl (gas evolution noted), and allowed to stir for 30 min. At this point the mixture was transferred to a separatory funnel containing water and extracted 3× with diethyl ether. The combined organic layers were dried over MgSO.sub.4, filtered and concentrated in vacuo. The resulting residue was purified via flash chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (290 mg, 46%) as a colorless oil. .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.42 (dd, J=8.1, 7.2 Hz, 1H), 7.27-7.21 (m, 2H), 6.91-6.85 (m, 2H), 6.66 (td, J=8.4, 2.4 Hz, 1H), 6.55 (dd, J=10.9, 2.4 Hz, 1H), 5.15 (t, J=3.5 Hz, 1H), 4.57 (d, J=11.6 Hz, 1H), 4.50 (d, J=11.6 Hz, 1H), 3.86-3.78 (m, 4H), 3.76 (s, 3H), 2.65 (dd, J=3.4, 2.0 Hz, 1H), 1.00 (d, J=6.4 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 162.88 (d, J=244.4 Hz), 159.19, 157.03 (d, J=9.6 Hz), 130.66, 129.30, 128.47 (d, J=9.9 Hz), 124.48 (d, J=3.2 Hz), 113.76, 106.79 (d, J=20.9 Hz), 98.43 (d, J=25.9 Hz), 75.79 (d), 70.35, 69.97, 55.45, 55.30, 13.46; ESIMS m/z 663 ([2M+Na].sup.+).

Example 2A: Preparation of 1-methoxy-2-((1R,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)benzene

[0078] ##STR00019##

[0079] To a solution of (1R,2S)-2-((4-methoxybenzyl)oxy)-1-(2-methoxyphenyl)propan-1-ol (500 mg, 1.654 mmol), N-cyclohexyl-N-methylcyclohexanamine (531 μl, 2.480 mmol) and Cu(OAc).sub.2 (60.1 mg, 0.331 mmol) in toluene (8.267 mL) was added Ph.sub.3Bi(OAc).sub.2 (1385 mg, 2.480 mmol). The resulting blue suspension was heated to and stirred at 50° C. for 16 h. The reaction was cooled to rt, filtered through a plug of Celite™, and concentrated. The resulting crude material was purified via flash column chromatography (SiO.sub.2, 0.fwdarw.30% acetone in hexanes) to give the title compound (555 mg, 67%) as a yellow oil: .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.41-7.33 (m, 3H), 7.18 (q, J=8.2 Hz, 5H), 7.08 (d, J=8.0 Hz, 1H), 6.89-6.81 (m, 7H), 5.73 (d, J=3.5 Hz, 1H), 4.60-4.49 (m, 2H), 3.88-3.82 (m, 4H), 3.79 (s, 3H), 1.25 (d, J=6.4 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 158.98, 158.27, 156.42, 129.42, 129.18, 128.47, 127.69, 125.82, 121.56, 120.76, 120.46, 115.71, 113.59, 110.12, 76.32, 75.29, 70.61, 55.38, 55.27, 14.75; ESIMS m/z 779 ([2M+Na].sup.+).

Example 2B: Preparation of 2-chloro-1-((1R,2S)-1-(4-fluoro-2-methoxyphenyl)-2-((4-methoxybenzyl)oxy)propoxy)-4-methylbenzene

[0080] ##STR00020##

[0081] To a solution of (1R,2S)-1-(4-fluoro-2-methoxyphenyl)-2-((4-methoxybenzyl)oxy)propan-1-ol (190 mg, 0.593 mmol) in anhydrous DMSO (2.97 mL) was added NaH (29.7 mg, 0.741 mmol, 60 wt % in mineral oil). After stirring for 10 min, 2-chloro-1-fluoro-4-methylbenzene (686 mg, 4.74 mmol) was added, and the reaction mixture was heated to 60° C. for 15 h. The reaction was quenched by slow addition of H.sub.2O. The mixture was extracted Et.sub.2O (3×50 mL) and the combined organic layers were dried by passing through a phase separator. Volatiles were removed under a gentle stream of N.sub.2 and the resulting residue was purified via flash column chromatography (SiO.sub.2, 0.fwdarw.30% acetone in hexanes) to afford the title compound (217 mg, 82%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.34 (dd, J=9.2, 6.8 Hz, 1H), 7.19 (d, J=8.7 Hz, 2H), 7.14 (d, J=1.7 Hz, 1H), 6.85-6.77 (m, 3H), 6.62-6.55 (m, 3H), 5.63 (d, J=3.8 Hz, 1H), 4.63 (d, J=11.9 Hz, 1H), 4.57 (d, J=11.9 Hz, 1H), 3.89 (qd, J=6.4, 3.9 Hz, 1H), 3.83 (s, 3H), 3.79 (s, 3H), 2.19 (s, 3H), 1.25 (d, J=6.4 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ×−112.06 (s); ESIMS m/z 467 ([M+Na].sup.+).

Example 2C: Preparation of 4-((1R,2S)-2-(benzyloxy)-1-(cyclopropylmethoxy)-propyl)-1,1′-biphenyl

[0082] ##STR00021##

[0083] To a solution of (1R,2S)-1-([1,1′-biphenyl]-4-yl)-2-(benzyloxy)propan-1-ol (272 mg, 0.854 mmol) in anhydrous DMF (2.8 mL) at 0° C. was added sodium hydride (NaH; 59.8 mg, 1.50 mmol, 60 wt % in mineral oil). The reaction mixture was stirred at 0° C. for 15 min. The mixture was removed from the ice bath, was stirred for 15 min, and then was recooled back to 0° C. The reaction was treated with (bromomethyl)cyclopropane (84 μL, 0.854 mmol) and was allowed to stir at 0° C. After 10 min, the reaction vessel was removed from the ice bath and the reaction mixture was allowed to stir and warm to rt overnight. The reaction mixture was carefully quenched by the addition of H.sub.2O. The crude reaction mixture was stirred for 10 min, and the phases were separated. The aq. phase was extracted with Et.sub.2O (3×), and the combined organic phases were dried over Na.sub.2SO.sub.4, filtered, and concentrated. The resulting oil was purified by flash column chromatography (SiO.sub.2, 0.fwdarw.10% acetone in hexanes) to afford the title compound (251 mg, 79%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.64-7.60 (m, 2H), 7.57 (d, J=8.2 Hz, 2H), 7.48-7.32 (m, 5H), 7.24-7.19 (m, 3H), 7.10-7.06 (m, 2H), 4.46 (d, J=11.9 Hz, 1H), 4.30 (d, J=11.9 Hz, 1H), 4.27 (d, J=6.4 Hz, 1H), 3.64 (p, J=6.2 Hz, 1H), 3.28-3.20 (m, 2H), 1.32 (d, J=6.2 Hz, 3H), 1.12-1.01 (m, 1H), 0.56-0.45 (m, 2H), 0.22-0.10 (m, 2H); .sup.13C NMR (101 MHz, CDCl3) δ 141.03, 140.33, 139.54, 138.60, 128.75, 128.18, 128.14, 127.67, 127.30, 127.18, 127.06, 126.73, 84.36, 78.56, 73.75, 71.47, 16.71, 10.74, 3.18, 2.83; ESIMS m/z 395 ([M+Na].sup.+).

Example 2D: Preparation (1R,2S)-1-(4-fluoro-2-methoxyphenyl)-2-((4-methoxybenzyl)oxy)propyl pivalate

[0084] ##STR00022##

[0085] To a solution of (1R,2S)-1-(4-fluoro-2-methoxyphenyl)-2-((4-methoxybenzyl)oxy)propan-1-ol (85 mg, 0.265 mmol)) in anhydrous pyridine (0.858 mL) at 25° C. was added pivaloyl chloride (65.3 μL, 0.531 mmol). The reaction mixture was stirred at 25° C. for 16 h. The reaction was diluted with toluene and volatiles were removed by rotary evaporation. The resulting oil was purified by flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (91 mg, 85%) as a colorless oil: .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.22 (dt, J=5.8, 2.9 Hz, 3H), 6.88-6.82 (m, 2H), 6.67-6.54 (m, 2H), 6.39 (d, J=3.3 Hz, 1H), 4.60 (d, J=11.6 Hz, 1H), 4.49 (d, J=11.6 Hz, 1H), 3.83-3.74 (m, 7H), 1.26 (s, 9H), 1.10 (d, J=6.5 Hz, 3H); .sup.19F NMR (471 MHz, CDCl.sub.3) δ −112.37-−112.55 (m); ESIMS m/z 427 ([M+Na].sup.+).

Example 3A: Preparation of 5-fluoro-2-((1R,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)phenol

[0086] ##STR00023##

[0087] To solution of 2-(allyloxy)-4-fluoro-1-((1R,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)benzene (294 mg, 0.696 mmol) and morpholine (72.8 μL, 0.835 mmol) in anhydrous THF (3.48 mL) was added Pd(PPh.sub.3).sub.4 (40.2 mg, 0.035 mmol). The mixture was stirred at 25° C. for 5 h, and then was quenched by the addition of water. The mixture was diluted with Et.sub.2O, transferred to a separatory funnel and washed with 1N HCl (3×50 mL). The organic layer was dried by passing through a phase separator, and the volatiles were removed in vacuo. The resulting residue was purified by flash column chromatography (SiO.sub.2, 5.fwdarw.15% acetone in hexanes) to afford the title compound (228 mg, 86%) as a viscous oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.01 (s, 1H), 7.18 (ddt, J=9.8, 4.7, 2.4 Hz, 4H), 7.07 (dd, J=8.5, 6.6 Hz, 1H), 6.91 (t, J=7.4 Hz, 1H), 6.86-6.79 (m, 4H), 6.61 (dd, J=10.3, 2.5 Hz, 1H), 6.54 (td, J=8.3, 2.6 Hz, 1H), 5.01 (d, J=6.3 Hz, 1H), 4.60 (d, J=11.2 Hz, 1H), 4.43 (d, J=11.2 Hz, 1H), 4.03 (p, J=6.2 Hz, 1H), 3.80 (s, 3H), 1.30 (d, J=6.2 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.86 (s); ESIMS m/z 381 ([M−H].sup.−).

Example 3B: Preparation of 2-(cyclopropylmethoxy)-4-fluoro-1-((1R,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)benzene

[0088] ##STR00024##

[0089] To a mixture of 5-fluoro-2-((1R,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)phenol (114 mg, 0.298 mmol), and K.sub.2CO.sub.3 (82 mg, 0.596 mmol) in acetone (1.49 mL) was added (bromomethyl)cyclopropane (43.4 μL, 0.447 mmol). The reaction mixture was stirred at 25° C. for 24 h. Potassium carbonate (82 mg, 0.596 mmol) and (bromomethyl)cyclopropane (43.4 μL, 0.447 mmol), and DMSO (1.49 mL) were then added to the reaction mixture. The reaction was stirred at 50° C. for 24 h at which point the volatiles were removed under a stream of nitrogen. The resulting residue was purified by flash column chromatography (SiO.sub.2, 0.fwdarw.30% acetone in hexanes) to afford the title compound (104 mg, 80%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.34-7.28 (m, 1H), 7.22-7.14 (m, 4H), 6.84 (dt, J=11.4, 8.1 Hz, 5H), 6.57 (dd, J=12.5, 6.0 Hz, 2H), 5.73 (d, J=3.3 Hz, 1H), 4.60 (s, 2H), 3.94-3.78 (m, 3H), 3.78 (s, 3H), 1.34-1.23 (m, 4H), 0.68-0.62 (m, 2H), 0.38 (q, J=4.8 Hz, 2H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.62 (s); ESIMS m/z 459 ([M+Na].sup.+).

Example 3C: Preparation of 1-((1R,2S)-1-(2-chlorophenoxy)-2-((4-methoxybenzyl)oxy)propyl)-4-fluoro-2-phenoxybenzene

[0090] ##STR00025##

[0091] To a solution of 2-((1R,2S)-1-(2-chlorophenoxy)-2-((4-methoxybenzyl)oxy)propyl)-5-fluorophenol (197 mg, 0.473 mmol), and phenylboronic acid (144 mg, 1.181 mmol) in anhydrous CH.sub.2Cl.sub.2 (2.36 mL) was added NEt.sub.3 (329 μL, 2.363 mmol), Cu(OAc).sub.2 (94 mg, 0.520 mmol) and 4 Å molecular sieves. The reaction mixture was stirred at 23° C. for 3 days (d), and then was filtered through Celite™ and concentrated. The resulting residue was purified by flash column chromatography (SiO.sub.2, 0.fwdarw.30% acetone in hexanes) to afford the title compound (102 mg, 44%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.50 (dd, J=8.6, 6.7 Hz, 1H), 7.35 (ddd, J=10.0, 7.8, 1.8 Hz, 3H), 7.18 (dd, J=17.1, 8.0 Hz, 3H), 7.07-7.01 (m, 1H), 7.01-6.97 (m, 2H), 6.84-6.70 (m, 5H), 6.46 (dd, J=10.1, 2.4 Hz, 1H), 5.77 (d, J=3.9 Hz, 1H), 4.64 (d, J=11.8 Hz, 1H), 4.58 (d, J=11.8 Hz, 1H), 4.05-3.97 (m, 1H), 3.77 (s, 3H), 1.33 (d, J=6.4 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −111.43 (d, J=2.1 Hz); ESIMS m/z 515 ([M+H].sup.+).

Example 4A: Preparation of (1R,2S)-1-([1,1′-biphenyl]-4-yl)-1-phenoxypropan-2-ol

[0092] ##STR00026##

[0093] To a magnetically stirred mixture of 4-((1R,2S)-2-(benzyloxy)-1-phenoxypropyl)-1,1′-biphenyl (72 mg, 0.183 mmol) in ethanol (1.22 mL) and cyclohexene (608 μL) was added Pd/C (78 mg, 0.018 mmol, 2.5 wt %). The reaction mixture was stirred at 70° C. for 2 h. The reaction mixture was cooled to rt, filtered through Celite™, and concentrated. The resulting residue was purified via flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (43 mg, 77%) as a white solid. .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.59-7.54 (m, 4H), 7.43 (dd, J=12.1, 5.0 Hz, 4H), 7.33 (t, J=7.3 Hz, 1H), 7.20 (t, J=8.0 Hz, 2H), 6.90 (t, J=8.1 Hz, 3H), 5.10 (d, J=4.7 Hz, 1H), 4.20-4.12 (m, 1H), 2.00 (s, 1H), 1.29 (d, J=6.4 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 157.83, 140.92, 140.61, 136.78, 129.42, 128.78, 127.45, 127.39, 127.31, 127.05, 121.12, 115.90, 83.43, 71.14, 18.11; ESIMS m/z 631 ([2M+Na].sup.+).

Example 4B: Preparation of (1S,2S)-1-phenoxy-1-(thiophen-2-yl)propan-2-ol

[0094] ##STR00027##

[0095] To a solution of 2-((1S,2S)-2-((4-methoxybenzyl)oxy)-1-phenoxypropyl)thiophene (0.223 g, 0.630 mmol) in a mixture of CH.sub.2Cl.sub.2 (3 mL) and H.sub.2O (0.3 mL) at 0° C. was added 4,5-dichloro-3,6-dioxocyclohexa-1,4-diene-1,2-dicarbonitrile (0.150 g, 0.661 mmol). The reaction mixture was stirred for 30 min. The reaction was quenched by addition of aq. 1 N NaOH (0.66 mL) and was diluted with CH.sub.2Cl.sub.2 (10 mL). The phases were separated, and the aq. phase was extracted with CH.sub.2Cl.sub.2 (2×10 mL). The combined organic phases were dried over Na.sub.2SO.sub.4, filtered, and concentrated. Purification via flash column chromatography (SiO.sub.2, 2.fwdarw.20% acetone in hexanes) afforded the title compound (116 mg, 75%) as a colorless oil: IR (Thin Film) 3390, 2923, 2851, 2865, 1597 cm.sup.−1; .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.33-7.16 (m, 3H), 7.07 (ddd, J=3.5, 1.2, 0.7 Hz, 1H), 7.03-6.88 (m, 4H), 5.26 (d, J=4.9 Hz, 1H), 4.28-4.09 (m, 1H), 2.08 (d, J=4.9 Hz, 1H), 1.29 (d, J=6.3 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 157.60, 140.58, 129.43, 126.59, 126.50, 125.94, 121.60, 116.21, 80.60, 70.73, 18.33.

Example 5: Preparation of (S)-(1R,2S)-1-phenoxy-1-(p-tolyl)propan-2-yl 2-((tert-butoxycarbonyl)amino)propanoate

[0096] ##STR00028##

[0097] To a solution of (1R,2S)-1-phenoxy-1-(p-tolyl)propan-2-ol (99 mg, 0.409 mmol) and (1R,2S)-1-phenoxy-1-(p-tolyl)propan-2-ol (99 mg, 0.409 mmol) in CH.sub.2Cl.sub.2 (2.04 mL) at 0° C. was added (S)-2-((tert-butoxycarbonyl)amino)propanoic acid (Boc-Ala-OH; 85 mg, 0.449 mmol), DMAP (4.99 mg, 0.041 mmol), and N.sup.1-((ethylimino)methylene)-N.sup.3,N.sup.3-dimethylpropane-1,3-diamine hydrochloride (EDC; 157 mg, 0.817 mmol). The reaction mixture was stirred at rt overnight. The reaction mixture was concentrated. Purification via flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) afforded the title compound (164 mg, 97%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.27 (d, J=6.8 Hz, 3H), 7.19-7.11 (m, 4H), 6.87 (t, J=7.4 Hz, 1H), 6.82 (d, J=7.8 Hz, 2H), 5.28-5.21 (m, 1H), 5.15 (d, J=4.8 Hz, 1H), 4.96 (d, J=7.2 Hz, 1H), 4.29-4.19 (m, 1H), 2.31 (s, 3H), 1.42 (s, 9H), 1.35 (d, J=6.4 Hz, 3H), 1.14 (d, J=7.2 Hz, 3H); .sup.13C NMR (100 MHz, CDCl.sub.3) δ 172.73, 157.95, 137.83, 134.48, 129.33, 129.19, 126.87, 121.09, 115.96, 81.07, 74.22, 28.31, 21.15, 18.51, 14.93; ESIMS m/z 414 ([M+H].sup.+).

Example 6A: Preparation of (S)-(1R,2S)-1-(4-fluorophenyl)-1-phenoxypropan-2-yl 2-aminopropanoate hydrochloride

[0098] ##STR00029##

[0099] To a solution of ((S)-(1R,2S)-1-(4-fluorophenyl)-1-phenoxypropan-2-yl 2-((tert-butoxycarbonyl)amino)propanoate (220 mg, 0.527 mmol) was added a 4 N solution of HCl in dioxane (1.98 mL, 7.9 mmol). The mixture was stirred for 1 h at rt. The solvent was evaporated under a stream of N.sub.2 to provide the title compound as a colorless, viscous oil, which was used in the next step without further purification: ESIMS m/z 318 ([M+H].sup.+).

Example 6B: Preparation of (S)-(1R,2S)-1-(4-fluorophenyl)-1-phenoxypropan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate

[0100] ##STR00030##

[0101] To a solution of (S)-(1R,2S)-1-(4-fluorophenyl)-1-phenoxypropan-2-yl 2-aminopropanoate hydrochloride (186 mg, 0.526 mmol), 3-hydroxy-4-methoxypicolinic acid (98 mg, 0.578 mmol), and PyBOP (301 mg, 0.578 mmol) in CH.sub.2Cl.sub.2 (2.63 mL) was added N,N-diisopropylethylamine (DIEA) (303 μL, 1.74 mmol). The reaction mixture was stirred overnight at room temperature. The solvent was evaporated, and the crude oil was purified by flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (215 mg, 80%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 (s, 1H), 8.39 (d, J=7.7 Hz, 1H), 7.97 (d, J=5.2 Hz, 1H), 7.40-7.34 (m, 2H), 7.20-7.13 (m, 2H), 7.03-6.96 (m, 2H), 6.88 (dd, J=15.2, 6.3 Hz, 2H), 6.82-6.78 (m, 2H), 5.31-5.24 (m, 1H), 5.18 (d, J=5.2 Hz, 1H), 4.64 (p, J=7.2 Hz, 1H), 3.93 (s, 3H), 1.39 (d, J=6.4 Hz, 3H), 1.33 (d, J=7.2 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.49, 168.69, 163.72, 161.27, 157.58, 155.39, 148.76, 140.48, 133.27, 133.24, 130.37, 129.41, 128.75, 128.67, 121.41, 115.95, 115.64, 115.43, 109.49, 80.61, 74.32, 56.07, 47.95, 18.01, 15.20; .sup.19F NMR (376 MHz, CDCl.sub.3) δ −113.62 (s); HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.25H.sub.26FN.sub.2O.sub.6, 469.1769; found, 469.1777.

Example 7: Preparation of (S)-(1R,2S)-1-(4-fluoro-2-methoxyphenyl)-1-(p-tolyloxy)propan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate

[0102] ##STR00031##

[0103] To a reaction vial was added (S)-(1R,2S)-1-(2-chloro-4-methylphenoxy)-1-(4-fluoro-2-methoxyphenyl)propan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate (79 mg, 0.144 mmol), NEt.sub.3 (60.4 μL, 0.433 mmol)), and 5% Pd/C (61.5 mg, 0.014 mmol). EtOAc (1.44 mL) was added, and the vial was sealed and stirred under approximately 1 atm (balloon) of H.sub.2 at rt for 6.5 h. The reaction mixture was filtered through a pad of Celite™ and the filtrate was concentrated to give an oil, which was purified by flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (66 mg, 85%) as a white foam: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.11 (s, 1H), 8.44 (d, J=7.8 Hz, 1H), 7.95 (d, J=5.2 Hz, 1H), 7.33 (dd, J=8.2, 6.8 Hz, 1H), 6.95 (d, J=8.3 Hz, 2H), 6.85 (d, J=5.2 Hz, 1H), 6.69 (t, J=5.7 Hz, 2H), 6.63-6.55 (m, 2H), 5.57 (d, J=4.6 Hz, 1H), 5.40-5.33 (m, 1H), 4.66 (p, J=7.2 Hz, 1H), 3.93 (s, 3H), 3.88 (s, 3H), 2.21 (s, 3H), 1.37 (d, J=7.2 Hz, 3H), 1.33 (d, J=6.5 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.43, 168.68, 163.36 (d, J=246.2 Hz), 157.81 (d, J=9.8 Hz), 155.53, 155.36, 148.76, 140.41, 130.49, 130.27, 129.77, 129.04 (d, J=10.1 Hz), 121.33 (d, J=3.2 Hz), 115.43, 109.42, 107.35 (d, J=21.3 Hz), 98.66 (d, J=25.9 Hz), 74.65, 73.23, 56.04, 55.77, 48.01, 20.42, 18.09, 15.00; .sup.19F NMR (376 MHz, CDCl.sub.3) δ −111.31 (s); HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.27H.sub.30FN.sub.2O.sub.7, 513.2032; found, 513.2027.

Example 8A: Preparation of (S)-(1R,2S)-1-phenoxy-1-(p-tolyl)propan-2-yl 2-(3-(acetoxymethoxy)-4-methoxypicolinamido)propanoate

[0104] ##STR00032##

[0105] To a suspension of (S)-(1R,2S)-1-phenoxy-1-(p-tolyl)propan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate (110 mg, 0.237 mmol), and K.sub.2CO.sub.3 (65.5 mg, 0.474 mmol) in acetone (2.37 mL) was added bromomethyl acetate (30.2 μL, 0.308 mmol) at rt. The reaction mixture was heated to 40° C. and stirred overnight. The solvent was evaporated, and the resulting crude material was purified by flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (94 mg, 74%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 (d, J=7.8 Hz, 1H), 8.24 (d, J=5.4 Hz, 1H), 7.28 (d, J=8.0 Hz, 2H), 7.19-7.10 (m, 4H), 6.93 (d, J=5.4 Hz, 1H), 6.87 (t, J=7.4 Hz, 1H), 6.84-6.80 (m, 2H), 5.75-5.70 (m, 2H), 5.26 (dt, J=11.4, 5.7 Hz, 1H), 5.18 (d, J=5.0 Hz, 1H), 4.67 (p, J=7.2 Hz, 1H), 3.90 (s, 3H), 2.31 (s, 3H), 2.06 (s, 3H), 1.38 (d, J=6.4 Hz, 3H), 1.28 (d, J=7.2 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.25, 170.27, 162.95, 160.27, 157.96, 145.68, 144.01, 142.49, 137.82, 134.51, 129.31, 129.19, 126.89, 121.06, 115.98, 109.53, 89.58, 81.10, 74.38, 56.17, 48.16, 21.14, 20.87, 18.23, 15.00; HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.29H.sub.33N.sub.2O, 537.2231; found, 537.2235.

Example 8B: Preparation of (S)-(1R,2S)-1-(2-chloro-4-methylphenoxy)-1-(4-fluoro-2-methoxyphenyl)propan-2-yl 2-(3-acetoxy-4-methoxypicolinamido)propanoate

[0106] ##STR00033##

[0107] To a solution of (S)-(1R,2S)-1-(2-chloro-4-methylphenoxy)-1-(4-fluoro-2-methoxyphenyl)propan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate (59 mg, 0.108 mmol) in pyridine (539 μL, 6.58 mmol) was added acetic anhydride (539 μL, 5.61 mmol). The reaction was stirred for 1 h and then the volatiles were removed in vacuo. The resulting residue was dissolved in toluene, and the volatiles were again removed in vacuo. The resulting residue was purified via flash column chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compound (62 mg, 98%) as a white foam: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 (d, J=6.6 Hz, 1H), 8.28 (d, J=5.4 Hz, 1H), 7.38 (dd, J=9.2, 6.7 Hz, 1H), 7.12 (d, J=1.7 Hz, 1H), 6.98 (d, J=5.5 Hz, 1H), 6.81-6.76 (m, 1H), 6.61 (ddd, J=10.8, 5.5, 2.3 Hz, 2H), 6.55 (d, J=8.4 Hz, 1H), 5.63 (d, J=4.4 Hz, 1H), 5.42-5.35 (m, 1H), 4.72-4.64 (m, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 2.39 (s, 3H), 2.19 (s, 3H), 1.35 (d, J=6.5 Hz, 3H), 1.33 (d, J=7.2 Hz, 3H); .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.95, 168.85, 163.47 (d, J=246.5 Hz), 159.42, 162.34, 157.82 (d, J=9.7 Hz), 150.89, 146.60, 141.58, 137.48, 131.22, 130.67, 129.17 (d, J=10.1 Hz), 127.84, 122.93, 120.74 (d, J=3.4 Hz), 114.38, 109.67, 107.46 (d, J=21.3 Hz), 98.64 (d, J=25.9 Hz), 75.32, 73.02, 56.25, 55.78, 47.97, 20.71, 20.20, 18.44, 14.99; .sup.19F NMR (376 MHz, CDCl.sub.3) δ −110.97 (d, J=2.0 Hz); HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.29H.sub.31ClFN.sub.2O.sub.8, 589.1747; found, 589.1749.

Example 9: Preparation of (S)-(1R,2S)-1-(4-fluoro-2-propoxyphenyl)-1-phenoxypropan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate and (S)-(1R,2S)-1-(4-fluoro-2-hydroxyphenyl)-1-phenoxypropan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate

[0108] ##STR00034##

[0109] To a magnetically stirred mixture of (S)-(1R,2S)-1-(2-(allyloxy)-4-fluorophenyl)-1-phenoxypropan-2-yl 2-(3-hydroxy-4-methoxypicolinamido)propanoate (91 mg, 0.173 mmol), and ruthenium chloride n-hydrate (3.91 mg, 0.017 mmol) in THF (651 μL) and water (217 μL) was added NaBH.sub.4 (13.13 mg, 0.347 mmol) (Note—rigorous gas evolution) under a N.sub.2 atmosphere according to the procedure of Sharma, P. K.; Kumar, S.; Kumar, P.; Nielsen, P. Tet. Lett. 2012, 48, 8704-8708. The reaction mixture was stirred at 0° C. for 1 h, at which point the reaction was carefully quenched by the addition of water and was extracted 3× with CH.sub.2Cl.sub.2. The combined organic extracts were dried by passing through a phase separator and volatiles were removed under a gentle stream of N.sub.2. The resulting residue was purified via flash chromatography (SiO.sub.2, 5.fwdarw.30% acetone in hexanes) to afford the title compounds (29 mg, 32%) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 (s, 1H), 8.43 (d, J=7.8 Hz, 1H), 7.96 (d, J=5.2 Hz, 1H), 7.32 (dd, J=8.3, 6.8 Hz, 1H), 7.20-7.13 (m, 2H), 6.86 (dd, J=10.0, 6.2 Hz, 2H), 6.82-6.77 (m, 2H), 6.61-6.53 (m, 2H), 5.62 (d, J=4.5 Hz, 1H), 5.43-5.36 (m, 1H), 4.66 (p, J=7.2 Hz, 1H), 3.98 (t, J=6.4 Hz, 2H), 3.94 (s, 3H), 1.96-1.86 (m, 2H), 1.37 (d, J=7.2 Hz, 3H), 1.34 (d, J=6.5 Hz, 3H), 1.11 (t, J=7.4 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ −111.41 (s, 1F). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.38, 168.68, 163.33 (d, J=246.1 Hz), 157.68, 157.21 (d, J=10.0 Hz), 155.36, 148.76, 140.40, 130.49, 129.30, 128.95 (d, J=10.2 Hz), 121.10 (d, J=3.2 Hz), 120.99, 115.53, 109.42, 107.16 (d, J=21.5 Hz), 99.24 (d, J=25.9 Hz), 74.64, 73.25, 70.01, 56.04, 48.01, 22.49, 18.13, 15.03, 10.67. HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.28H.sub.32FN.sub.2O.sub.7, 527.2188; found, 527.2188, and (33 mg, 39%) as an oily white solid: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.44 (s, 1H), 9.00 (s, 1H), 8.35 (d, J=7.6 Hz, 1H), 8.09 (d, J=5.3 Hz, 1H), 7.22 (ddd, J=8.4, 7.0, 3.6 Hz, 3H), 6.97 (d, J=5.3 Hz, 1H), 6.94 (t, J=7.3 Hz, 1H), 6.88 (d, J=7.8 Hz, 2H), 6.54 (td, J=8.4, 2.5 Hz, 1H), 6.32 (dd, J=10.0, 2.2 Hz, 1H), 5.50 (d, J=6.9 Hz, 1H), 5.20 (p, J=6.1 Hz, 1H), 4.65 (p, J=7.1 Hz, 1H), 3.99 (s, 3H), 1.51 (d, J=6.3 Hz, 3H), 1.45 (d, J=7.1 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.15 (s, 1F). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 170.47, 168.33, 163.09 (d, J=246.5 Hz), 157.25, 156.26, 155.47 (d, J=11.1 Hz), 149.58, 140.15, 130.12, 129.54, 128.71 (d, J=10.3 Hz), 121.77, 119.93 (d, J=3.4 Hz), 115.76, 109.65, 107.75 (d, J=21.7 Hz), 103.82 (d, J=24.0 Hz), 74.78, 56.25, 48.98, 29.26, 18.55, 16.20. HRMS-ESI (m/z) ([M+H].sup.+) calcd for C.sub.25H.sub.26FN.sub.2O.sub.7, 485.1719; found, 485.1717, respectively.

Example 10A: (E)-4-fluoro-2-methoxy-1-(prop-1-en-1-yl)benzene

[0110] ##STR00035##

[0111] To a suspension of magnesium metal (486 mg, 20.0 mmol) and lithium chloride (933 mg, 22.0 mmol) in THF (20.0 mL) was added 1-bromo-4-fluoro-2-methoxybenzene (1.93 mL, 15.00 mmol) and the mixture was heated to 70° C. for 1 h at which point the reaction was cooled to 0° C. and Fe(acac).sub.3 (0.5 M in THF, 2.00 mL, 1.00 mmol) was added. After 1 min allyl chloride (0.814 mL, 10.0 mmol) was added and the reaction was stirred at 0° C. for 30 min, then at rt for 1 h. The reaction was then heated to 70° C. overnight. The reaction was quenched by addition of sat. NaHCO.sub.3(aq) and diluted with petroleum ether and filtered through a pad of Celite™. The biphasic solution was extracted with petroleum ether and the combined organic phases were dried over Na.sub.2SO.sub.4, carefully concentrated in vacua (25° C., 250 mbar) and purified via flash column chromatography (SiO.sub.2, 100% petroleum ether) to afford the title compound (1.07 g, 52%, 15:1 E:Z) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.31 (dd, J=8.4, 6.8 Hz, 1H), 6.66-6.51 (m, 3H), 6.14 (dq, J=15.9, 6.6 Hz, 1H), 3.82 (s, 3H), 1.88 (dd, J=6.6, 1.7 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −113.30 (s).

Example 10B: (2S,3S)-2-(4-fluoro-2-methoxyphenyl)-3-methyloxirane

[0112] ##STR00036##

[0113] To a round-bottom flask was added buffer (0.05M Na.sub.2B.sub.4O.sub.7.10 H.sub.20 in 4×10.sup.−4 M aqueous Na.sub.2(EDTA), 26.5 mL), acetonitrile (40.1 mL), (E)-4-fluoro-2-methoxy-1-(prop-1-1en-1-yo)benzene (0.55 g, 2.65 mmol), tetrabutylammonium hydrogen sulfate (0.036 g, 0.106 mmol) and 1,2,4,5-Bis-O-(isopropylidene)-β-L-erythro-2,3-hexodiulo-2,6-pyranose (Shi epoxidation catalyst enantiomer, 0.205 g, 0.794 mmol) and the reaction mixture was cooled to 0° C. A solution of Oxone (2.246 g, 3.65 mmol) in aqeuous Na.sub.2(EDTA) (4×10.sup.−4 M, 15 mL) and a solution of potassium carbonate (2.122 g, 15.36 mmol) in water 15 mL were simultaneously added dropwise through two syringe pumps over 1.5 h. Upon completion of the syringe pump additions, the reaction was immediately quenched with petroleum ether and water. The mixture was extracted 3× with petroleum ether, washed with brine, dried over Na.sub.2SO.sub.4, filtered and concentrated in vacuo. The resulting residue was purified via flash column chromatography (SiO.sub.2, 0.fwdarw.10% acetone in hexanes) to afford the title compound (455 mg, 85%, 15:1 dr) as a colorless oil: .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.06 (dd, J=8.3, 6.7 Hz, 1H), 6.67-6.52 (m, 2H), 3.89-3.80 (m, 1H), 3.84 (s, 3H), 2.91 (qd, J=5.1, 2.1 Hz, 1H), 1.45 (d, J=5.2 Hz, 3H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.15.

Example 10C: (1S,2S)-1-cyclopropoxy-1-(4-fluoro-2-methoxyphenyl)propan-2-ol and (1R,2S)-1-cyclopropoxy-1-(4-fluoro-2-methoxyphenyl)propan-2-ol

[0114] ##STR00037##

[0115] To a solution of (2S,3S)-2-(4-fluoro-2-methoxyphenyl)-3-methyloxirane (50 mg, 0.274 mmol), in cyclopropanol (1.37 mL) was added sulfuric (1 drop). The reaction mixture was stirred at 0° C. for 10 min then quenched by addition of solid K.sub.2CO.sub.3. Volatiles were removed under a gentle stream of N.sub.2 and the resulting residue was purified via flash chromatography (SiO2, 5.fwdarw.30% acetone in hexanes) to yield the title compounds as two diastereomers: Major (1S,2S) (32 mg, 49%): .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.31 (dd, J=8.4, 6.9 Hz, 1H), 6.69 (td, J=8.3, 2.4 Hz, 1H), 6.62 (dd, J=10.9, 2.4 Hz, 1H), 4.62 (d, J=7.5 Hz, 1H), 3.82 (s, 3H), 3.78 (dt, J=13.2, 4.6 Hz, 1H), 3.16 (dq, J=9.1, 3.0 Hz, 1H), 2.62 (s, 1H), 0.99 (d, J=6.4 Hz, 3H), 0.66-0.50 (m, 2H), 0.40 (dddd, J=16.3, 14.5, 10.4, 6.2 Hz, 2H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.05 (s); ESIMS m/z 263 ([M+Na].sup.+). Minor (1R,2S) (18 mg, 27%): .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.38 (dd, J=8.4, 7.0 Hz, 1H), 6.70 (td, J=8.4, 2.4 Hz, 1H), 6.61 (dd, J=10.9, 2.4 Hz, 1H), 4.83 (d, J=4.2 Hz, 1H), 4.00-3.91 (m, 1H), 3.82 (s, 3H), 3.24 (dq, J=9.2, 3.0 Hz, 1H), 1.94 (d, J=6.2 Hz, 1H), 1.00 (d, J=6.5 Hz, 3H), 0.70-0.63 (m, 1H), 0.59-0.52 (m, 1H), 0.51-0.43 (m, 1H), 0.42-0.35 (m, 1H); .sup.19F NMR (376 MHz, CDCl.sub.3) δ −112.65 (s); ESIMS m/z 263 ([M+Na].sup.+).

Example A: Evaluation of Fungicidal Activity: Leaf Blotch of Wheat (Zymoseptoria tritici; Bayer Code SEPTTR)

[0116] Technical grades of materials were dissolved in acetone, which were then mixed with nine volumes of water containing 110 ppm Triton X-100. The fungicide solutions were applied onto wheat seedlings using an automated booth sprayer to run-off. All sprayed plants were allowed to air dry prior to further handling. All fungicides were evaluated using the aforementioned method for their activity vs. all target diseases, unless stated otherwise. Wheat leaf blotch and brown rust activity were also evaluated using track spray applications, in which case the fungicides were formulated as EC formulations, containing 0.1% Trycol 5941 in the spray solutions.

[0117] Wheat plants (variety Yuma) were grown from seed in a greenhouse in 50% mineral soil/50% soil-less Metro mix until the first leaf was fully emerged, with 7-10 seedlings per pot. These plants were inoculated with an aqueous spore suspension of Zymoseptoria tritici either prior to or after fungicide treatments. After inoculation the plants were kept in 100% relative humidity (one day in a dark dew chamber followed by two to three days in a lighted dew chamber at 20° C.) to permit spores to germinate and infect the leaf. The plants were then transferred to a greenhouse set at 20° C. for disease to develop. When disease symptoms were fully expressed on the 1.sup.st leaves of untreated plants, infection levels were assessed on a scale of 0 to 100 percent disease severity. Percent disease control was calculated using the ratio of disease severity on treated plants relative to untreated plants.

Example B: Evaluation of Fungicidal Activity: Wheat Brown Rust (Puccinia triticina; Synonym: Puccinia recondita f. sp. Tritici; Bayer Code PUCCRT)

[0118] Wheat plants (variety Yuma) were grown from seed in a greenhouse in 50% mineral soil/50% soil-less Metro mix until the first leaf was fully emerged, with 7-10 seedlings per pot. These plants were inoculated with an aqueous spore suspension of Puccinia triticina either prior to or after fungicide treatments. After inoculation the plants were kept in a dark dew room at 22° C. with 100% relative humidity overnight to permit spores to germinate and infect the leaf. The plants were then transferred to a greenhouse set at 24° C. for disease to develop. Fungicide formulation, application and disease assessment followed the procedures as described in the Example A.

Example C: Evaluation of Fungicidal Activity: Wheat Glume Blotch (Leptosphaeria nodorum; Bayer Code LEPTNO)

[0119] Wheat plants (variety Yuma) were grown from seed in a greenhouse in 50% mineral soil/50% soil-less Metro mix until the first leaf was fully emerged, with 7-10 seedlings per pot. These plants were inoculated with an aqueous spore suspension of Leptosphaeria nodorum 24 hr after fungicide treatments. After inoculation the plants were kept in 100% relative humidity (one day in a dark dew chamber followed by two days in a lighted dew chamber at 20° C.) to permit spores to germinate and infect the leaf. The plants were then transferred to a greenhouse set at 20° C. for disease to develop. Fungicide formulation, application and disease assessment followed the procedures as described in the Example A.

Example D: Evaluation of Fungicidal Activity: Apple Scab (Venturia inaequalis; Bayer Code VENTIN)

[0120] Apple seedlings (variety McIntosh) were grown in soil-less Metro mix, with one plant per pot. Seedlings with two expanding young leaves at the top (older leaves at bottom of the plants were trimmed) were used in the test. Plants were inoculated with a spore suspension of Venturia inaequalis 24 hr after fungicide treatment and kept in a 22° C. dew chamber with 100% relative humidity for 48 hr, and then moved to a greenhouse set at 20° C. for disease to develop. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

Example E: Evaluation of Fungicidal Activity: Leaf Spot of Sugar Beets (Cercospora beticola; Bayer Code CERCBE)

[0121] Sugar beet plants (variety HH88) were grown in soil-less Metro mix and trimmed regularly to maintain a uniform plant size prior to test. Plants were inoculated with a spore suspension 24 hr after fungicide treatments. Inoculated plants were kept in a dew chamber at 22° C. for 48 hr then incubated in a greenhouse set at 24° C. under a clear plastic hood with bottom ventilation until disease symptoms were fully expressed. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

Example F: Evaluation of Fungicidal Activity: Asian Soybean Rust (Phakopsora pachyrhizi; Bayer Code PHAKPA)

[0122] Technical grades of materials were dissolved in acetone, which were then mixed with nine volumes of water containing 0.011% Tween 20. The fungicide solutions were applied onto soybean seedlings using an automated booth sprayer to run-off. All sprayed plants were allowed to air dry prior to further handling.

[0123] Soybean plants (variety Williams 82) were grown in soil-less Metro mix, with one plant per pot. Two weeks old seedlings were used for testing. Plants were inoculated either 3 days prior to or 1 day after fungicide treatments. Plants were incubated for 24 h in a dark dew room at 22° C. and 100% relative humidity then transferred to a growth room at 23° C. for disease to develop. Disease severity was assessed on the sprayed leaves.

Example G: Evaluation of Fungicidal Activity: Barley Scald (Rhyncosporium secalis; Bayer Code RHYNSE)

[0124] Barley seedlings (variety Harrington) were propagated in soil-less Metro mix, with each pot having 8 to 12 plants, and used in the test when first leaf was fully emerged. Test plants were inoculated by an aqueous spore suspension of Rhyncosporium secalis 24 hr after fungicide treatments. After inoculation the plants were kept in a dew room at 22° C. with 100% relative humidity for 48 hr. The plants were then transferred to a greenhouse set at 20° C. for disease to develop. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

Example H: Evaluation of Fungicidal Activity: Rice Blast (Pyricularia oryzae; Bayer Code PYRIOR)

[0125] Rice seedlings (variety Japonica) were propagated in soil-less Metro mix, with each pot having 8 to 14 plants, and used in the test when 12 to 14 days old. Test plants were inoculated with an aqueous spore suspension of Pyricularia oryzae 24 hr after fungicide treatments. After inoculation the plants were kept in a dew room at 22° C. with 100% relative humidity for 48 hr to permit spores to germinate and infect the leaf. The plants were then transferred to a greenhouse set at 24° C. for disease to develop. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

Example I: Evaluation of Fungicidal Activity: Tomato Early Blight (Alternaria solani; Bayer Code ALTESO)

[0126] Tomato plants (variety Outdoor Girl) were propagated in soil-less Metro mix, with each pot having one plant, and used when 12 to 14 days old. Test plants were inoculated with an aqueous spore suspension of Alternaria solani 24 hr after fungicide treatments. After inoculation the plants were kept in a dew room at 22° C. with 100% relative humidity for 48 hr to permit spores to germinate and infect the leaf. The plants were then transferred to a growth room at 22° C. for disease to develop. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

Example J: Evaluation of Fungicidal Activity: Cucumber Anthracnose (Colletotrichum lagenarium; Bayer Code COLLLA)

[0127] Cucumber seedlings (variety Bush Pickle) were propagated in soil-less Metro mix, with each pot having one plant, and used in the test when 12 to 14 days old. Test plants were inoculated with an aqueous spore suspension of Colletotrichum lagenarium 24 hr after fungicide treatments. After inoculation the plants were kept in a dew room at 22° C. with 100% relative humidity for 48 hr to permit spores to germinate and infect the leaf. The plants were then transferred to a growth room set at 22° C. for disease to develop. Fungicide formulation, application and disease assessment on the sprayed leaves followed the procedures as described in the Example A.

TABLE-US-00001 TABLE 1 Compound Structure, Appearance, and Preparation Method Prepared According *Cmpd. to Colorless No. Structure Example Semi-Solid  1 [00038] Example 1A; Example 2C; Example 4A; Example 5 Colorless Semi-Solid  2 [00039] Example 1A; Example 2A; Example 4B; Example 5 White Solid  3 [00040] Example 1A; Example 2A; Example 4B; Example 5 Sticky Oil  4 [00041] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  5 [00042] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  6 [00043] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  7 [00044] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  8 [00045] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  9 [00046] Example 1A; Example 2A; Example 4A; Example 5 Sticky Wax  10 [00047] Example 1A; Example 2A; Example 4A; Example 5 Sticky Wax  11 [00048] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  12 [00049] Example 1A; Example 2B; Example 4A; Example 5 White Solid  13 [00050] Example 1A; Example 2B; Example 4A; Example 5 Sticky Glass  14 [00051] Example 1A; Example 2B; Example 4A; Example 5 Sticky Glass  15 [00052] Example 1A; Example 2B; Example 4A; Example 5 Sticky Oil  16 [00053] Example 1A; Example 2B; Example 4A; Example 5 Semi-Solid  17 [00054] Example 1A; Example 2C; Example 4A; Example 5 Colorless Oil  18 [00055] Example 1A; Example 2C; Example 4A; Example 5 Colorless Oil  19 [00056] Example 1D; Example 2A; Example 4B; Example 5 Colorless Oil  20 [00057] Example 1D; Example 2A; Example 4B; Example 5 Colorless Oil  21 [00058] Example 1B; Example 1C; Example 2B; Example 4A; Example 5 Colorless Oil  22 [00059] Example 1D; Example 2A; Example 4B; Example 5 Colorless Oil  23 [00060] Example 1D; Example 2A; Example 4B; Example 5 Colorless Oil  24 [00061] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  25 [00062] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  26 [00063] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  27 [00064] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  28 [00065] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  29 [00066] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  30 [00067] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  31 [00068] Example 1B; Example 1C; Example 2C; Example 4A; Example 5 Colorless Oil  32 [00069] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  33 [00070] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  34 [00071] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  35 [00072] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  36 [00073] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  37 [00074] Example 1A; Example 2B; Example 4A; Example 5 Colorless Oil  38 [00075] Example 1A; Example 2B; Example 4A; Example 5 Colorless Oil  39 [00076] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  40 [00077] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  41 [00078] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  42 [00079] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  43 [00080] Example 1A; Example 2B; Example 4B; Example 5 Colorless Oil  44 [00081] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  45 [00082] Example 1A; Example 2A; Example 4A; Example 5 Colorless Oil  46 [00083] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  47 [00084] Example 1A; Example 2A; Example 4B; Example 5 White Waxy Solid  48 [00085] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  49 [00086] Example 1E; Example 2A; Example 4B; Example 5 Colorless Oil  50 [00087] Example 1A; Example 2A; Example 4B; Example 5 Colorless Oil  51 [00088] Example 1A; Example 2A; Example 4B; Example 5 White Foam  52 [00089] Example 1E; Example 2A; Example 4B; Example 5 Foamy Solid  53 [00090] Example 1E; Example 2B; Example 4B; Example 5 Colorless Oil  54 [00091] Example 1E; Example 2A; Example 4B; Example 5 Colorless Oil  56 [00092] Example 1E; Example 2A; Example 4B; Example 5 White Foam  57 [00093] Example 1E; Example 2B; Example 4B; Example 5 White Foam  58 [00094] Example 1E; Example 2B; Example 4B; Example 5 Colorless Oil  59 [00095] Example 1E; Example 2A; Examples 3A, B; Example 4B; Example 5 White Solid  60 [00096] Example 1E; Example 2A; Examples 3A ,B; Example 4B; Example 5 Colorless Oil  61 [00097] Example 1E; Example 2B; Examples 3A, C; Example 4B; Example 5 Colorless Oil  62 [00098] Example 6, Step 1 White Solid  63 [00099] Example 6, Step 1 White Solid  64 [00100] Example 6, Step 1 Clear Glass  65 [00101] Example 6, Step 1 Clear Glass  66 [00102] Example 6, step 1 White Powder  67 [00103] Example 6, step 1 White Powder  68 [00104] Example 6, step 1 White Powder  69 [00105] Example 6, step 1 White Powder  70 [00106] Example 6, step 1 White Powder  71 [00107] Example 6, step 1 White Powder  72 [00108] Example 6, step 1 White Powder  73 [00109] Example 6, step 1 White Powder  74 [00110] Example 6, step 1 White Powder  75 [00111] Example 6, step 1 White Powder  76 [00112] Example 6, step 1 White Powder  77 [00113] Example 6, step 1 White Powder  78 [00114] Example 6, step 1 Colorless Oil  79 [00115] Example 6, step 1 Colorless Oil  80 [00116] Example 6, Step 1 Colorless Oil  81 [00117] Example 6, step 1 Colorless Oil  82 [00118] Example 6, Step 1 Colorless Oil  83 [00119] Example 6, Step 1 Colorless Oil  84 [00120] Example 6, step 1 Beige Solid  85 [00121] Example 6, step 1 Colorless Oil  86 [00122] Example 6, Step 1 Colorless Oil  87 [00123] Example 6, Step 1 Colorless Oil  88 [00124] Example 6, Step 1 Colorless Oil  89 [00125] Example 6, Step 1 Colorless Oil  90 [00126] Example 6, step 1 Colorless Viscous Oil  91 [00127] Example 6, step 1 Colorless Oil  92 [00128] Example 6, step 1 Oily White Solid  93 [00129] Example 6, step 1 Colorless Oil  94 [00130] Example 6, step 1 Colorless Oil  95 [00131] Example 6, Step 1 Colorless Oil  96 [00132] Example 6, Step 1 Colorless Oil  97 [00133] Example 6, Step 1 Colorless Oil  98 [00134] Example 6, step 1 Colorless Oil  99 [00135] Example 6, step 1 Clear Viscous Oil 100 [00136] Example 6, step 1 Colorless Viscous Oil 101 [00137] Example 6, step 1 Colorless Oil 102 [00138] Example 6, step 1 Colorless Oil 103 [00139] Example 6, step 1 Colorless Oil 104 [00140] Example 6, step 1 Colorless Oil 105 [00141] Example 6, step 1 Oily White Solid 106 [00142] Example 6, step 1 Colorless Oil 107 [00143] Example 6, step 1 Colorless Oil 108 [00144] Example 6, step 1 Oily White Solid 109 [00145] Example 6, step 1 White Solid 110 [00146] Example 6, step 1 Colorless Oil 111 [00147] Example 6, step 1 Colorless Oil 112 [00148] Example 6, step 1 Colorless Oil 113 [00149] Example 6, Steps 1, 2 Colorless Semi-Solid 114 [00150] Example 6, Step 2 White Solid 115 [00151] Example 6, Step 2 White Foam 116 [00152] Example 6, Step 2 White Foam 117 [00153] Example 6, Step 2 White Powder 118 [00154] Example 6, Step 2 White Powder 119 [00155] Example 6, Step 2 White Powder 120 [00156] Example 6, Step 2 White Powder 121 [00157] Example 6, Step 2 Hygroscopic White Powder 122 [00158] Example 6, Step 2 Hygroscopic White Powder 123 [00159] Example 6, Step 2 Hygroscopic White Powder 124 [00160] Example 6, Step 2 Hygroscopic White Powder 125 [00161] Example 6, Step 2 White Powder 126 [00162] Example 6, Step 2 White Powder 127 [00163] Example 6, Step 2 Hygroscopic White Powder 128 [00164] Example 6, Step 2 White Powder 129 [00165] Example 6, Steps 1, 2 Colorless Oil 130 [00166] Example 6, Steps 1, 2 Colorless Oil 131 [00167] Example 6, Step 2 Colorless Oil 132 [00168] Example 6, Steps 1, 2 Colorless Foam/Oil 133 [00169] Example 6, Step 2 Foamy White Solid 134 [00170] Example 6, Step 2 White Foam 135 [00171] Example 7A Colorless Oil 136 [00172] Example 6, Step 2 Colorless Oil 137 [00173] Example 6, Step 2 Colorless Oil 138 [00174] Example 6, Steps 1, 2 Colorless Oil 139 [00175] Example 6, Steps 1, 2 Colorless Oil 140 [00176] Example 6, Steps 1 ,2 Colorless Oil 141 [00177] Example 6, Steps 1, 2 Colorless Oil 142 [00178] Example 6, Steps 1, 2 Colorless Oil 143 [00179] Example 6, Step 2 Beige Solid 144 [00180] Example 6, Step 2 Colorless Oil 145 [00181] Example 6, Step 2 Colorless Oil 146 [00182] Example 6, Step 2 Colorless Oil 147 [00183] Example 6, Step 2 Colorless Oil 148 [00184] Example 6, Step 2 Colorless Oil 149 [00185] Example 6, Step 2 Colorless Oil 150 [00186] Example 6, Step 2 Colorless Oil 151 [00187] Example 7A Colorless Oil 152 [00188] Example 7A Colorless Oil 153 [00189] Example 6, Step 2 Colorless Oil 154 [00190] Example 6, Step 2 Viscous Foam 155 [00191] Example 6, Step 2 Colorless Oil 156 [00192] Example 6, Step 2 Colorless Oil 157 [00193] Example 7A Colorless Oil 158 [00194] Example 6, Step 2 Colorless Foam 159 [00195] Example 6, Step 2 Colorless Foam 160 [00196] Example 6, Step 2 Colorless Oil 161 [00197] Example 6, Step 2 Colorless Oil 162 [00198] Example 6, Step 2 Colorless Oil 163 [00199] Example 6, Step 2 Colorless Foamy Oil 164 [00200] Example 6, Step 2 Colorless Oil 165 [00201] Example 6, Step 2 White Foam 166 [00202] Example 6, Step 2 White Foam 167 [00203] Example 6, Step 2 Foamy White Solid 168 [00204] Example 6, Step 2 White Foam 169 [00205] Example 6, Step 2 White Foam 170 [00206] Example 6, Step 2; Example 7B Oily White Solid 171 [00207] Example 6, Step 2; Example 7B Colorless Oil 172 [00208] Example 6, Step 2 White Foam 173 [00209] Example 6, Step 2; Example 7A White Foam 174 [00210] Example 6, Step 2 White Foamy Solid 175 [00211] Example 6, Step 2 Colorless Oil 176 [00212] Example 6, Step 2 Colorless Oil 177 [00213] Example 6, Step 2; Example 7A Colorless Oil 178 [00214] Example 6, Step 2; Example 7A White Foam 179 [00215] Example 6, Step 2 White Foam 180 [00216] Example 6, Step 2 Colorless Oil 181 [00217] Example 6, Step 2 Colorless Oil 182 [00218] Example 8A Light Yellow Semi-Solid 183 [00219] Example 8A Yellow Solid 184 [00220] Example 8B White Solid 185 [00221] Example 8A White Foam 186 [00222] Example 8A White Foam 187 [00223] Example 8A White Powder 188 [00224] Example 8B White Powder 189 [00225] Example 8A White Powder 190 [00226] Example 8B White Powder 191 [00227] Example 8A White Powder 192 [00228] Example 8B White Powder 193 [00229] Example 8A Hygroscopic Solid 194 [00230] Example 8B White Powder 195 [00231] Example 8A White Powder 196 [00232] Example 8B White Powder 197 [00233] Example 8A Hygroscopic Powder 198 [00234] Example 8B White Powder 199 [00235] Example 8A White Powder 200 [00236] Example 8B White Powder 201 [00237] Example 8A White Powder 202 [00238] Example 8A Sticky Oil 203 [00239] Example 8B White Powder 204 [00240] Example 8A White Powder 205 [00241] Example 8B White Powder 206 [00242] Example 8A Semi-Solid 207 [00243] Example 8B White Powder 208 [00244] Example 8A Sticky White Solid 209 [00245] Example 8B White Powder 210 [00246] Example 8B Colorless Oil 211 [00247] Example 8B Colorless Oil 212 [00248] Example 8B Colorless Foam/Oil 213 [00249] Example 8A Colorless Foam/Oil 214 [00250] Example 8B Colorless Oil 215 [00251] Example 8B Colorless Oil 216 [00252] Example 8A Colorless Oil 217 [00253] Example 8B Colorless Oil 218 [00254] Example 8B Colorless Oil 219 [00255] Example 8A Colorless Oil 220 [00256] Example 8A Colorless Oil 221 [00257] Example 8A Colorless Oil 222 [00258] Example 8B Colorless Oil 223 [00259] Example 8B Off White Foam 224 [00260] Example 8B Colorless Oil 225 [00261] Example 8B Colorless Oil 226 [00262] Example 8A Colorless Oil 227 [00263] Example 8B Colorless Oil 228 [00264] Example 8B Colorless Oil 229 [00265] Example 8B Colorless Oil 230 [00266] Example 8A Colorless Oil 231 [00267] Example 8B Colorless Oil 232 [00268] Example 8B Colorless Oil 233 [00269] Example 8B Colorless Oil 234 [00270] Example 8A Colorless Oil 235 [00271] Example 8B Colorless Oil 236 [00272] Example 8B Colorless Oil 237 [00273] Example 8A Colorless Oil 238 [00274] Example 8A Colorless Oil 239 [00275] Example 8A Colorless Oil 240 [00276] Example 8A Colorless Oil 241 [00277] Example 8A Colorless Oil 242 [00278] Example 8B Light Yellow Oil 243 [00279] Example 8B Colorless Oil 244 [00280] Example 8A Colorless Oil 245 [00281] Example 8A Colorless Oil 246 [00282] Example 8B Colorless Oil 247 [00283] Example 8B Colorless Oil 248 [00284] Example 8A Colorless Oil 249 [00285] Example 8A Colorless Oil 250 [00286] Example 8A Colorless Oil 251 [00287] Example 8B Faint Yellow Oil 252 [00288] Example 8A Colorless Oil 253 [00289] Example 8A Colorless Oil 254 [00290] Example 8A Colorless Oil 255 [00291] Example 8A Colorless Oil 256 [00292] Example 8A Faint Yellow Oil 257 [00293] Example 8A Colorless Oil 258 [00294] Example 8A Colorless Oil 259 [00295] Example 8A Colorless Oil 260 [00296] Example 8A Colorless Oil 261 [00297] Example 8A White Foam 262 [00298] Example 8A White Foam 263 [00299] Example 8A White Foam 264 [00300] Example 8B White Foam 265 [00301] Example 8B White Foam 266 [00302] Example 8B White Foam 267 [00303] Example 8B White Foam 268 [00304] Example 8B White Foam 269 [00305] Example 8B Off White Foam 270 [00306] Example 8B White Foam 271 [00307] Example 8B White Foam 272 [00308] Example 8B Colorless Oil 273 [00309] Example 8B Colorless Oil 274 [00310] Example 8B White Foam 275 [00311] Example 8B White Foam 276 [00312] Example 6A White Oily Solid 277 [00313] Example 6A Colorless Oil 278 [00314] Example 6A Colorless Oil 279 [00315] Example 6A Colorless Oil 280 [00316] Example 6A Colorless Oil 281 [00317] Example 6A Colorless Oil 282 [00318] Example 1E; Example 2C; Example 4B; Example 5 Colorless Oil 283 [00319] Example 1E; Example 2C; Example 4B; Example 5 Colorless Oil 284 [00320] Example 1E; Example 2D; Example 4B; Example 5 Colorless Oil 285 [00321] Example 1E; Example 2D; Example 4B; Example 5 Colorless Oil 286 [00322] Examples 10A-C; Example 5 Colorless Oil 287 [00323] Examples 10A-C; Example 5 Colorless Oil 288 [00324] Example 6B Colorless Oil 289 [00325] Example 6B Colorless Oil 290 [00326] Example 6B Colorless Oil 291 [00327] Example 6B Oily White Solid 292 [00328] Example 6B White Wax 293 [00329] Example 6B Colorless Oil 294 [00330] Example 8B White Foam 295 [00331] Example 8B White Foam 296 [00332] Example 8B White Foam 297 [00333] Example 8B White Foam 298 [00334] Example 8B Off White Foam 299 [00335] Example 8B Colorless Oil

TABLE-US-00002 TABLE 2 Analytical Data *Cmpd. NMR No. IR (cm.sup.−1) MASS (.sup.1H, .sup.13C or .sup.19F) 1 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.36-7.22 [M].sup.+ calcd for (m, 5H), 5.09 (p, J = 6.3 Hz, C.sub.21H.sub.31NO.sub.5, 1H), 5.01-4.93 (m, 1H), 4.31 (d, J = 377.2202; found, 6.2 Hz, 1H), 4.23-4.13 (m, 1H), 377.2206 3.19 (d, J = 6.8 Hz, 2H), 1.42 (s, 9H), 1.32 (d, J = 6.4 Hz, 3H), 1.04 (d, J = 7.2 Hz, 3H), 1.03-0.96 (m, 1H), 0.54-0.40 (m, 2H), 0.19-0.04 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.47, 154.95, 138.76, 128.21, 127.95, 127.59, 83.05, 79.63, 74.05, 73.71, 49.19, 28.32, 18.43, 16.01, 10.58, 3.19, 2.71. 2 ESIMS m/z 400 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.43-7.22 ([M + H].sup.+) (m, 5H), 7.23-7.12 (m, 2H), 6.93-6.78 (m, 3H), 5.26 (qd, J = 6.3, 4.8 Hz, 1H), 5.18 (d, J = 5.0 Hz, 1H), 4.97 (d, J = 8.2 Hz, 1H), 4.24 (h, J = 7.4, 6.8 Hz, 1H), 1.42 (s, 9H), 1.37 (d, J = 6.4 Hz, 3H), 1.12 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.72, 157.90, 137.59, 129.37, 128.52, 128.15, 126.97, 126.80, 121.20, 115.98, 81.23, 79.75, 74.16, 49.28, 28.32, 18.45, 15.04. 3 ESIMS m/z 456 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.39-7.30 ([M + Na].sup.+) (m, 5H), 7.16-7.09 (m, 2H), 6.79-6.71 (m, 2H), 5.25 (qd, J = 6.5, 4.8 Hz, 1H), 5.13 (d, J = 4.9 Hz, 1H), 4.94 (d, J = 8.0 Hz, 1H), 4.24 (t, J = 7.6 Hz, 1H), 1.42 (s, 9H), 1.35 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.71, 156.42, 155.02, 137.00, 129.28, 128.62, 128.36, 126.90, 126.13, 117.25, 81.62, 79.82, 73.96, 49.25, 28.30, 18.46, 14.90. 4 ESIMS m/z 434 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.26 ([M + H].sup.+) (m, 5H), 7.08 (ddd, J = 8.4, 7.7, 0.6 Hz, 1H), 6.91-6.82 (m, 2H), 6.70 (ddd, J = 8.4, 2.4, 1.0 Hz, 1H), 5.30-5.19 (m, 1H), 5.16 (d, J = 4.9 Hz, 1H), 4.95 (d, J = 8.3 Hz, 1H), 4.28-4.19 (m, 1H), 1.42 (s, 9H), 1.35 (d, J = 6.5 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.71, 158.54, 155.01, 136.85, 134.75, 130.15, 128.65, 128.40, 126.87, 121.47, 116.59, 114.09, 81.48, 79.81, 73.95, 49.26, 28.30, 18.44, 14.89. 5 ESIMS m/z 456 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.44-7.26 ([M + Na]).sup.+ (m, 6H), 7.00 (ddd, J = 8.3, 7.5, 1.7 Hz, 1H), 6.82 (td, J = 7.7, 1.4 Hz, 1H), 6.66 (dd, J = 8.3, 1.4 Hz, 1H), 5.36-5.22 (m, 2H), 4.97 (d, J = 8.2 Hz, 1H), 4.29-4.20 (m, 1H), 1.45-1.39 (m, 12H), 1.15 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.71, 155.00, 153.31, 136.81, 130.34, 128.61, 128.39, 127.44, 126.90, 123.54, 121.78, 115.14, 82.01, 79.75, 74.19, 49.30, 28.30, 18.43, 14.86. 6 ESIMS m/z 436 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.42-7.27 ([M + H].sup.+) (m, 5H), 6.98 (ddd, J = 10.6, 9.0, 5.3 Hz, 1H), 6.58-6.44 (m, 2H), 5.30 (qd, J = 6.4, 5.0 Hz, 1H), 5.17 (d, J = 5.0 Hz, 1H), 4.95 (d, J = 8.0 Hz, 1H), 4.24 (t, J = 7.7 Hz, 1H), 1.42 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.66, 158.32 (dd, J = 242.4, 2.5 Hz), 155.00, 149.47 (dd, J = 242.1, 3.4 Hz), 146.24 (dd, J = 12.1, 10.8 Hz), 136.27, 128.69, 128.66, 126.99, 116.41 (dd, J = 20.8, 10.1 Hz), 107.68 (dd, J = 24.0, 6.9 Hz), 105.12 (dd, J = 27.2, 1.7 Hz), 83.04, 79.80, 73.72, 49.25, 28.29, 18.35, 15.03. 7 ESIMS m/z 468 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.40-7.28 ([M + H].sup.+) (m, 6H), 6.97 (dd, J = 8.8, 2.6 Hz, 1H), 6.57 (d, J = 8.9 Hz, 1H), 5.30 (qd, J = 6.4, 4.6 Hz, 1H), 5.21 (d, J = 4.6 Hz, 1H), 4.96 (d, J = 8.1 Hz, 1H), 4.29-4.22 (m, 1H), 1.43-1.39 (m, 12H), 1.16 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.70, 155.00, 152.06, 136.27, 130.04, 128.71, 128.59, 127.36, 126.86, 126.20, 124.35, 115.83, 82.37, 79.80, 73.97, 49.27, 28.29, 18.43, 14.82. 8 ESIMS m/z 452 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.38-7.30 ([M + H].sup.+) (m, 5H), 6.68-6.60 (m, 2H), 6.48-6.40 (m, 1H), 5.29-5.20 (m, 1H), 5.14 (d, J = 4.7 Hz, 1H), 4.94 (d, J = 8.2 Hz, 1H), 4.28-4.21 (m, 1H), 1.42 (s, 9H), 1.34 (d, J = 6.5 Hz, 3H), 1.15 (d, J = 7.3 Hz, 3H). .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.38-7.30 (m, 5H), 6.68-6.60 (m, 2H), 6.48-6.40 (m, 1H), 5.29-5.20 (m, 1H), 5.14 (d, J = 4.7 Hz, 1H), 4.94 (d, J = 8.2 Hz, 1H), 4.28-4.21 (m, 1H), 1.42 (s, 9H), 1.34 (d, J = 6.5 Hz, 3H), 1.15 (d, J = 7.3 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.69, 163.12 (d, J = 248.4 Hz), 159.25 (d, J = 12.4 Hz), 155.00, 136.22, 135.29 (d, J = 13.3 Hz), 128.78, 128.62, 126.80, 112.55 (d, J = 3.3 Hz), 109.25 (d, J = 25.2 Hz), 102.25 (d, J = 25.0 Hz), 81.78, 79.86, 73.72, 49.24, 28.29, 18.43, 14.82. 9 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.42-7.37 3364.14, 2978.73, ([M + Na].sup.+) calcd for (m, 2H), 7.37-7.30 (m, 2H), 1709.99, 1492.42, C.sub.23H.sub.29NNaO.sub.5, 7.31-7.22 (m, 1H), 7.22-7.14 (m, 1235.09, 1160.57 422.1938; found, 2H), 6.92-6.81 (m, 3H), 5.29-5.20 422.1940 (m, 2H), 4.93 (d, J = 8.0 Hz, 1H), 4.31-4.16 (m, 1H), 1.43 (s, 9H), 1.37-1.31 (m, 3H), 1.28 (d, J = 7.2 Hz, 3H). 10 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.37 3366.73, 1708.90, ([M + Na].sup.+) calcd for (m, 2H), 7.36-7.30 (m, 2H), 1492.33, 1236.49, C.sub.23H.sub.29NNaO.sub.5, 7.29-7.23 (m, 1H), 7.21-7.12 (m, 1159.90 422.1938; found, 2H), 6.90-6.85 (m, 1H), 6.85-6.80 422.1939 (m, 2H), 5.26 (dq, J = 6.2, 4.8 Hz, 1H), 5.18 (d, J = 5.0 Hz, 1H), 4.97 (d, J = 8.3 Hz, 1H), 4.31-4.16 (m, 1H), 1.42 (s, 9H), 1.37 (d, J = 6.4 Hz, 3H), 1.12 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.72, 157.90, 155.00, 137.59, 129.37, 128.53, 128.16, 126.97, 121.20, 115.98, 81.23, 79.76, 74.17, 49.28, 28.32, 18.45, 15.04. 11 ESIMS m/z 467 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.27 ([M + H].sup.+) (m, 5H), 6.68-6.59 (m, 2H), 6.43 (dt, J = 10.4, 2.3 Hz, 1H), 5.29-5.18 (m, 1H), 5.14 (d, J = 4.7 Hz, 1H), 4.96 (d, J = 8.2 Hz, 1H), 4.22 (q, J = 6.8 Hz, 1H), 1.73-1.61 (m, 1H), 1.54-1.40 (m, 10H), 1.33 (d, J = 6.4 Hz, 3H), 0.72 (t, J = 7.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.06, 163.12 (d, J = 248.2 Hz), 159.24 (d, J = 12.4 Hz), 155.27, 136.21, 135.29 (d, J = 13.3 Hz), 128.80, 128.63, 126.78, 112.54 (d, J = 3.3 Hz), 109.24 (d, J = 25.2 Hz), 102.23 (d, J = 25.1 Hz), 81.77, 79.80, 73.79, 54.48, 28.30, 25.65, 14.81, 9.14. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-109.89. 12 ESIMS m/z 473 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.43-7.28 ([M + Na].sup.+) (m, 5H), 6.98 (ddd, J = 10.6, 9.0, 5.3 Hz, 1H), 6.59-6.42 (m, 2H), 5.29 (qd, J = 6.4, 4.8 Hz, 1H), 5.17 (d, J = 4.9 Hz, 1H), 4.97 (d, J = 8.3 Hz, 1H), 4.22 (q, J = 6.8 Hz, 1H), 1.72-1.58 (m, 1H), 1.48-1.36 (m, 13H), 0.69 (t, J = 7.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.01, 158.32 (dd, J = 242.4, 2.5 Hz), 155.25, 149.44 (dd, J = 242.0, 3.3 Hz), 146.24 (dd, J = 12.3, 10.6 Hz), 136.29, 128.71, 128.66, 126.94, 116.38 (dd, J = 20.8, 10.2 Hz), 107.66 (d, J = 24.0 Hz), 105.03 (dd, J = 27.3, 1.4 Hz), 83.01, 79.74, 73.84, 54.48, 28.30, 25.61, 15.03, 9.05. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.68 (d, J = 15.0 Hz), −138.71 (d, J = 15.0 Hz). 13 ESIMS m/z 469 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.47-7.41 ([M + H].sup.+) (m, 2H), 7.40-7.27 (m, 5H), 6.92-6.86 (m, 2H), 5.32-5.21 (m, 2H), 4.94 (d, J = 8.1 Hz, 1H), 4.25 (t, J = 7.6 Hz, 1H), 1.41 (s, 9H), 1.37 (d, J = 6.3 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.72, 160.16, 155.00, 136.58, 128.73, 128.51, 126.85 (q, J = 3.7 Hz), 126.83, 124.25 (q, J = 271.2 Hz), 123.34 (q, J = 32.6 Hz), 115.78, 81.32, 79.85, 73.87, 49.26, 28.29, 18.43, 14.84. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-61.67. 14 ESIMS m/z 497 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.47-7.40 ([M + H].sup.+) (m, 2H), 7.40-7.28 (m, 5H), 6.91-6.84 (m, 2H), 5.32-5.23 (m, 2H), 4.93 (d, J = 9.3 Hz, 1H), 4.19 (dd, J = 9.2, 4.5 Hz, 1H), 2.01-1.90 (m, 1H), 1.42 (s, 9H), 1.36 (d, J = 6.2 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H), 0.62 (d, J = 6.8 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.85, 160.12, 155.66, 136.53, 128.78, 128.50, 126.82 (q, J = 4.1 Hz), 126.78, 124.25 (q, J = 271.5 Hz), 123.30 (q, J = 32.9 Hz), 115.72, 81.20, 79.77, 73.97, 58.46, 31.11, 28.28, 18.97, 16.93, 14.69. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-61.67. 15 ESIMS m/z 418 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.40-7.25 ([M + H].sup.+) (m, 5H), 7.11 (td, J = 8.3, 6.8 Hz, 1H), 6.64-6.51 (m, 3H), 5.25 (qd, J = 6.4, 4.8 Hz, 1H), 5.16 (d, J = 4.9 Hz, 1H), 4.95 (d, J = 8.2 Hz, 1H), 4.28-4.21 (m, 1H), 1.42 (s, 9H), 1.36 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.71, 163.39 (d, J = 245.6 Hz), 159.11 (d, J = 10.8 Hz), 155.00, 136.93, 130.13 (d, J = 10.0 Hz), 128.64, 128.37, 126.87, 111.57 (d, J = 2.9 Hz), 108.08 (d, J = 21.3 Hz), 103.73 (d, J = 24.8 Hz), 81.50, 79.80, 73.93, 49.25, 28.30, 18.44, 14.91. 16 ESIMS m/z 495 .sup.1H NMR (500 MHz, CDCl.sub.3) δ 7.40-7.26 ([M + H].sup.+) (m, 5H), 7.19-7.08 (m, 4H), 6.97-6.92 (m, 2H), 6.65-6.50 (m, 3H), 5.17 (qd, J = 6.4, 3.8 Hz, 1H), 5.12 (d, J = 4.4 Hz, 1H), 4.88 (d, J = 8.5 Hz, 1H), 4.59-4.51 (m, 1H), 2.97 (dd, J = 13.9, 5.8 Hz, 1H), 2.90 (dd, J = 13.9, 5.9 Hz, 1H), 1.40 (s, 9H), 1.34 (d, J = 6.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.29, 163.41 (d, J = 245.4 Hz), 158.96 (d, J = 10.9 Hz), 155.00, 136.91, 135.75, 130.14 (d, J = 10.0 Hz), 129.33, 128.73, 128.43, 126.93, 126.80, 111.63 (d, J = 2.9 Hz), 108.07 (d, J = 21.2 Hz), 103.75 (d, J = 24.9 Hz), 81.24, 79.86, 74.68, 54.31, 37.92, 28.27, 14.49. 17 ESIMS m/z 454 ([M + Na].sup.+) 18 ESIMS m/z 454 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.59-7.54 ([M + H].sup.+) (m, 3H), 7.51 (dd, J = 7.6, 1.2 Hz, 1H), 7.47-7.29 (m, 6H), 5.15 (p, J = 6.4 Hz, 1H), 4.96 (d, J = 7.2 Hz, 1H), 4.39 (d, J = 6.3 Hz, 1H), 4.26-4.13 (m, 1H), 3.28-3.20 (m, 2H), 1.42 (s, 9H), 1.36 (d, J = 6.3 Hz, 3H), 1.09-0.99 (m, 4H), 0.56-0.44 (m, 2H), 0.20-0.08 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.56, 154.96, 141.18, 140.86, 139.40, 128.81, 128.71, 127.41, 127.09, 126.76, 126.51, 126.33, 83.14, 79.68, 74.08, 73.85, 49.18, 30.94, 28.31, 16.04, 10.62, 3.24, 2.75. 19 (Thin film) ESIMS m/z 428 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.28 3356, 2923, ([M + Na].sup.+) (dd, J = 5.1, 1.2 Hz, 1H), 7.24-7.17 2850, 1712 (m, 2H), 7.07 (dd, J = 3.5, 1.2 Hz, 1H), 6.97 (dd, J = 5.0, 3.5 Hz, 1H), 6.95-6.85 (m, 3H), 5.46-5.34 (m, 2H), 5.06 (d, J = 7.0 Hz, 1H), 4.41-4.22 (m, 1H), 1.44 (s, 9H), 1.29 (d, J = 7.2 Hz, 3H), 1.25 (d, J = 6.0 Hz, 3H). 20 (Thin film) ESIMS m/z 428 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.31-7.17 3358, 2979, ([M + Na].sup.+) (m, 3H), 7.07 (dt, J = 3.4, 1.0 2929, 1712 Hz, 1H), 7.00-6.85 (m, 4H), 5.42 (d, J = 5.1 Hz, 1H), 5.39-5.31 (m, 1H), 5.06-4.93 (m, 1H), 4.40-4.21 (m, 1H), 1.43 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.21 (d, J = 7.2 Hz, 3H). 21 ESIMS m/z 491 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.40-7.29 [(M + Na).sup.+] (m, 6H), 6.97 (dd, J = 8.8, 2.6 Hz, 1H), 6.64 (d, J = 8.9 Hz, 1H), 5.50-5.37 (m, 1H), 5.14 (d, J = 6.8 Hz, 1H), 5.07 (d, J = 8.1 Hz, 1H), 4.37-4.24 (m, 1H), 1.44 (s, 9H), 1.29 (d, J = 7.2 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 206.90, 172.67, 155.04, 151.85, 136.01, 130.07, 128.88, 128.81, 127.30, 127.18, 125.99, 124.11, 115.42, 82.78, 79.76, 73.14, 49.33, 28.33, 18.68, 16.21. 22 ESIMS m/z 401 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.66 ([M + H].sup.+) (d, J = 2.2 Hz, 1H), 8.55 (dd, J = 4.8, 1.7 Hz, 1H), 7.74 (dt, J = 7.9, 2.0 Hz, 1H), 7.33-7.27 (m, 1H), 7.24-7.10 (m, 2H), 6.92 (tt, J = 7.3, 1.1 Hz, 1H), 6.87-6.74 (m, 2H), 5.32-5.24 (m, 1H), 5.21 (d, J = 5.4 Hz, 1H), 4.95 (d, J = 7.4 Hz, 1H), 4.31-4.14 (m, 1H), 1.42 (s, 9H), 1.40 (d, J = 6.3 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). 23 (Thin film) ESIMS m/z 407 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.80 3351, 2979, ([M + H].sup.+) (dd, J = 3.2, 1.3 Hz, 1H), 7.35 (t, J = 1704, 1491 3.2 Hz, 1H), 7.25-7.16 (m, 2H), 7.03-6.89 (m, 3H), 5.66-5.54 (m, 1H), 5.54-5.45 (m, 1H), 5.18-5.01 (m, 1H), 4.38-4.22 (m, 1H), 1.44 (s, 9H), 1.35 (d, J = 6.4 Hz, 3H), 1.25 (d, J = 7.8 Hz, 3H). 24 ESIMS m/z 494 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.59-7.51 ([M + H].sup.+) (m, 4H), 7.46-7.40 (m, 3H), 7.35 (ddd, J = 4.9, 4.1, 2.6 Hz, 2H), 7.16-7.09 (m, 1H), 6.61 (ddt, J = 13.3, 4.6, 2.3 Hz, 3H), 5.33-5.27 (m, 2H), 5.23 (d, J = 4.9 Hz, 1H), 4.95 (d, J = 7.2 Hz, 1H), 4.30-4.20 (m, 1H), 1.42 (s, 9H), 1.40 (d, J = 6.4 Hz, 3H), 1.11 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 164.64, 141.66, 140.57, 137.60, 130.24, 129.12, 128.84, 127.58, 127.20, 127.14, 125.75, 125.53, 111.62, 108.30, 108.09, 103.94, 103.69, 99.99, 81.63, 74.01, 60.39, 28.29, 18.39, 14.90, 14.20. 25 ESIMS m/z 380.6 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.38-7.27 ([M + H].sup.+) (m, 5H), 5.26-4.89 (m, 2H), 4.39-4.26 (m, 1H), 4.22 (d, J = 6.8 Hz, 1H), 3.15-2.97 (m, 2H), 1.92-1.74 (m, 1H), 1.44 (s, 9H), 1.35 (dd, J = 7.0, 2.6 Hz, 3H), 1.06 (d, J = 6.5 Hz, 3H), 0.86 (d, J = 6.7 Hz, 6H). 26 ESIMS m/z 380.6 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.37-7.27 ([M + H].sup.+) (m, 5H), 5.11-5.03 (m, 1H), 4.97 (d, J = 7.9 Hz, 1H), 4.22 (d, J = 6.1 Hz, 1H), 4.18 (d, J = 8.1 Hz, 1H), 3.14 (dd, J = 8.8, 6.5 Hz, 1H), 3.04 (dd, J = 8.8, 6.4 Hz, 1H), 1.92-1.76 (m, 1H), 1.43 (s, 9H), 1.30 (d, J = 6.3 Hz, 3H), 1.06 (d, J = 7.2 Hz, 3H), 0.90 (d, J = 3.9 Hz, 3H), 0.88 (d, J = 3.9 Hz, 3H). 27 ESIMS m/z 388 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.39-7.27 ([M + Na].sup.+) (m, 5H), 5.22-5.10 (m, 1H), 5.09 (d, J = 7.8 Hz, 1H), 4.40-4.27 (m, 1H), 4.22 (d, J = 6.9 Hz, 1H), 3.36-3.16 (m, 2H), 1.60-1.48 (m, 2H), 1.44 (s, 9H), 1.35 (d, J = 7.1 Hz, 3H), 1.06 (d, J = 6.5 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H). 28 ESIMS m/z 388 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.39-7.27 ([M + Na].sup.+) (m, 5H), 5.18-5.02 (m, 1H), 4.98 (d, J = 8.0 Hz, 1H), 4.24 (d, J = 6.1 Hz, 1H), 4.23-4.12 (m, 1H), 3.33 (dt, J = 9.1, 6.6 Hz, 1H), 3.25 (dt, J = 9.1, 6.4 Hz, 1H), 1.57 (dtd, J = 13.8, 7.4, 6.5 Hz, 2H), 1.43 (s, 9H), 1.29 (d, J = 6.4 Hz, 3H), 1.06 (d, J = 7.2 Hz, 3H), 0.90 (t, J = 7.4 Hz, 3H). 29 ESIMS m/z 360 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.28 ([M + Na].sup.+) (m, 5H), 5.24-5.12 (m, 1H), 5.08 (d, J = 5.5 Hz, 1H), 4.40-4.24 (m, 1H), 4.11 (d, J = 6.9 Hz, 1H), 3.90 (s, 3H), 1.44 (s, 9H), 1.36 (d, J = 7.0 Hz, 3H), 1.07 (d, J = 6.5 Hz, 3H). 30 ESIMS m/z 360 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.38-7.28 ([M + Na].sup.+) (m, 5H), 5.16-5.05 (m, 1H), 4.97 (d, J = 7.7 Hz, 1H), 4.31-4.18 (m, 1H), 4.17 (d, J = 5.9 Hz, 1H), 3.26 (s, 3H), 1.43 (s, 9H), 1.28 (d, J = 6.4 Hz, 3H), 1.08 (d, J = 7.2 Hz, 3H). 31 ESIMS m/z 400 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.36-7.28 ([M + Na].sup.+) (m, 5H), 5.22-5.11 (m, 1H), 5.10 (d, J = 5.1 Hz, 1H), 4.37-4.27 (m, 2H), 3.90 (s, 3H), 3.21-3.08 (m, 2H), 1.44 (s, 9H), 1.37 (d, J = 7.1 Hz, 3H), 1.08 (d, J = 6.5 Hz, 3H), 1.01-0.94 (m, 1H), 0.54-0.39 (m, 2H), 0.17-0.02 (m, 2H). 32 ESIMS m/z 476 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.62 ([M + H].sup.+) (s, 1H), 7.55 (d, J = 7.4 Hz, 2H), 7.51 (dd, J = 7.0, 1.7 Hz, 1H), 7.46-7.32 (m, 5H), 7.19 (dd, J = 8.2, 7.6 Hz, 2H), 6.88 (dd, J = 13.9, 7.9 Hz, 3H), 5.34-5.28 (m, 1H), 5.25 (d, J = 5.0 Hz, 1H), 4.96 (d, J = 7.3 Hz, 1H), 4.29-4.17 (m, 1H), 1.44-1.39 (m, 12H), 1.09 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.80, 157.95, 154.98, 141.49, 140.68, 138.25, 129.41, 129.01, 128.81, 127.50, 127.13, 126.97, 125.86, 125.65, 121.29, 116.04, 81.38, 74.23, 49.24, 28.30, 18.39, 15.03. 33 ESIMS m/z 498 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.58-7.54 ([M + Na].sup.+) (m, 4H), 7.48-7.40 (m, 4H), 7.36-7.31 (m, 1H), 7.23-7.17 (m, 2H), 6.93-6.84 (m, 3H), 5.29 (p, J = 6.3 Hz, 1H), 5.23 (d, J = 4.9 Hz, 1H), 4.96 (d, J = 7.1 Hz, 1H), 4.31-4.20 (m, 1H), 1.42 (s, 9H), 1.40 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.77, 157.90, 141.05, 140.53, 136.56, 129.40, 128.77, 127.42, 127.39, 127.24, 127.04, 121.25, 116.00, 81.03, 74.17, 49.29, 28.30, 18.47, 15.03. 34 ESIMS m/z 418 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.40-7.34 ([M + H].sup.+) (m, 2H), 7.22-7.15 (m, 2H), 7.02 (dd, J = 14.6, 5.9 Hz, 2H), 6.90 (t, J = 7.4 Hz, 1H), 6.83-6.78 (m, 2H), 5.26-5.19 (m, 1H), 5.15 (d, J = 5.1 Hz, 1H), 4.94 (d, J = 7.2 Hz, 1H), 4.24 (dt, J = 13.4, 6.8 Hz, 1H), 1.42 (s, 9H), 1.37 (d, J = 6.4 Hz, 3H), 1.13 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.75 (s, 1F). 35 ESIMS m/z 419 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.39-7.27 ([M + H].sup.+) (m, 5H), 6.90-6.81 (m, 2H), 6.81-6.68 (m, 2H), 5.24 (qd, J = 6.4, 4.8 Hz, 1H), 5.09 (d, J = 4.9 Hz, 1H), 5.00-4.89 (m, 1H), 4.32-4.16 (m, 1H), 1.42 (s, 9H), 1.36 (d, J = 6.5 Hz, 3H), 1.12 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.15. 36 ESIMS m/z 437 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.39-7.29 ([M + H].sup.+) (m, 2H), 7.11-6.98 (m, 2H), 6.92-6.81 (m, 2H), 6.79-6.68 (m, 2H), 5.39-5.27 (m, 1H), 5.05-4.98 (m, 2H), 4.38-4.25 (m, 1H), 1.44 (s, 9H), 1.27 (d, J = 7.3 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.06, −122.98. 37 ESIMS m/z 449 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.44-7.27 ([M + H].sup.+) (m, 5H), 7.19-7.12 (m, 1H), 6.78 (ddd, J = 8.4, 2.2, 0.8 Hz, 1H), 6.54 (d, J = 8.4 Hz, 1H), 5.35-5.27 (m, 1H), 5.20 (d, J = 4.8 Hz, 1H), 4.97 (d, J = 7.2 Hz, 1H), 4.37-4.15 (m, 1H), 2.19 (s, 3H), 1.46-1.32 (m, 12H), 1.15 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.71, 151.07, 137.00, 131.53, 130.75, 128.57, 128.54, 128.31, 127.84, 126.97, 123.12, 115.12, 82.12, 79.73, 74.17, 28.30, 20.24, 18.45. 38 ESIMS m/z 467 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.44-7.32 ([M + H].sup.+) (m, 2H), 7.15 (dd, J = 2.2, 0.8 Hz, 1H), 7.10-6.96 (m, 2H), 6.80 (ddd, J = 8.5, 2.1, 0.8 Hz, 1H), 6.53 (d, J = 8.4 Hz, 1H), 5.27 (qd, J = 6.4, 4.8 Hz, 1H), 5.18 (d, J = 4.9 Hz, 1H), 4.96 (d, J = 8.2 Hz, 1H), 4.36-4.12 (m, 1H), 2.20 (s, 3H), 1.42 (s, 9H), 1.41 (d, J = 8.0 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-113.45. 39 ESIMS m/z 436 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.43 ([M + H].sup.+) (td, J = 8.7, 6.5 Hz, 1H), 7.25-7.16 (m, 2H), 6.95-6.89 (m, 1H), 6.89-6.78 (m, 4H), 5.47 (d, J = 5.8 Hz, 1H), 5.33 (p, J = 6.1 Hz, 1H), 4.97 (d, J = 7.2 Hz, 1H), 4.32-4.18 (m, 1H), 1.43 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.17 (d, J = 7.2 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.59 (d, J = 6.7 Hz), −113.96 (s). 40 ESIMS m/z 414 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.27 ([M + H].sup.+) (d, J = 6.8 Hz, 3H), 7.19-7.11 (m, 4H), 6.87 (t, J = 7.4 Hz, 1H), 6.82 (d, J = 7.8 Hz, 2H), 5.28-5.21 (m, 1H), 5.15 (d, J = 4.8 Hz, 1H), 4.96 (d, J = 7.2 Hz, 1H), 4.29-4.19 (m, 1H), 2.31 (s, 3H), 1.42 (s, 9H), 1.35 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.73, 157.95, 137.83, 134.48, 129.33, 129.19, 126.87, 121.09, 115.96, 81.07, 74.22, 28.31, 21.15, 18.51, 14.93. 41 ESIMS m/z 452 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.37 ([M + Na].sup.+). (d, J = 7.6 Hz, 1H), 7.26-7.21 (m, 1H), 7.16 (t, J = 7.8 Hz, 2H), 6.86 (dt, J = 18.3, 8.1 Hz, 5H), 5.66 (d, J = 4.6 Hz, 1H), 5.39-5.31 (m, 1H), 5.01 (s, 1H), 4.25 (s, 1H), 3.91 (s, 3H), 1.42 (s, 9H), 1.33 (d, J = 6.5 Hz, 3H), 1.17 (d, J = 7.2 Hz, 3H). .sup.13C NMR (376 MHz, CDCl.sub.3) δ 172.50, 157.92, 156.64, 154.95, 129.29, 129.11, 127.82, 125.54, 120.89, 120.85, 115.65, 110.22, 79.63, 74.92, 73.02, 55.48, 49.36, 28.32, 18.60, 15.02. 42 ESIMS m/z 470 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.33 ([M + Na].sup.+) (t, J = 7.7 Hz, 1H), 7.17 (t, J = 7.9 Hz, 2H), 6.87 (t, J = 7.3 Hz, 1H), 6.80 (d, J = 8.2 Hz, 2H), 6.60 (dd, J = 13.0, 5.7 Hz, 2H), 5.58 (d, J = 4.7 Hz, 1H), 5.33 (dd, J = 11.9, 5.7 Hz, 1H), 4.99 (s, 1H), 4.25 (s, 1H), 3.90 (s, 3H), 1.42 (s, 9H), 1.32 (d, J = 6.5 Hz, 3H), 1.18 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.46, 163.39 (d, J = 246.4 Hz), 157.82 (d, J = 9.7 Hz), 157.68, 154.95, 129.34, 128.98 (d, J = 10.1 Hz), 121.31 (d, J = 3.2 Hz), 121.07, 115.60, 107.38 (d, J = 21.3 Hz), 98.70 (d, J = 25.8 Hz), 79.70, 74.55, 72.89, 55.78, 49.36, 28.31, 18.59, 15.08. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.26 (s, 1F). 43 ESIMS m/z 462 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.27 ([M + H].sup.+) (d, J = 6.6 Hz, 2H), 7.19-7.08 (m, 3H), 6.78 (ddd, J = 8.6, 2.1, 0.9 Hz, 1H), 6.54 (d, J = 8.4 Hz, 1H), 5.33-5.23 (m, 1H), 5.17 (d, J = 4.6 Hz, 1H), 4.98 (d, J = 8.0 Hz, 1H), 4.37-4.15 (m, 1H), 2.31 (s, 3H), 2.19 (s, 3H), 1.42 (s, 9H), 1.39 (d, J = 6.5 Hz, 3H), 1.17 (d, J = 7.2 Hz, 3H). 44 ESIMS m/z 432 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.28-7.21 ([M + H].sup.+) (m, 2H), 7.14 (d, J = 7.8 Hz, 2H), 6.89-6.80 (m, 2H), 6.80-6.72 (m, 2H), 5.23 (qd, J = 6.4, 4.7 Hz, 1H), 5.06 (d, J = 4.8 Hz, 1H), 5.02-4.92 (m, 1H), 4.33-4.17 (m, 1H), 2.31 (s, 3H), 1.42 (s, 9H), 1.35 (d, J = 6.4 Hz, 3H), 1.15 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.28. 45 ESIMS m/z 436 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.30 ([M + H].sup.+) (m, 2H), 7.09-6.97 (m, 2H), 6.90-6.81 (m, 2H), 6.80-6.66 (m, 2H), 5.22 (qd, J = 6.4, 4.9 Hz, 1H), 5.08 (d, J = 5.1 Hz, 1H), 5.04-4.91 (m, 1H), 4.31-4.18 (m, 1H), 1.42 (s, 9H), 1.36 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.44, −122.75. 46 ESIMS m/z 430 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.24 ([M + H].sup.+) (t, J = 7.9 Hz, 1H), 7.20-7.15 (m, 2H), 6.98 (d, J = 7.6 Hz, 1H), 6.94-6.92 (m, 1H), 6.89 (t, J = 7.4 Hz, 1H), 6.85-6.78 (m, 3H), 5.28-5.21 (m, 1H), 5.15 (d, J = 4.9 Hz, 1H), 4.97 (d, J = 5.5 Hz, 1H), 4.31-4.17 (m, 1H), 3.77 (s, 3H), 1.42 (s, 9H), 1.37 (d, J = 6.4 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.72, 159.79, 157.98, 154.99, 139.27, 129.54, 129.35, 121.23, 119.32, 115.98, 113.49, 112.51, 81.16, 79.76, 74.18, 55.20, 49.30, 28.30, 18.44, 14.92. 47 ESIMS m/z 432 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.36 ([M + H].sup.+) (dd, J = 8.6, 5.9 Hz, 1H), 7.20-7.15 (m, 2H), 6.85 (ddd, J = 12.0, 11.1, 5.0 Hz, 3H), 6.76-6.71 (m, 2H), 5.36 (d, J = 5.0 Hz, 1H), 5.21-5.13 (m, 1H), 4.93 (d, J = 7.0 Hz, 1H), 4.24 (s, 1H), 2.50 (s, 3H), 1.43-1.39 (m, 12H), 1.09 (d, J = 7.2 Hz, 3H). .sup.19F NMR (101 MHz, CDCl.sub.3) δ-114.88 (s, 1F). 48 ESIMS m/z 474 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.48 ([M + Na].sup.+) (dd, J = 8.8, 6.1 Hz, 1H), 7.24-7.17 (m, 2H), 7.13 (dd, J = 8.4, 2.6 Hz, 1H), 6.94 (ddd, J = 18.0, 11.6, 4.9 Hz, 2H), 6.82-6.77 (m, 2H), 5.61 (d, J = 5.4 Hz, 1H), 5.35-5.28 (m, 1H), 4.97 (d, J = 5.8 Hz, 1H), 4.32-4.21 (m, 1H), 1.42 (s, 9H), 1.39 (d, J = 6.4 Hz, 3H), 1.17 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.26 (s, 1F). 49 ESIMS m/z 432 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.30 ([M + H].sup.+) (t, J = 7.7 Hz, 1H), 7.22-7.16 (m, 2H), 6.92-6.81 (m, 5H), 5.48 (d, J = 5.6 Hz, 1H), 5.34 (p, J = 6.3 Hz, 1H), 4.99 (d, J = 6.4 Hz, 1H), 4.31-4.18 (m, 1H), 2.30 (s, 3H), 1.42 (s, 9H), 1.38 (d, J = 6.4 Hz, 3H), 1.16 (d, J = 7.1 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-119.17 (s, 1F). 50 ESIMS m/z 450 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.40 ([M + H].sup.+) (d, J = 8.5 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.64 (t, J = 8.0 Hz, 2H), 7.54 (t, J = 7.5 Hz, 1H), 7.44-7.38 (m, 1H), 7.12 (dd, J = 8.5, 7.5 Hz, 2H), 6.85 (t, J = 7.3 Hz, 1H), 6.79 (d, J = 8.5 Hz, 2H), 6.07 (d, J = 4.0 Hz, 1H), 5.46-5.39 (m, 1H), 4.96 (d, J = 5.1 Hz, 1H), 4.31-4.18 (m, 1H), 1.44-1.38 (m, 12H), 1.00 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 173.23, 158.01, 155.02, 133.75, 133.03, 130.60, 129.39, 129.02, 128.66, 126.78, 125.85, 125.47, 124.72, 122.88, 121.13, 115.68, 79.78, 77.52, 73.84, 49.25, 28.31, 18.25, 14.36. 51 ESIMS m/z 467 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.87-7.77 ([M + NH.sub.4].sup.+) (m, 4H), 7.53 (dd, J = 8.5, 1.6 Hz, 1H), 7.50-7.44 (m, 2H), 7.16 (dd, J = 9.6, 6.5 Hz, 2H), 6.90-6.84 (m, 3H), 5.40-5.31 (m, 2H), 4.94 (d, J = 5.8 Hz, 1H), 4.31-4.18 (m, 1H), 1.43-1.38 (m, 12H), 1.09 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.74, 157.99, 154.99, 135.15, 133.18, 133.10, 129.38, 128.44, 127.94, 127.73, 126.32, 126.28, 126.20, 124.37, 121.28, 116.07, 81.46, 79.77, 74.22, 49.27, 28.30, 18.43, 14.95. 52 ESIMS m/z 491 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.34 ([M + NH.sub.4].sup.+) (dd, J = 9.2, 6.1 Hz, 1H), 7.21-7.15 (m, 2H), 6.88 (t, J = 7.4 Hz, 1H), 6.81 (d, J = 7.9 Hz, 2H), 6.61 (ddd, J = 10.9, 5.1, 2.4 Hz, 2H), 6.09 (ddt, J = 17.2, 10.4, 5.1 Hz, 1H), 5.63 (d, J = 4.6 Hz, 1H), 5.47 (ddd, J = 17.3, 3.0, 1.5 Hz, 1H), 5.39-5.31 (m, 2H), 5.02 (d, J = 6.1 Hz, 1H), 4.67-4.56 (m, 2H), 4.32-4.19 (m, 1H), 1.42 (s, 9H), 1.32 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.28 (s, 1F). 53 ESIMS m/z 504 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.34 ([M + Na].sup.+) (ddd, J = 9.5, 8.5, 4.1 Hz, 2H), 7.05-7.00 (m, 1H), 6.82 (td, J = 7.7, 1.3 Hz, 1H), 6.67-6.60 (m, 3H), 5.66 (d, J = 4.4 Hz, 1H), 5.41-5.32 (m, 1H), 5.01 (d, J = 6.6 Hz, 1H), 4.33-4.21 (m, 1H), 3.90 (s, 3H), 1.42 (s, 9H), 1.36 (d, J = 6.5 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.78 (s). 54 ESIMS m/z 484 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.35-7.29 ([M + Na].sup.+) (m, 1H), 7.21-7.14 (m, 2H), 6.88 (t, J = 7.3 Hz, 1H), 6.81 (d, J = 7.9 Hz, 2H), 6.62-6.55 (m, 2H), 5.60 (d, J = 4.4 Hz, 1H), 5.39-5.31 (m, 1H), 5.03 (d, J = 5.3 Hz, 1H), 4.33-4.20 (m, 1H), 4.10 (q, J = 7.0 Hz, 2H), 1.49 (t, J = 7.0 Hz, 3H), 1.42 (s, 9H), 1.31 (d, J = 6.5 Hz, 3H), 1.20 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.52 (s, 1F). 56 ESIMS m/z 461 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.23 ([M + NH.sub.4].sup.+) (d, J = 7.6 Hz, 1H), 7.19-7.13 (m, 2H), 6.88-6.79 (m, 3H), 6.70 (d, J = 7.8 Hz, 2H), 5.61 (d, J = 4.5 Hz, 1H), 5.37-5.30 (m, 1H), 5.04 (d, J = 5.9 Hz, 1H), 4.32-4.20 (m, 1H), 3.89 (s, 3H), 2.31 (s, 3H), 1.42 (s, 9H), 1.31 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.50, 157.97, 156.56, 154.98, 139.18, 129.26, 127.66, 122.44, 121.53, 120.79, 115.64, 111.13, 79.64, 74.88, 73.09, 55.42, 49.39, 28.33, 21.56, 18.64, 14.97. 57 ESIMS m/z 518 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.36 ([M + Na].sup.+) (dd, J = 8.7, 6.7 Hz, 1H), 7.14 (d, J = 1.7 Hz, 1H), 6.81 (dd, J = 8.4, 1.6 Hz, 1H), 6.63 (dd, J = 12.8, 5.8 Hz, 2H), 6.54 (d, J = 8.4 Hz, 1H), 5.61 (d, J = 4.4 Hz, 1H), 5.39-5.32 (m, 1H), 5.02 (d, J = 6.1 Hz, 1H), 4.32-4.19 (m, 1H), 3.89 (s, 3H), 2.20 (s, 3H), 1.42 (s, 9H), 1.35 (d, J = 6.5 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.94 (s). 58 ESIMS m/z 514 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.26 ([M + Na].sup.+) (d, J = 7.7 Hz, 1H), 7.12 (d, J = 1.8 Hz, 1H), 6.79 (dd, J = 8.4, 1.6 Hz, 1H), 6.72 (d, J = 7.9 Hz, 1H), 6.69 (s, 1H), 6.56 (d, J = 8.4 Hz, 1H), 5.63 (d, J = 4.2 Hz, 1H), 5.37 (qd, J = 6.5, 4.4 Hz, 1H), 5.05 (d, J = 7.1 Hz, 1H), 4.32-4.20 (m, 1H), 3.88 (s, 3H), 2.31 (s, 3H), 2.18 (s, 3H), 1.42 (s, 9H), 1.35 (d, J = 6.5 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.46, 156.52, 154.99, 151.15, 139.39, 130.93, 130.58, 127.85, 127.70, 122.80, 121.86, 121.61, 114.38, 111.08, 79.60, 75.69, 73.10, 55.41, 49.41, 28.31, 21.58, 20.20, 18.65, 14.85. 59 ESIMS m/z 510 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.35-7.30 ([M + Na].sup.+) (m, 1H), 7.21-7.16 (m, 2H), 6.88 (t, J = 7.3 Hz, 1H), 6.83 (d, J = 7.8 Hz, 2H), 6.62-6.54 (m, 2H), 5.63 (d, J = 4.7 Hz, 1H), 5.39-5.32 (m, 1H), 5.02 (d, J = 8.5 Hz, 1H), 4.31-4.21 (m, 1H), 3.89 (d, J = 6.8 Hz, 2H), 1.42 (s, 9H), 1.36-1.27 (m, 4H), 1.21 (d, J = 7.2 Hz, 3H), 0.71-0.65 (m, 2H), 0.40 (q, J = 4.6 Hz, 2H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.48 (s). 60 ESIMS m/z 498 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.37 ([M + H].sup.+) (dd, J = 8.6, 6.6 Hz, 1H), 7.22-7.15 (m, 2H), 6.89 (t, J = 7.4 Hz, 1H), 6.82-6.77 (m, 2H), 6.69 (td, J = 8.3, 2.3 Hz, 1H), 6.59 (dd, J = 10.2, 2.3 Hz, 1H), 6.24 (tt, J = 54.8, 4.0 Hz, 1H), 5.59 (d, J = 4.3 Hz, 1H), 5.35-5.29 (m, 1H), 5.00 (d, J = 6.3 Hz, 1H), 4.34-4.18 (m, 3H), 1.42 (s, 9H), 1.32 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.58 (s), −124.95 (d, J = 296.8 Hz), −125.95 (d, J = 296.7 Hz). 61 ESIMS m/z 566 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.53 ([M + Na].sup.+) (dd, J = 8.7, 6.5 Hz, 1H), 7.45-7.39 (m, 2H), 7.33 (dd, J = 7.9, 1.6 Hz, 1H), 7.22 (t, J = 7.4 Hz, 1H), 7.09-7.01 (m, 3H), 6.85 (td, J = 7.7, 1.2 Hz, 1H), 6.76 (dd, J = 13.8, 5.4 Hz, 2H), 6.50 (dd, J = 10.1, 2.4 Hz, 1H), 5.78 (d, J = 4.6 Hz, 1H), 5.53-5.46 (m, 1H), 5.05 (d, J = 6.2 Hz, 1H), 4.36-4.22 (m, 1H), 1.43 (d, J = 6.6 Hz, 3H), 1.42 (s, 9H), 1.25 (d, J = 6.8 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.21 (s). 62 ESIMS m/z 278 ([M + H].sup.+) 63 ESIMS m/z 301 ([M + H].sup.+) 64 ESIMS m/z 300 ([M + H].sup.+) 65 ESIMS m/z 300 ([M + H].sup.+) 66 ESIMS m/z 334 ([M + H].sup.+) 67 ESIMS m/z 334 ([M + H].sup.+) 68 ESIMS m/z 334 ([M + H].sup.+) 69 ESIMS m/z 368 ([M + H].sup.+) 70 ESIMS m/z 336 ([M + H].sup.+) 71 ESIMS m/z 352 ([M + H].sup.+) 72 ESIMS m/z 350 ([M + H].sup.+) 73 ESIMS m/z 366 ([M + H].sup.+) 74 ESIMS m/z 368 ([M + H].sup.+) 75 ESIMS m/z 396 ([M + H].sup.+) 76 ESIMS m/z 318 ([M + H].sup.+) 77 ESIMS m/z 394 ([M + H].sup.+) 78 ESIMS m/z 354 ([M + H].sup.+) 79 ESIMS m/z 354 ([M + H].sup.+) 80 ESIMS m/z 368 ([M + H].sup.+) 81 ESIMS m/z 394 ([M + H].sup.+) 82 ESIMS m/z 280 ([M + H].sup.+) 83 ESIMS m/z 280 ([M + H].sup.+) 84 ESIMS m/z 376 ([M + H].sup.+) 85 ESIMS m/z 376 ([M + H].sup.+) 86 ESIMS m/z 319 ([M + H].sup.+) 87 ESIMS m/z 337 ([M + H].sup.+) 88 ESIMS m/z 348 ([M + H].sup.+) 89 ESIMS m/z 366 ([M + H].sup.+) 90 ESIMS m/z 318 ([M + H].sup.+) 91 ESIMS m/z 336 ([M + H].sup.+) 92 ESIMS m/z 314 ([M + H].sup.+) 93 ESIMS m/z 330 ([M + H].sup.+) 94 ESIMS m/z 348 ([M + H].sup.+) 95 ESIMS m/z 362 ([M + H].sup.+) 96 ESIMS m/z 332 ([M + H].sup.+) 97 ESIMS m/z 336 ([M + H].sup.+) 98 ESIMS m/z 330 ([M + H].sup.+) 99 ESIMS m/z 332 ([M + H].sup.+) 100 ESIMS m/z 352 ([M + H].sup.+) 101 ESIMS m/z 332 ([M + H].sup.+) 102 ESIMS m/z 350 ([M + H].sup.+) 103 ESIMS m/z 350 ([M + H].sup.+) 104 ESIMS m/z 374 ([M + H].sup.+) 105 ESIMS m/z 382 ([M + H].sup.+) 106 ESIMS m/z 362 ([M + H].sup.+) 107 ESIMS m/z 344 ([M + H].sup.+) 108 ESIMS m/z 396 ([M + H].sup.+) 109 ESIMS m/z 392 ([M + H].sup.+) 110 ESIMS m/z 388 ([M + H].sup.+) 111 ESIMS m/z 398 ([M + H].sup.+) 112 ESIMS m/z 444 ([M + H].sup.+) 113 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.12 [M].sup.+ calcd for (d, J = 0.6 Hz, 1H), 8.40 (d, J = 8.1 C.sub.23H.sub.28N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 428.1947; found, 7.36-7.19 (m, 5H), 6.86 (d, J = 5.2 428.1953 Hz, 1H), 5.14 (h, J = 6.3 Hz, 1H), 4.66-4.52 (m, 1H), 4.33 (d, J = 6.4 Hz, 1H), 3.94 (s, 3H), 3.26-3.12 (m, 2H), 1.35 (d, J = 6.3 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H), 1.01 (ttt, J = 8.1, 6.7, 4.8 Hz, 1H), 0.54-0.40 (m, 2H), 0.19-0.04 (m, 2H). 114 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.08 [M].sup.+ calcd for (s, 1H), 8.40 (d, J = 7.9 Hz, 1H), C.sub.25H.sub.26N.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.42-7.34 450.1791; found, (m, 2H), 7.35-7.20 (m, 3H), 7.21-7.08 450.1795 (m, 2H), 6.91-6.75 (m, 4H), 5.30 (qd, J = 6.5, 5.2 Hz, 1H), 5.20 (d, J = 5.1 Hz, 1H), 4.64 (p, J = 7.3 Hz, 1H), 3.93 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.55, 168.65, 157.83, 155.34, 148.72, 140.44, 137.48, 130.40, 129.34, 128.53, 128.19, 126.95, 121.19, 115.92, 109.42, 81.18, 74.52, 56.06, 47.93, 18.02, 15.09. 115 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 3367.32, 2984.27, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.9 1737.93, 1648.90, C.sub.25H.sub.27N.sub.2O.sub.6, Hz, 1H), 7.99 (d, J = 5.2 Hz, 1H), 1527.87, 1480.95, 451.1864; found, 7.42-7.37 (m, 2H), 7.35-7.28 (m, 1237.99 451.1869 2H), 7.20-7.11 (m, 2H), 6.90-6.80 (m, 5H), 5.32-5.22 (m, 2H), 4.73-4.49 (m, 1H), 3.95 (s, 3H), 1.45 (d, J = 7.2 Hz, 3H), 1.37 (d, J = 6.3 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.45, 168.64, 157.85, 155.38, 148.76, 140.45, 137.46, 130.48, 129.35, 128.54, 128.12, 126.83, 121.22, 116.05, 109.44, 81.10, 74.75, 56.08, 47.92, 18.13, 14.56. 116 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.08 3367.65, 2984.35, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.40 (d, J = 7.9 1738.51, 1648.67, C.sub.25H.sub.27N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 1528.19, 1480.80, 451.1864; found, 7.43-7.37 (m, 2H), 7.34-7.27 (m, 1238.38 451.1872 2H), 7.20-7.11 (m, 2H), 6.93-6.78 (m, 5H), 5.30 (qd, J = 6.4, 5.1 Hz, 1H), 5.20 (d, J = 5.1 Hz, 1H), 4.69-4.58 (m, 1H), 3.94 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.55, 168.66, 157.85, 155.36, 148.74, 140.44, 137.50, 130.43, 129.35, 128.54, 128.20, 126.96, 121.20, 115.94, 109.44, 81.21, 74.53, 56.06, 47.94, 18.02, 15.10. 117 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.05 3368, 2939, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.40 (d, J = 7.9 1739, 1648, C.sub.25H.sub.26ClN.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 1577, 1528, 485.1474; found, 7.44-7.38 (m, 2H), 7.36-7.28 (m, 1480, 1446, 485.1476 4H), 7.00 (ddd, J = 8.3, 7.5, 1.7 Hz, 1242, 1059 1H), 6.89-6.77 (m, 2H), 6.66 (dd, J = 8.3, 1.4 Hz, 1H), 5.40-5.30 (m, 1H), 5.28 (d, J = 4.7 Hz, 1H), 4.70-4.59 (m, 1H), 3.94 (s, 3H), 1.45 (d, J = 6.4 Hz, 3H), 1.34 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.59, 168.69, 155.34, 153.24, 148.72, 140.45, 136.73, 130.41, 130.30, 128.63, 128.43, 127.44, 126.89, 123.48, 121.77, 115.06, 109.43, 81.93, 74.57, 56.06, 47.97, 17.97, 14.86. 118 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.04 3368, 2939, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.9 1739, 1648, C.sub.25H.sub.26ClN.sub.2O.sub.6, Hz, 1H), 7.96 (d, J = 5.2 Hz, 1H), 1576, 1528, 485.1474; found, 7.38-7.27 (m, 5H), 7.11-7.02 (m, 1476, 1452, 485.1474 1H), 6.89-6.80 (m, 3H), 6.67 (ddd, 1241 J = 8.3, 2.3, 1.1 Hz, 1H), 5.35-5.24 (m, 1H), 5.19 (d, J = 4.9 Hz, 1H), 4.64 (dq, J = 8.4, 7.3 Hz, 1H), 3.93 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.51, 168.71, 158.47, 155.35, 148.73, 140.47, 136.75, 134.71, 130.35, 130.15, 128.68, 128.43, 126.85, 121.46, 116.56, 113.93, 109.47, 81.40, 74.29, 56.06, 47.99, 17.98, 14.87. 119 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.04 3368, 2939, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.37 (d, J = 8.0 1739, 1649, C.sub.25H.sub.26ClN.sub.2O.sub.6, Hz, 1H), 7.96 (d, J = 5.2 Hz, 1H), 1577, 1529, 485.1474; found, 7.37-7.27 (m, 5H), 7.13-7.05 (m, 1488, 1452, 485.1465 2H), 6.89-6.82 (m, 1H), 6.76-6.69 1240 (m, 2H), 5.35-5.24 (m, 1H), 5.15 (d, J = 4.8 Hz, 1H), 4.70-4.57 (m, 1H), 3.94 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.34 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.50, 168.74, 156.35, 155.37, 148.74, 140.45, 136.88, 130.33, 129.24, 128.65, 128.39, 126.86, 126.09, 117.14, 109.43, 81.55, 74.31, 56.08, 48.03, 17.95, 14.81. 120 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.00 3368, 2939, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.37 (d, J = 7.8 1739, 1648, C.sub.25H.sub.25Cl.sub.2N.sub.2O.sub.6, Hz, 1H), 7.96 (d, J = 5.2 Hz, 1H), 1576, 1528, 519.1084; found, 7.40-7.25 (m, 6H), 6.94 (dd, J = 1478, 1452, 519.1067 8.8, 2.5 Hz, 1H), 6.89-6.82 (m, 1262, 1243, 1H), 6.55 (d, J = 8.8 Hz, 1H), 5.38-5.30 1058 (m, 1H), 5.23 (d, J = 4.5 Hz, 1H), 4.71-4.58 (m, 1H), 3.94 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.37 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.51, 168.77, 155.34, 151.97, 148.72, 140.46, 136.16, 130.31, 129.97, 128.75, 128.62, 127.35, 126.80, 126.14, 124.24, 115.67, 109.42, 82.26, 74.33, 56.08, 48.08, 17.90, 14.64. 121 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.05 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.9 C.sub.25H.sub.25F.sub.2N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 487.1675; found, 7.43-7.27 (m, 5H), 6.96 (ddd, J = 487.1675 10.6, 8.9, 5.3 Hz, 1H), 6.86 (dd, J = 5.3, 0.7 Hz, 1H), 6.58-6.43 (m, 2H), 5.35 (qd, J = 6.4, 5.1 Hz, 1H), 5.18 (d, J = 5.1 Hz, 1H), 4.70-4.58 (m, 1H), 3.94 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.32 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.48, 168.67, 158.31 (dd, J = 242.3, 2.6 Hz), 155.36, 149.45 (d, J = 239.0 Hz), 148.74, 146.17 (dd, J = 12.6, 10.5 Hz), 140.46, 136.19, 130.39, 128.71, 126.99, 116.40 (dd, J = 20.9, 10.1 Hz), 109.45, 107.72 (dd, J = 23.7, 6.9 Hz), 105.13 (dd, J = 27.3, 1.5 Hz), 83.03, 74.07, 56.07, 47.91, 17.93, 15.13. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.63 (d, J = 15.0 Hz), −138.72 (d, J = 15.0 Hz). 122 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.01 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.38 (d, J = 7.8 C.sub.25H.sub.25ClFN.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 503.1380; found, 7.38-7.27 (m, 5H), 6.86 (dd, J = 503.1361 5.3, 0.7 Hz, 1H), 6.66-6.58 (m, 2H), 6.41 (dt, J = 10.5, 2.3 Hz, 1H), 5.29 (qd, J = 6.4, 4.7 Hz, 1H), 5.16 (d, J = 4.8 Hz, 1H), 4.70-4.58 (m, 1H), 3.94 (s, 3H), 1.36 (app dd, J = 6.8, 2.3 Hz, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.45, 168.74, 163.09 (d, J = 248.1 Hz), 159.18 (d, J = 12.3 Hz), 155.37, 148.74, 140.47, 136.11, 135.26 (d, J = 13.4 Hz), 130.30, 128.80, 128.65, 126.76, 112.46 (d, J = 3.2 Hz), 109.48, 109.24 (d, J = 25.1 Hz), 102.15 (d, J = 25.0 Hz), 81.71, 74.04, 56.06, 48.02, 17.95, 14.76. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-109.82. 123 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.08 3371, 2972, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.43 (d, J = 8.4 2939, 1739, C.sub.26H.sub.27F.sub.2N.sub.2O.sub.6, Hz, 1H), 7.98 (d, J = 5.2 Hz, 1H), 1650, 1577, 501.1832; found, 7.42-7.36 (m, 2H), 7.36-7.28 (m, 1509, 1432, 501.1831 3H), 6.96 (ddd, J = 10.5, 9.0, 5.3 1251, 1203, Hz, 1H), 6.87 (d, J = 5.3 Hz, 1H), 1146 6.57-6.49 (m, 1H), 6.46 (ddd, J = 9.7, 6.6, 3.0 Hz, 1H), 5.34 (qd, J = 6.4, 5.0 Hz, 1H), 5.18 (d, J = 5.1 Hz, 1H), 4.62 (ddd, J = 8.4, 6.8, 5.2 Hz, 1H), 3.94 (s, 3H), 1.89-1.78 (m, 1H), 1.67 (dt, J = 14.2, 7.2 Hz, 1H), 1.42 (d, J = 6.4 Hz, 3H), 0.79 (t, J = 7.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 170.84, 168.86, 158.31 (dd, J = 242.4, 2.6 Hz), 155.36, 149.41 (dd, J = 242.1, 3.3 Hz), 148.71, 146.16 (dd, J = 12.5, 10.7 Hz), 140.48, 136.20, 130.43, 128.73, 128.71, 126.96, 116.37 (dd, J = 20.9, 10.0 Hz), 109.43, 107.65 (dd, J = 23.9, 6.9 Hz), 105.00 (dd, J = 27.2, 1.7 Hz), 82.95, 74.15, 56.07, 53.08, 25.36, 15.15, 9.28. 124 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.04 ([M + H].sup.+) calcd for (d, J = 0.7 Hz, 1H), 8.41 (d, J = 8.3 C.sub.26H.sub.27ClFN.sub.2O.sub.6, Hz, 1H), 7.98 (d, J = 5.2 Hz, 1H), 517.1536; found, 7.37-7.28 (m, 5H), 6.87 (dd, J = 517.1534 5.2, 0.7 Hz, 1H), 6.65-6.58 (m, 2H), 6.40 (dt, J = 10.4, 2.3 Hz, 1H), 5.29 (qd, J = 6.4, 4.7 Hz, 1H), 5.16 (d, J = 4.7 Hz, 1H), 4.61 (ddd, J = 8.3, 6.9, 5.3 Hz, 1H), 3.94 (s, 3H), 1.92-1.80 (m, 1H), 1.71 (dt, J = 14.2, 7.2 Hz, 1H), 1.36 (d, J = 6.4 Hz, 3H), 0.83 (t, J = 7.5 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 170.82, 168.91, 163.07 (d, J = 248.1 Hz), 159.14 (d, J = 12.3 Hz), 155.36, 148.71, 140.49, 136.08, 135.24 (d, J = 13.3 Hz), 130.34, 128.81, 128.65, 126.74, 112.44 (d, J = 3.3 Hz), 109.47, 109.21 (d, J = 25.1 Hz), 102.12 (d, J = 25.0 Hz), 81.66, 74.07, 56.07, 53.21, 25.38, 14.78, 9.41. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.83. 125 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.03 ([M + H].sup.+) calcd for (d, J = 0.7 Hz, 1H), 8.37 (d, J = 7.8 C.sub.26H.sub.26F.sub.3N.sub.2O.sub.6, Hz, 1H), 7.95 (d, J = 5.2 Hz, 1H), 519.1737; found, 7.44-7.27 (m, 7H), 6.90-6.82 (m, 519.1739 3H), 5.36-5.27 (m, 1H), 5.25 (d, J = 4.8 Hz, 1H), 4.69-4.60 (m, 1H), 3.94 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.49, 168.74, 160.08, 155.36, 148.74, 140.45, 136.46, 130.31, 128.75, 128.53, 126.80 (q, J = 3.8 Hz), 126.80, 124.25 (q, J = 271.7 Hz), 123.29 (q, J = 32.8 Hz), 115.71, 109.44, 81.26, 74.20, 56.06, 48.02, 17.95, 14.81. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-61.64. 126 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.07 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.43 (d, J = 9.2 C.sub.28H.sub.30F.sub.3N.sub.2O.sub.6, Hz, 1H), 7.95 (d, J = 5.2 Hz, 1H), 547.2050; found, 7.43-7.26 (m, 7H), 6.88-6.82 (m, 547.2059 3H), 5.35-5.25 (m, 2H), 4.59 (dd, J = 9.2, 4.9 Hz, 1H), 3.94 (s, 3H), 2.21-2.10 (m, 1H), 1.38 (d, J = 6.4 Hz, 3H), 0.92 (d, J = 6.9 Hz, 3H), 0.80 (d, J = 6.9 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 170.52, 169.07, 160.05, 155.37, 148.69, 140.48, 136.40, 130.39, 128.76, 128.52, 126.77 (q, J = 3.8 Hz), 126.76, 124.25 (q, J = 271.4 Hz), 123.24 (q, J = 32.7 Hz), 115.67, 109.42, 81.15, 74.25, 57.08, 56.06, 31.17, 19.11, 17.38, 14.69. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-61.64. 127 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.04 3369, 2940, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.8 1740, 1649, C.sub.25H.sub.26FN.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 1529, 1482, 469.1769; found, 7.40-7.26 (m, 5H), 7.10 (td, J = 1450, 1262, 469.1784 8.3, 6.9 Hz, 1H), 6.86 (dd, J = 5.2, 1132 0.7 Hz, 1H), 6.62-6.49 (m, 3H), 5.29 (qd, J = 6.5, 5.0 Hz, 1H), 5.18 (d, J = 4.9 Hz, 1H), 4.69-4.59 (m, 1H), 3.94 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.51, 168.70, 163.35 (d, J = 245.3 Hz), 159.04 (d, J = 10.8 Hz), 155.35, 148.73, 140.46, 136.83, 130.35, 130.12 (d, J = 10.0 Hz), 128.66, 128.41, 126.85, 111.44 (d, J = 2.9 Hz), 109.45, 108.08 (d, J = 21.4 Hz), 103.69 (d, J = 24.8 Hz), 81.45, 74.28, 56.06, 47.97, 17.99, 14.91. 128 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 11.98 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.40 (d, J = 8.4 C.sub.31H.sub.30FN.sub.2O.sub.6, Hz, 1H), 7.94 (d, J = 5.3 Hz, 1H), 545.2082; found, 7.38-7.25 (m, 5H), 7.20-7.07 (m, 545.2090 4H), 7.07-7.00 (m, 2H), 6.85 (d, J = 5.3 Hz, 1H), 6.63-6.54 (m, 2H), 6.50 (dt, J = 10.8, 2.4 Hz, 1H), 5.20 (qd, J = 6.4, 4.3 Hz, 1H), 5.12 (d, J = 4.3 Hz, 1H), 4.94 (ddd, J = 8.5, 6.4, 5.7 Hz, 1H), 3.94 (s, 3H), 3.12 (dd, J = 14.0, 5.8 Hz, 1H), 3.06 (dd, J = 14.0, 6.4 Hz, 1H), 1.35 (d, J = 6.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 170.23, 168.73, 163.37 (d, J = 245.4 Hz), 158.91 (d, J = 10.9 Hz), 155.29, 148.67, 140.56, 136.79, 135.42, 130.30, 130.12 (d, J = 10.0 Hz), 129.25, 128.72, 128.59, 128.42, 127.16, 126.75, 111.52 (d, J = 2.9 Hz), 109.44, 108.05 (d, J = 21.2 Hz), 103.72 (d, J = 24.9 Hz), 81.17, 74.95, 56.06, 53.08, 37.82, 14.43. 129 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.11 ([M + Na].sup.+) calcd for (s, 1H), 8.49 (d, J = 8.0 Hz, 1H), C.sub.23H.sub.24N.sub.2O.sub.6SNa, 7.98 (d, J = 5.2 Hz, 1H), 7.32-7.26 479.1253; found, (m, 1H), 7.24-7.15 (m, 2H), 7.07 479.1244. (dd, J = 3.5, 1.2 Hz, 1H), 6.96 (dd, J = 5.1, 3.5 Hz, 1H), 6.93-6.88 (m, 3H), 6.86 (d, J = 5.2 Hz, 1H), 5.50-5.35 (m, 2H), 4.79-4.65 (m, 1H), 3.94 (s, 3H), 1.47 (d, J = 7.2 Hz, 3H), 1.34-1.22 (m, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.68, 168.70, 157.64, 155.36, 148.75, 140.46, 140.15, 129.41, 126.78, 126.28, 125.92, 121.59, 115.96, 109.44, 78.29, 77.22, 73.83, 56.07, 48.02, 18.38, 16.14. 130 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 ([M + H].sup.+) calcd for (s, 1H), 8.66 (d, J = 2.2 Hz, 1H), C.sub.24H.sub.26N.sub.3O.sub.6, 8.53 (td, J = 5.0, 1.7 Hz, 1H), 8.38 452.1821; found, (s, 1H), 7.97 (d, J = 5.3 Hz, 1H), 452.1814. 7.78 (dt, J = 7.9, 2.0 Hz, 1H), 7.31-7.27 (m, 1H), 7.23-7.14 (m, 2H), 6.92 (ddt, J = 8.5, 7.3, 1.1 Hz, 1H), 6.88-6.85 (m, 1H), 6.84-6.78 (m, 2H), 5.36-5.28 (m, 1H), 5.24 (d, J = 5.4 Hz, 1H), 4.62 (q, J = 7.4 Hz, 1H), 3.94 (s, 3H), 1.41 (d, J = 6.3 Hz, 3H), 1.32 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.41, 157.15, 149.21, 148.33, 135.34, 133.62, 129.58, 123.91, 121.85, 115.97, 109.47, 79.13, 77.22, 73.82, 56.09, 47.90, 17.90, 15.49. 131 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.8 Hz, 1H), C.sub.29H.sub.33N.sub.2O.sub.6, 7.96 (d, J = 5.1 Hz, 1H), 7.57 (dd, J = 505.2333; found, 10.0, 2.0 Hz, 3H), 7.53-7.49 (m, 505.2333. 1H), 7.46-7.40 (m, 3H), 7.39-7.30 (m, 3H), 6.87-6.82 (m, 1H), 5.20 (p, J = 6.3 Hz, 1H), 4.63-4.54 (m, 1H), 4.42 (d, J = 6.3 Hz, 1H), 3.93 (s, 3H), 3.28-3.20 (m, 2H), 1.39 (d, J = 6.3 Hz, 3H), 1.21 (d, J = 7.2 Hz, 3H), 1.08-0.98 (m, 1H), 0.54-0.44 (m, 2H), 0.18-0.07 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.42, 168.59, 155.32, 148.70, 141.20, 140.81, 140.44, 139.33, 130.43, 128.80, 128.75, 127.40, 127.09, 126.81, 126.46, 126.29, 109.40, 83.10, 74.50, 73.89, 56.05, 47.89, 17.94, 16.03, 10.61, 3.22, 2.75. 132 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.19-12.04 3369, 2985, ([M + H].sup.+) calcd for (m, 1H), 8.56-8.39 (m, 2939, 1742 C.sub.22H.sub.24N.sub.3O.sub.6S, 1H), 8.09-7.95 (m, 1H), 7.87-7.74 458.1379; found, (m, 1H), 7.45-7.30 (m, 1H), 458.1374 7.23 (t, J = 8.0 Hz, 2H), 6.98-6.92 (m, 3H), 6.86 (d, J = 5.2 Hz, 1H), 5.66-5.42 (m, 2H), 4.81-4.56 (m, 1H), 3.95 (s, 3H), 1.42 (d, J = 7.2 Hz, 3H), 1.38 (d, J = 6.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 168.69, 168.08, 157.49, 155.36, 148.74, 142.82, 142.50, 140.46, 129.60, 122.04, 120.24, 115.92, 115.57, 109.44, 79.67, 73.19, 56.08, 47.97, 18.28, 16.05. 133 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.02 ([M + H].sup.+) calcd for (s, 1H), 8.39 (d, J = 8.0 Hz, 1H), C.sub.31H.sub.30FN.sub.2O.sub.6, 7.96 (d, J = 5.2 Hz, 1H), 7.60-7.50 545.2082; found, (m, 4H), 7.47-7.33 (m, 5H), 7.11 545.2098. (dd, J = 15.1, 8.2 Hz, 1H), 6.85 (d, J = 5.3 Hz, 1H), 6.64-6.55 (m, 3H), 5.34 (dt, J = 11.6, 6.6 Hz, 1H), 5.26 (d, J = 4.9 Hz, 1H), 4.69-4.60 (m, 1H), 3.94 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.32 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.60, 168.72, 159.13, 155.34, 148.72, 141.69, 140.46, 137.50, 130.33, 130.23, 130.15, 129.16, 128.83, 127.58, 127.23, 127.13, 125.70, 125.46, 111.44, 109.44, 108.11, 103.87, 103.67, 81.54, 74.39, 56.06, 47.98, 31.87, 17.95, 14.83. 134 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.47 (d, J = 8.2 Hz, 1H), C.sub.25H.sub.25Cl.sub.2N.sub.2O.sub.6, 7.95 (d, J = 5.1 Hz, 1H), 7.43-7.22 519.1089; found, (m, 6H), 6.95 (dd, J = 8.8, 2.6 Hz, 519.1077 1H), 6.86 (d, J = 5.3 Hz, 1H), 6.63 (d, J = 8.9 Hz, 1H), 5.53-5.39 (m, 1H), 5.16 (d, J = 6.8 Hz, 1H), 4.81-4.63 (m, 1H), 3.94 (s, 3H), 1.47 (d, J = 7.2 Hz, 3H), 1.24 (d, J = 6.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.43, 168.67, 155.34, 151.86, 148.74, 140.44, 135.93, 130.42, 130.01, 128.91, 128.82, 127.27, 127.16, 125.98, 124.14, 115.40, 109.44, 82.80, 73.57, 56.08, 48.02, 18.26, 16.18. 135 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.48 (d, J = 8.0 C.sub.25H.sub.27N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 451.1869; found, 7.42-7.35 (m, 2H), 7.36-7.24 (m, 451.1868 3H), 7.22-7.08 (m, 2H), 6.93-6.79 (m, 4H), 5.53-5.33 (m, 1H), 5.13 (d, J = 6.5 Hz, 1H), 4.79-4.61 (m, 1H), 3.93 (s, 3H), 1.42 (d, J = 7.2 Hz, 3H), 1.24 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.71, 168.67, 157.82, 155.35, 148.75, 140.46, 137.30, 130.49, 129.35, 128.64, 128.41, 127.12, 121.09, 115.75, 109.44, 81.86, 74.06, 56.07, 48.01, 18.41, 16.35. 136 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.18 ([M + H].sup.+) calcd for (s, 1H), 8.50 (d, J = 8.0 Hz, 1H), C.sub.23H.sub.31N.sub.2O.sub.6, 8.00 (d, J = 5.2 Hz, 1H), 7.39-7.27 431.2182; found, (m, 5H), 6.87 (d, J = 5.2 Hz, 1H), 431.2192 5.19 (p, J = 6.5 Hz, 1H), 4.72 (dq, J = 8.6, 7.2 Hz, 1H), 4.25 (d, J = 6.7 Hz, 1H), 3.95 (s, 3H), 3.18-2.99 (m, 2H), 1.89-1.75 (m, 1H), 1.50 (d, J = 7.2 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 0.89-0.81 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.63, 168.62, 155.36, 148.75, 140.45, 138.47, 130.57, 128.31, 128.10, 127.62, 109.41, 84.00, 76.10, 74.45, 56.07, 48.04, 28.63, 19.41, 19.36, 18.47, 16.34. 137 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.9 Hz, 1H), C.sub.23H.sub.31N.sub.2O.sub.6, 7.98 (d, J = 5.2 Hz, 1H), 7.43-7.21 431.2182; found, (m, 5H), 6.86 (d, J = 5.3 Hz, 1H), 431.2187 5.13 (p, J = 6.3 Hz, 1H), 4.67-4.49 (m, 1H), 4.25 (d, J = 6.1 Hz, 1H), 3.94 (s, 3H), 3.14 (dd, J = 8.8, 6.5 Hz, 1H), 3.05 (dd, J = 8.8, 6.4 Hz, 1H), 1.92-1.76 (m, 1H), 1.33 (d, J = 6.3 Hz, 3H), 1.25 (d, J = 7.2 Hz, 3H), 0.89 (d, J = 3.1 Hz, 3H), 0.87 (d, J = 3.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.40, 168.58, 155.36, 148.73, 140.44, 138.80, 130.49, 128.21, 127.94, 127.54, 109.42, 83.71, 76.27, 74.67, 56.07, 47.89, 28.63, 19.33, 18.00, 15.85. 138 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.18 3372, 2964, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.50 (d, J = 7.8 2875, 1650 C.sub.22H.sub.29N.sub.2O.sub.6, Hz, 1H), 8.00 (d, J = 5.2 Hz, 1H), 417.2025; found, 7.40-7.27 (m, 5H), 6.87 (d, J = 5.3 417.2016. Hz, 1H), 5.27-5.11 (m, 1H), 4.80-4.67 (m, 1H), 4.26 (d, J = 6.7 Hz, 1H), 3.95 (s, 3H), 3.30 (dt, J = 9.0, 6.8 Hz, 1H), 3.23 (dt, J = 9.1, 6.5 Hz, 1H), 1.60-1.53 (m, 2H), 1.50 (d, J = 7.2 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H). 139 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 3370, 2964, ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 8.0 Hz, 1H), 2876, 1734 C.sub.22H.sub.29N.sub.2O.sub.6, 7.98 (d, J = 5.2 Hz, 1H), 7.37-7.26 417.2025; found, (m, 5H), 6.86 (d, J = 5.2 Hz, 1H), 417.2018. 5.20-5.06 (m, 1H), 4.66-4.51 (m, 1H), 4.27 (d, J = 6.1 Hz, 1H), 3.94 (s, 3H), 3.33 (dt, J = 9.1, 6.5 Hz, 1H), 3.25 (dt, J = 9.2, 6.5 Hz, 1H), 1.55 (dtd, J = 13.8, 7.4, 6.5 Hz, 2H), 1.32 (d, J = 6.3 Hz, 3H), 1.24 (d, J = 7.2 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.40, 168.58, 155.35, 148.73, 140.44, 138.84, 130.50, 128.23, 127.97, 127.53, 109.41, 83.51, 74.57, 71.13, 56.08, 47.90, 23.00, 18.01, 15.87, 10.65. 140 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.17 3367, 2984, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.50 (d, J = 8.0 2938, 1739 C.sub.20H.sub.25N.sub.2O.sub.6, Hz, 1H), 8.00 (d, J = 5.2 Hz, 1H), 389.1712; found, 7.40-7.28 (m, 5H), 6.87 (d, J = 5.1 389.1713. Hz, 1H), 5.28-5.15 (m, 1H), 4.80-4.64 (m, 1H), 4.14 (d, J = 6.8 Hz, 1H), 3.95 (s, 3H), 3.24 (s, 3H), 1.51 (d, J = 7.2 Hz, 3H), 1.11 (d, J = 6.5 Hz, 3H). 141 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 3366, 2938, ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 8.0 Hz, 1H), 1737, 1648 C.sub.20H.sub.25N.sub.2O.sub.6, 7.98 (d, J = 5.2 Hz, 1H), 7.37-7.28 389.1712; found, (m, 5H), 6.86 (d, J = 5.2 Hz, 1H), 389.1709. 5.14 (p, J = 6.4 Hz, 1H), 4.66-4.54 (m, 1H), 4.19 (d, J = 5.9 Hz, 1H), 3.94 (s, 3H), 3.26 (s, 3H), 1.31 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H). 142 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.18 3367, 2985, ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.51 (d, J = 8.3 2872, 1738 C.sub.23H.sub.29N.sub.2O.sub.6, Hz, 1H), 8.00 (d, J = 5.2 Hz, 1H), 429.2025; found, 7.36-7.26 (m, 5H), 6.87 (d, J = 5.3 429.2009. Hz, 1H), 5.27-5.15 (m, 1H), 4.80-4.65 (m, 1H), 4.34 (d, J = 6.8 Hz, 1H), 3.95 (s, 3H), 3.17 (dd, J = 6.8, 3.2 Hz, 2H), 1.52 (d, J = 7.2 Hz, 3H), 1.12 (d, J = 6.5 Hz, 3H), 1.03-0.93 (m, 1H), 0.53-0.34 (m, 2H), 0.16-0.05 (m, 2H). 143 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.9 Hz, 1H), C.sub.29H.sub.33N.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.59-7.52 505.2330; found, (m, 4H), 7.46-7.38 (m, 4H), 7.38-7.32 505.2347. (m, 1H), 6.84 (d, J = 5.2 Hz, 1H), 5.23-5.14 (m, 1H), 4.66-4.57 (m, 1H), 4.40 (d, J = 6.2 Hz, 1H), 3.93 (s, 3H), 3.23 (d, J = 6.8 Hz, 2H), 1.38 (d, J = 6.3 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H), 1.09-0.98 (m, 1H), 0.55-0.44 (m, 2H), 0.19-0.09 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.42, 168.61, 155.35, 148.73, 140.91, 140.70, 140.45, 137.70, 130.47, 128.77, 128.02, 127.34, 127.05, 126.98, 109.40, 82.77, 74.48, 73.84, 56.06, 47.90, 18.00, 16.02, 10.60, 3.21, 2.74. 144 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.08 ([M + H].sup.+) calcd for (s, 1H), 8.41 (d, J = 7.9 Hz, 1H), C.sub.31H.sub.31N.sub.2O.sub.6, 7.96 (d, J = 5.2 Hz, 1H), 7.57-7.52 527.2177; found, (m, 4H), 7.48-7.40 (m, 4H), 7.34 527.2184. (ddd, J = 7.3, 3.8, 1.2 Hz, 1H), 7.21-7.16 (m, 2H), 6.91-6.83 (m, 4H), 5.38-5.31 (m, 1H), 5.26 (d, J = 4.9 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.61, 168.69, 157.86, 155.36, 148.75, 141.08, 140.52, 140.45, 136.45, 130.42, 129.40, 128.77, 127.42, 127.40, 127.26, 127.05, 121.27, 115.97, 109.43, 81.01, 74.54, 56.06, 47.96, 18.05, 15.10. 145 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.8 Hz, 1H), C.sub.31H.sub.31N.sub.2O.sub.6, 7.95 (d, J = 5.2 Hz, 1H), 7.63 (s, 527.2177; found, 1H), 7.56 (dd, J = 5.2, 3.3 Hz, 2H), 527.2187. 7.52-7.49 (m, 1H), 7.46-7.32 (m, 6H), 7.20-7.15 (m, 2H), 6.90-6.83 (m, 4H), 5.36 (dt, J = 12.2, 6.1 Hz, 1H), 5.28 (s, 1H), 4.64 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 1.44 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.65, 168.69, 157.92, 155.35, 148.73, 141.53, 140.65, 140.46, 138.18, 130.40, 129.41, 129.05, 128.81, 127.51, 127.13, 127.03, 125.85, 125.62, 121.31, 116.01, 109.43, 81.35, 74.63, 56.06, 47.95, 17.98, 15.04. 146 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.05 ([M + H].sup.+) calcd for (s, 1H), 8.38 (d, J = 7.9 Hz, 1H), C.sub.25H.sub.26FN.sub.2O.sub.6, 7.96 (d, J = 5.2 Hz, 1H), 7.41-7.18 469.1775; found, (m, 5H), 6.91-6.77 (m, 3H), 6.77-6.60 469.1778 (m, 2H), 5.29 (qd, J = 6.4, 4.9 Hz, 1H), 5.11 (d, J = 4.9 Hz, 1H), 4.76-4.55 (m, 1H), 3.94 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.13. 147 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 8.0 Hz, 1H), C.sub.25H.sub.25F.sub.2N.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.41-7.29 487.1680; found, (m, 2H), 7.16-6.95 (m, 2H), 6.91-6.78 487.1678 (m, 3H), 6.78-6.60 (m, 2H), 5.42-5.30 (m, 1H), 5.03 (d, J = 6.6 Hz, 1H), 4.79-4.66 (m, 1H), 3.94 (s, 3H) 1.45 (d, J = 7.2 Hz, 3H), 1.21 (d, J = 6.4 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.00, −122.95. 148 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 ([M + H].sup.+) calcd for (s, 1H), 8.39 (d, J = 7.7 Hz, 1H), C.sub.25H.sub.26FN.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.40-7.34 469.1769; found, (m, 2H), 7.20-7.13 (m, 2H), 7.03-6.96 469.1777. (m, 2H), 6.88 (dd, J = 15.2, 6.3 Hz, 2H), 6.82-6.78 (m, 2H), 5.31-5.24 (m, 1H), 5.18 (d, J = 5.2 Hz, 1H), 4.64 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.62. 149 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.06 ([M + Na].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.6 Hz, 1H), C.sub.26H.sub.27ClN.sub.2O.sub.6Na, 7.97 (d, J = 5.3 Hz, 1H), 7.45-7.26 521.1456; found, (m, 5H), 7.12 (dd, J = 2.2, 0.8 Hz, 521.1450 1H), 6.86 (d, J = 5.2 Hz, 1H), 6.78 (ddd, J = 8.4, 2.2, 0.8 Hz, 1H), 6.54 (d, J = 8.3 Hz, 1H), 5.41-5.30 (m, 1H), 5.23 (d, J = 4.8 Hz, 1H), 4.78-4.57 (m, 1H), 3.94 (s, 3H), 2.19 (s, 3H), 1.44 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 171.60, 168.67, 155.33, 151.00, 148.71, 140.46, 136.91, 131.54, 130.72, 130.41, 128.58, 128.37, 127.85, 126.96, 123.06, 115.04, 109.41, 82.02, 74.56, 56.08, 47.97, 20.25, 18.00, 14.97. 150 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.04 ([M + H].sup.+) calcd for (s, 1H), 8.39 (d, J = 7.9 Hz, 1H), C.sub.26H.sub.27ClFN.sub.2O.sub.6, 7.98 (d, J = 5.2 Hz, 1H), 7.46-7.31 517.1541; found, (m, 2H), 7.12 (dd, J = 2.1, 0.8 Hz, 517.1537 1H), 7.08-6.92 (m, 2H), 6.86 (d, J = 5.2 Hz, 1H), 6.79 (ddd, J = 8.4, 2.2, 0.9 Hz, 1H), 6.52 (d, J = 8.4 Hz, 1H), 5.32 (qd, J = 6.4, 4.8 Hz, 1H), 5.20 (d, J = 4.9 Hz, 1H), 4.80-4.53 (m, 1H), 3.94 (s, 3H), 2.20 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 7.2 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-113.34. 151 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.09 ([M + H].sup.+) calcd for (d, J = 0.7 Hz, 1H), 8.41 (d, J = 8.0 C.sub.26H.sub.29N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 465.2025; found, 7.47-7.34 (m, 2H), 7.34-7.19 (m, 465.2012 3H), 7.00-6.91 (m, 2H), 6.90-6.81 (m, 1H), 6.78-6.65 (m, 2H), 5.29 (qd, J = 6.4, 5.2 Hz, 1H), 5.15 (d, J = 5.2 Hz, 1H), 4.75-4.56 (m, 1H), 3.94 (s, 3H), 2.21 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 171.57, 168.65, 155.71, 155.35, 148.73, 140.46, 137.67, 130.46, 130.42, 129.80, 128.50, 128.14, 126.99, 115.81, 109.42, 81.36, 74.55, 56.10, 56.06, 47.93, 20.44, 18.05, 15.14. 152 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.07 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.9 C.sub.26H.sub.28FN.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 483.1931; found, 7.47-7.31 (m, 2H), 7.05-6.93 (m, 483.1918 4H), 6.86 (dd, J = 5.3, 0.7 Hz, 1H), 6.75-6.62 (m, 2H), 5.26 (qd, J = 6.4, 5.2 Hz, 1H), 5.13 (d, J = 5.3 Hz, 1H), 4.74-4.57 (m, 1H), 3.94 (s, 3H), 2.22 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 171.51, 168.67, 162.46 (d, J = 246.8 Hz), 155.41 (d, J = 5.7 Hz), 148.75, 140.48, 133.42 (d, J = 3.3 Hz), 130.70, 130.37, 129.85, 128.73 (d, J = 8.1 Hz), 115.82, 115.64, 115.36, 109.45, 80.76, 74.34, 56.10, 47.93, 20.44, 18.05, 15.24. 153 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.07 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.9 C.sub.25H.sub.25F.sub.2N.sub.2O.sub.6, Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 487.1675; found, (td, J = 8.7, 6.4 Hz, 1H), 7.23-7.42 487.1690. 7.16 (m, 2H), 6.94-6.88 (m, 1H), 6.87 (d, J = 5.1 Hz, 1H), 6.85-6.74 (m, 4H), 5.49 (d, J = 5.7 Hz, 1H), 5.38 (p, J = 6.1 Hz, 1H), 4.66 (dq, J = 14.5, 7.2 Hz, 1H), 3.94 (s, 3H), 1.41 (d, J = 6.3 Hz, 3H), 1.36 (d, J = 7.2 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.47 (dt, J = 15.4, 7.9 Hz), −113.95 (dd, J = 17.3, 8.3 Hz). 154 ESIMS m/z 465 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.09 ([M + H].sup.+) (s, 1H), 8.41 (d, J = 7.8 Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 7.27 (d, J = 8.0 Hz, 2H), 7.18-7.09 (m, 4H), 6.89-6.79 (m, 4H), 5.29 (dq, J = 12.9, 6.4 Hz, 1H), 5.17 (d, J = 5.0 Hz, 1H), 4.64 (p, J = 7.3 Hz, 1H), 3.94 (s, 3H), 2.31 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.57, 168.66, 157.90, 155.36, 148.74, 140.44, 137.89, 134.39, 130.45, 129.32, 129.21, 126.87, 121.10, 115.93, 109.43, 81.06, 74.59, 56.06, 47.96, 21.15, 18.06, 15.03. 155 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.07 ([M + H].sup.+) calcd for (d, J = 0.6 Hz, 1H), 8.39 (d, J = 7.8 C.sub.26H.sub.28FN.sub.2O.sub.6, Hz, 1H), 7.96 (d, J = 5.2 Hz, 1H), 483.1931; found, 7.34-7.19 (m, 2H), 7.19-7.05 (m, 483.1928 2H), 6.92-6.65 (m, 5H), 5.28 (qd, J = 6.4, 4.8 Hz, 1H), 5.08 (d, J = 4.8 Hz, 1H), 4.74-4.57 (m, 1H), 3.93 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 7.2 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-123.34. 156 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.04 ([M + H].sup.+) calcd for (s, 1H), 8.36 (d, J = 7.8 Hz, 1H), C.sub.25H.sub.25F.sub.2N.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.41-7.28 487.1680; found, (m, 2H), 7.11-6.92 (m, 2H), 6.93-6.78 487.1678 (m, 3H), 6.78-6.62 (m, 2H), 5.26 (qd, J = 6.4, 4.9 Hz, 1H), 5.09 (d, J = 5.0 Hz, 1H), 4.72-4.57 (m, 1H), 3.94 (s, 3H), 1.37 (d, J = 6.6 Hz, 3H), 1.35 (d, J = 7.6 Hz, 3H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-113.40, −122.82. 157 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.09 ([M + H].sup.+) calcd for (s, 1H), 8.41 (d, J = 8.0 Hz, 1H), C.sub.27H.sub.31N.sub.2O.sub.6, 7.96 (d, J = 5.2 Hz, 1H), 7.41-7.16 479.2182; found, (m, 2H), 7.10 (d, J = 7.8 Hz, 2H), 479.2180 6.94 (d, J = 8.1 Hz, 2H), 6.85 (d, J = 5.2 Hz, 1H), 6.75-6.64 (m, 2H), 5.33-5.23 (m, 1H), 5.12 (d, J = 5.0 Hz, 1H), 4.64 (p, J = 7.3 Hz, 1H), 3.93 (s, 3H), 2.30 (s, 3H), 2.20 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.32 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.55, 168.66, 155.82, 155.37, 148.78, 140.41, 137.80, 134.60, 130.51, 130.35, 129.75, 129.16, 126.90, 115.84, 109.42, 81.29, 74.60, 56.04, 47.96, 21.11, 20.41, 18.07, 15.06. 158 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.11 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.7 Hz, 1H), C.sub.26H.sub.29N.sub.2O.sub.7, 7.94 (d, J = 5.2 Hz, 1H), 7.38 (d, J = 481.1969; found, 7.5 Hz, 1H), 7.26-7.21 (m, 1H), 481.1958. 7.15 (t, J = 7.8 Hz, 2H), 6.91-6.80 (m, 6H), 5.69 (d, J = 4.5 Hz, 1H), 5.45-5.38 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.91 (s, 3H), 1.37-1.32 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.46, 168.67, 157.89, 156.63, 155.34, 148.75, 140.38, 130.54, 129.27, 129.14, 127.84, 125.40, 120.88, 120.86, 115.61, 110.21, 109.40, 74.91, 73.33, 56.03, 55.47, 48.01, 18.07, 14.94. 159 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.42 (d, J = 7.7 Hz, 1H), C.sub.26H.sub.28FN.sub.2O.sub.7, 7.95 (d, J = 5.2 Hz, 1H), 7.37-7.29 499.1875; found, (m, 1H), 7.16 (t, J = 7.9 Hz, 2H), 499.1876. 6.86 (dd, J = 11.0, 6.2 Hz, 2H), 6.79 (d, J = 8.0 Hz, 2H), 6.64-6.54 (m, 2H), 5.61 (d, J = 4.5 Hz, 1H), 5.42-5.34 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.89 (s, 3H), 1.37 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.41, 168.69, 163.41 (d, J = 246.4 Hz), 157.81 (d, J = 9.7 Hz), 157.65, 155.37, 148.76, 140.40, 130.49, 129.32, 129.02 (d, J = 10.0 Hz), 121.15 (d, J = 3.3 Hz), 121.05, 115.57, 109.43, 107.39 (d, J = 21.4 Hz), 98.69 (d, J = 25.8 Hz), 74.53, 73.20, 56.04, 55.78, 48.01, 18.06, 14.98. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.20 (s, 1F). 160 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.08 (s, 1H), 8.42 (d, J = 7.9 Hz, 1H), 7.97 (d, J = 5.2 Hz, 1H), 7.37-7.23 (m, 2H), 7.20-7.06 (m, 3H), 6.85 (d, J = 5.2 Hz, 1H), 6.77 (ddd, J = 8.4, 2.2, 0.8 Hz, 1H), 6.54 (d, J = 8.4 Hz, 1H), 5.33 (qd, J = 6.4, 4.7 Hz, 1H), 5.20 (d, J = 4.7 Hz, 1H), 4.77-4.53 (m, 1H), 3.93 (s, 3H), 2.31 (s, 3H), 2.18 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.36 (d, J = 7.2 Hz, 3H). 161 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.07 ([M + H].sup.+) calcd for (s, 1H), 8.41 (d, J = 7.8 Hz, 1H), C.sub.26H.sub.29N.sub.2O.sub.7, 7.96 (d, J = 5.2 Hz, 1H), 7.23 (t, J = 481.1969; found, 7.9 Hz, 1H), 7.16 (dd, J = 8.4, 7.5 481.1971. Hz, 2H), 7.00-6.92 (m, 2H), 6.91-6.78 (m, 5H), 5.33-5.26 (m, 1H), 5.18 (d, J = 5.0 Hz, 1H), 4.65 (p, J = 7.3 Hz, 1H), 3.93 (s, 3H), 3.77 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.58, 168.69, 159.80, 157.93, 155.36, 148.76, 140.43, 139.19, 130.45, 129.57, 129.34, 121.24, 119.31, 115.94, 113.49, 112.53, 109.44, 81.13, 74.55, 56.05, 55.21, 47.95, 18.02, 14.97. 162 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.04 ([M + H].sup.+) calcd for (s, 1H), 8.37 (d, J = 7.7 Hz, 1H), C.sub.26H.sub.28FN.sub.2O.sub.6, 7.96 (d, J = 5.2 Hz, 1H), 7.37 (dd, J = 483.1926; found, 8.5, 5.9 Hz, 1H), 7.19-7.13 (m, 483.1936. 2H), 6.90-6.80 (m, 4H), 6.76-6.70 (m, 2H), 5.39 (d, J = 4.9 Hz, 1H), 5.26-5.18 (m, 1H), 4.63 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 2.50 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.66, 168.74, 162.19 (d, J = 246.5 Hz), 157.70, 155.38, 148.77, 140.44, 137.84 (d, J = 7.8 Hz), 131.39 (d, J = 3.1 Hz), 130.38, 129.42, 128.68 (d, J = 8.5 Hz), 121.32, 115.70, 117.18 (d, J = 21.2 Hz), 113.25 (d, J = 21.1 Hz), 109.48, 77.73, 73.55, 56.05, 47.95, 19.26 (d, J = 1.2 Hz), 17.86, 14.75. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-114.75 (d, J = 2.1 Hz, 1F). 163 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 ([M + H].sup.+) calcd for (s, 1H), 8.39 (d, J = 7.7 Hz, 1H), C.sub.25H.sub.25ClFN.sub.2O.sub.6, 7.96 (dd, J = 5.1, 0.9 Hz, 1H), 7.48 503.1380; found, (dd, J = 8.7, 6.1 Hz, 1H), 7.19 (t, J = 503.1386. 7.7 Hz, 2H), 7.09 (dd, J = 8.4, 2.4 Hz, 1H), 6.96-6.82 (m, 3H), 6.78 (d, J = 8.0 Hz, 2H), 5.63 (d, J = 5.4 Hz, 1H), 5.37 (p, J = 6.3 Hz, 1H), 4.66 (p, J = 7.3 Hz, 1H), 3.93 (d, J = 1.3 Hz, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.37 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.29, 168.71, 162.08 (d, J = 251.1 Hz), 157.07, 155.39, 148.78, 140.42, 133.93 (d, J = 10.2 Hz), 130.42, 131.14 (d, J = 3.6 Hz), 129.99 (d, J = 9.0 Hz), 129.52, 121.54, 116.71 (d, J = 24.8 Hz), 115.51, 114.83 (d, J = 21.2 Hz), 109.48, 76.63, 73.19, 56.05, 47.98, 17.95, 15.56. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.13 (d, J = 3.2 Hz). 164 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.41 (d, J = 7.9 Hz, 1H), C.sub.26H.sub.28FN.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.30 (t, J = 483.1926; found, 7.7 Hz, 1H), 7.18 (dd, J = 8.5, 7.5 483.1935. Hz, 2H), 6.85 (ddd, J = 12.2, 11.0, 7.5 Hz, 6H), 5.50 (d, J = 5.7 Hz, 1H), 5.39 (p, J = 6.2 Hz, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.94 (s, 3H), 2.29 (s, 3H), 1.41 (d, J = 6.4 Hz, 3H), 1.35 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.32, 168.64, 160.23 (d, J = 245.5 Hz), 157.37, 155.36, 148.76, 140.51 (d, J = 8.0 Hz), 140.40, 130.51, 129.42, 128.21 (d, J = 4.2 Hz), 125.34 (d, J = 2.9 Hz), 121.33, 121.31 (d, J = 13.6 Hz), 115.78, 115.58, 74.30, 73.35, 56.04, 47.93, 21.04, 18.01, 15.84. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-119.17 (s, 1F). 165 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.05 ([M + H].sup.+) calcd for (s, 1H), 8.41 (t, J = 6.4 Hz, 2H), C.sub.29H.sub.29N.sub.2O.sub.6, 7.97 (d, J = 5.2 Hz, 1H), 7.89 (d, J = 501.2020; found, 8.1 Hz, 1H), 7.80 (d, J = 8.2 Hz, 501.2031. 1H), 7.64 (t, J = 6.1 Hz, 2H), 7.53 (t, J = 7.5 Hz, 1H), 7.41 (t, J = 7.7 Hz, 1H), 7.11 (t, J = 8.0 Hz, 2H), 6.87-6.82 (m, 2H), 6.78 (d, J = 8.1 Hz, 2H), 6.11 (d, J = 4.0 Hz, 1H), 5.52-5.44 (m, 1H), 4.64 (p, J = 7.3 Hz, 1H), 3.93 (s, 3H), 1.43 (d, J = 6.5 Hz, 3H), 1.19 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.08, 168.73, 157.99, 155.37, 148.77, 140.45, 133.75, 132.92, 130.57, 130.44, 129.38, 129.03, 128.71, 126.85, 125.87, 125.47, 124.73, 122.84, 121.15, 115.63, 109.46, 77.48, 74.16, 56.05, 47.94, 17.80, 14.35. 166 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.06 ([M + H].sup.+) calcd for (s, 1H), 8.39 (d, J = 7.8 Hz, 1H), C.sub.29H.sub.29N.sub.2O.sub.6, 7.95 (d, J = 5.2 Hz, 1H), 7.85 (s, 501.2020; found, 1H), 7.83-7.76 (m, 3H), 7.53 (dd, J = 501.2027. 8.5, 1.5 Hz, 1H), 7.49-7.43 (m, 2H), 7.18-7.11 (m, 2H), 6.89-6.83 (m, 4H), 5.44-5.36 (m, 2H), 4.65 (p, J = 7.3 Hz, 1H), 3.93 (s, 3H), 1.44 (d, J = 6.1 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.60, 168.69, 157.94, 155.37, 148.76, 140.43, 135.05, 133.19, 133.10, 130.44, 129.38, 128.48, 127.92, 127.73, 126.33, 126.29, 126.22, 124.33, 121.29, 116.04, 109.45, 81.43, 74.60, 56.05, 47.96, 18.00, 14.99. 167 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.11 ([M + H].sup.+) calcd for (s, 1H), 8.43 (d, J = 7.8 Hz, 1H), C.sub.28H.sub.30FN.sub.2O.sub.7, 7.96 (d, J = 5.2 Hz, 1H), 7.34 (t, J = 525.2032; found, 7.6 Hz, 1H), 7.21-7.11 (m, 2H), 525.2022. 6.84 (ddd, J = 20.4, 10.4, 7.6 Hz, 4H), 6.63-6.54 (m, 2H), 6.09 (ddt, J = 17.2, 10.4, 5.1 Hz, 1H), 5.65 (d, J = 4.5 Hz, 1H), 5.47 (ddd, J = 17.4, 3.0, 1.6 Hz, 1H), 5.44-5.38 (m, 1H), 5.35 (dd, J = 10.6, 1.3 Hz, 1H), 4.71-4.63 (m, 1H), 4.63-4.59 (m, 2H), 3.93 (s, 3H), 1.38 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.38, 168.68, 163.23 (d, J = 246.5 Hz), 157.61, 156.70 (d, J = 9.8 Hz), 155.37, 148.77, 140.40, 132.39, 130.49, 129.32, 129.16 (d, J = 10.2 Hz), 121.38 (d, J = 3.3 Hz), 121.06, 117.99, 115.59, 109.43, 107.62 (d, J = 21.3 Hz), 99.83 (d, J = 25.8 Hz), 74.57, 73.20, 69.23, 56.04, 48.01, 18.12, 15.11. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.20. 168 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.8 Hz, 1H), C.sub.27H.sub.30FN.sub.2O.sub.7, 7.95 (d, J = 5.2 Hz, 1H), 7.31 (dd, J = 513.2032; found, 8.4, 6.8 Hz, 1H), 7.19-7.13 (m, 513.1999. 2H), 6.89-6.83 (m, 2H), 6.81-6.77 (m, 2H), 6.61-6.53 (m, 2H), 5.62 (d, J = 4.3 Hz, 1H), 5.45-5.38 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 4.09 (q, J = 7.0 Hz, 2H), 3.93 (s, 3H), 1.50 (t, J = 7.0 Hz, 3H), 1.38 (d, J = 7.2 Hz, 3H), 1.33 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.38, 168.69, 163.32 (d, J = 246.1 Hz), 157.70, 157.07 (d, J = 9.9 Hz), 155.36, 148.76, 140.40, 130.49, 129.30, 128.97 (d, J = 10.1 Hz), 121.10 (d, J = 3.2 Hz), 121.01, 115.57, 109.43, 107.19 (d, J = 21.4 Hz), 99.31 (d, J = 25.7 Hz), 74.70, 73.15, 64.11, 56.04, 48.03, 18.12, 14.95, 14.65. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.45 (d, J = 3.1 Hz). 169 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.9 Hz, 1H), C.sub.27H.sub.29ClFN.sub.2O.sub.7, 7.95 (dd, J = 5.2, 0.7 Hz, 1H), 7.37 547.1642; found, (dd, J = 9.2, 6.6 Hz, 1H), 7.10 (d, J = 547.1642. 1.9 Hz, 1H), 6.85 (d, J = 5.2 Hz, 1H), 6.79 (dd, J = 8.4, 1.9 Hz, 1H), 6.64-6.57 (m, 2H), 6.54 (d, J = 8.4 Hz, 1H), 5.65 (d, J = 4.3 Hz, 1H), 5.45-5.38 (m, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.93 (d, J = 0.6 Hz, 3H), 3.89 (s, 3H), 2.19 (s, 3H), 1.40 (d, J = 7.2 Hz, 3H), 1.37 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.40, 168.68, 163.49 (d, J = 246.8 Hz), 157.80 (d, J = 9.7 Hz), 155.33, 150.82, 148.73, 140.40, 131.29, 130.67, 130.47, 129.13 (d, J = 10.1 Hz), 127.86, 122.88, 120.59 (d, J = 3.0 Hz), 114.31, 109.40, 107.47 (d, J = 21.2 Hz), 98.68 (d, J = 25.9 Hz), 75.29, 73.17, 56.03, 55.79, 48.01, 20.20, 18.06, 14.87. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.85 (d, J = 2.9 Hz). 170 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.44 ([M + H].sup.+) calcd for (s, 1H), 9.00 (s, 1H), 8.35 (d, J = 7.6 C.sub.25H.sub.26FN.sub.2O.sub.7, Hz, 1H), 8.09 (d, J = 5.3 Hz, 1H), 485.1719; found, 7.22 (ddd, J = 8.4, 7.0, 3.6 Hz, 3H), 485.1717. 6.97 (d, J = 5.3 Hz, 1H), 6.94 (t, J = 7.3 Hz, 1H), 6.88 (d, J = 7.8 Hz, 2H), 6.54 (td, J = 8.4, 2.5 Hz, 1H), 6.32 (dd, J = 10.0, 2.2 Hz, 1H), 5.50 (d, J = 6.9 Hz, 1H), 5.20 (p, J = 6.1 Hz, 1H), 4.65 (p, J = 7.1 Hz, 1H), 3.99 (s, 3H), 1.51 (d, J = 6.3 Hz, 3H), 1.45 (d, J = 7.1 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 170.47, 168.33, 163.09 (d, J = 246.5 Hz), 157.25, 156.26, 155.47 (d, J = 11.1 Hz), 149.58, 140.15, 130.12, 129.54, 128.71 (d, J = 10.3 Hz), 121.77, 119.93 (d, J = 3.4 Hz), 115.76, 109.65, 107.75 (d, J = 21.7 Hz), 103.82 (d, J = 24.0 Hz), 74.78, 56.25, 48.98, 29.26, 18.55, 16.20. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-112.15. 171 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 ([M + H].sup.+) calcd for (s, 1H), 8.43 (d, J = 7.8 Hz, 1H), C.sub.28H.sub.32FN.sub.2O.sub.7, 7.96 (d, J = 5.2 Hz, 1H), 7.32 (dd, J = 527.2188; found, 8.3, 6.8 Hz, 1H), 7.20-7.13 (m, 527.2188 2H), 6.86 (dd, J = 10.0, 6.2 Hz, 2H), 6.82-6.77 (m, 2H), 6.61-6.53 (m, 2H), 5.62 (d, J = 4.5 Hz, 1H), 5.43-5.36 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.98 (t, J = 6.4 Hz, 2H), 3.94 (s, 3H), 1.96-1.86 (m, 2H), 1.37 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.5 Hz, 3H), 1.11 (t, J = 7.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.38, 168.68, 163.33 (d, J = 246.1 Hz), 157.68, 157.21 (d, J = 10.0 Hz), 155.36, 148.76, 140.40, 130.49, 129.30, 128.95 (d, J = 10.2 Hz), 121.10 (d, J = 3.2 Hz), 120.99, 115.53, 109.42, 107.16 (d, J = 21.5 Hz), 99.24 (d, J = 25.9 Hz), 74.64, 73.25, 70.01, 56.04, 48.01, 22.49, 18.13, 15.03, 10.67. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.41 (s, 1F). 172 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.46 (d, J = 7.8 Hz, 1H), C.sub.27H.sub.31N.sub.2O.sub.7, 7.94 (d, J = 5.2 Hz, 1H), 7.24 (d, J = 495.2126; found, 8.1 Hz, 1H), 7.17-7.12 (m, 2H), 495.2123. 6.83 (ddd, J = 11.1, 8.0, 6.7 Hz, 4H), 6.70 (d, J = 6.4 Hz, 2H), 5.64 (d, J = 4.4 Hz, 1H), 5.43-5.36 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.89 (s, 3H), 2.31 (s, 3H), 1.36 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.48, 168.66, 157.92, 156.54, 155.33, 148.74, 140.39, 139.23, 130.54, 129.25, 127.68, 122.28, 121.53, 120.78, 115.59, 111.11, 109.39, 74.84, 73.41, 56.03, 55.41, 48.03, 21.57, 18.11, 14.89. 173 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.11 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.8 Hz, 1H), C.sub.27H.sub.30FN.sub.2O.sub.7, 7.95 (d, J = 5.2 Hz, 1H), 7.33 (dd, J = 513.2032; found, 8.2, 6.8 Hz, 1H), 6.95 (d, J = 8.3 513.2027. Hz, 2H), 6.85 (d, J = 5.2 Hz, 1H), 6.69 (t, J = 5.7 Hz, 2H), 6.63-6.55 (m, 2H), 5.57 (d, J = 4.6 Hz, 1H), 5.40-5.33 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.88 (s, 3H), 2.21 (s, 3H), 1.37 (d, J = 7.2 Hz, 3H), 1.33 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.43, 168.68, 163.36 (d, J = 246.2 Hz), 157.81 (d, J = 9.8 Hz), 155.53, 155.36, 148.76, 140.41, 130.49, 130.27, 129.77, 129.04 (d, J = 10.1 Hz), 121.33 (d, J = 3.2 Hz), 115.43, 109.42, 107.35 (d, J = 21.3 Hz), 98.66 (d, J = 25.9 Hz), 74.65, 73.23, 56.04, 55.77, 48.01, 20.42, 18.09, 15.00. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.31 (s). 174 ESIMS m/z 533 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.08 ([M + H].sup.+) (s, 1H), 8.43 (d, J = 7.9 Hz, 1H), 7.95 (d, J = 5.2 Hz, 1H), 7.36 (dd, J = 9.1, 6.7 Hz, 1H), 7.29 (dd, J = 7.9, 1.5 Hz, 1H), 7.04-6.98 (m, 1H), 6.85 (d, J = 5.2 Hz, 1H), 6.80 (td, J = 7.7, 1.1 Hz, 1H), 6.66-6.58 (m, 3H), 5.69 (d, J = 4.3 Hz, 1H), 5.43 (qd, J = 6.5, 4.4 Hz, 1H), 4.68 (p, J = 7.3 Hz, 1H), 3.94 (s, 3H), 3.90 (s, 3H), 1.40 (d, J = 7.2 Hz, 3H), 1.38 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.39, 168.69, 163.54 (d, J = 246.9 Hz), 157.78 (d, J = 9.7 Hz), 155.34, 153.03, 148.73, 140.40, 130.47, 130.25, 129.07 (d, J = 10.1 Hz), 127.44, 123.32, 121.58, 120.39 (d, J = 3.3 Hz), 114.39, 109.42, 107.53 (d, J = 21.3 Hz), 98.72 (d, J = 25.9 Hz), 75.25, 73.14, 56.04, 55.82, 48.01, 18.05, 14.81. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.71 (s, 1F). 175 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.8 Hz, 1H), C.sub.29H.sub.32FN.sub.2O.sub.7, 7.96 (d, J = 5.2 Hz, 1H), 7.33 (dd, J = 539.2188; found, 9.2, 6.7 Hz, 1H), 7.20-7.14 (m, 539.2194. 2H), 6.85 (ddd, J = 13.7, 10.5, 7.6 Hz, 4H), 6.56 (ddd, J = 11.1, 5.1, 2.5 Hz, 2H), 5.66 (d, J = 4.5 Hz, 1H), 5.47-5.39 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.94 (s, 3H), 3.89 (d, J = 6.8 Hz, 2H), 1.39 (d, J = 7.2 Hz, 3H), 1.37-1.30 (m, 4H), 0.72-0.66 (m, 2H), 0.41 (q, J = 5.1 Hz, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.37, 168.67, 163.28 (d, J = 246.4 Hz), 157.67, 157.10 (d, J = 9.9 Hz), 155.36, 148.77, 140.40, 130.50, 129.29, 129.08 (d, J = 10.1 Hz), 121.24 (d, J = 3.4 Hz), 120.98, 115.55, 109.42, 107.25 (d, J = 21.3 Hz), 99.41 (d, J = 25.6 Hz), 74.53, 73.30, 72.96, 56.04, 48.02, 18.17, 15.18, 10.08, 3.26, 3.12. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.40 (s). 176 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.09 ([M + H].sup.+) calcd for (s, 1H), 8.40 (d, J = 7.8 Hz, 1H), C.sub.27H.sub.28F.sub.3N.sub.2O.sub.7, 7.97 (d, J = 5.2 Hz, 1H), 7.37 (dd, J = 549.1843; found, 8.5, 6.6 Hz, 1H), 7.20-7.13 (m, 549.1844 2H), 6.91-6.84 (m, 2H), 6.81-6.75 (m, 2H), 6.67 (td, J = 8.3, 2.3 Hz, 1H), 6.57 (dd, J = 10.2, 2.3 Hz, 1H), 6.23 (tt, J = 54.8, 4.0 Hz, 1H), 5.60 (d, J = 4.2 Hz, 1H), 5.42-5.35 (m, 1H), 4.65 (p, J = 7.2 Hz, 1H), 4.29-4.19 (m, 2H), 3.94 (s, 3H), 1.38 (d, J = 7.2 Hz, 3H), 1.34 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.42, 168.69, 163.14 (d, J = 247.8 Hz), 157.52, 155.56 (d, J = 9.8 Hz), 155.39, 148.77, 140.42, 130.43, 129.51 (d, J = 9.9 Hz), 129.40, 121.72 (d, J = 3.4 Hz), 121.26, 115.55, 113.24 (t, J = 241.4 Hz), 109.46, 108.86 (d, J = 21.2 Hz), 99.64 (d, J = 26.1 Hz), 74.59, 73.00, 67.61 (t, J = 29.7 Hz), 56.05, 48.01, 18.05, 14.73. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.47 (s), −124.95 (d, J = 296.7 Hz), −125.91 (d, J = 296.7 Hz). 177 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.14 ([M + H].sup.+) calcd for (s, 1H), 8.46 (d, J = 7.9 Hz, 1H), C.sub.28H.sub.33N.sub.2O.sub.7, 7.95 (d, J = 5.2 Hz, 1H), 7.24 (d, J = 509.2282; found, 7.5 Hz, 1H), 6.94 (d, J = 8.2 Hz, 509.2284. 2H), 6.85 (d, J = 5.2 Hz, 1H), 6.73-6.67 (m, 4H), 5.59 (d, J = 4.4 Hz, 1H), 5.42-5.35 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.88 (s, 3H), 2.31 (s, 3H), 2.20 (s, 3H), 1.36 (d, J = 7.2 Hz, 3H), 1.33 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.49, 168.65, 156.56, 155.81, 155.34, 148.74, 140.38, 139.13, 130.57, 129.94, 129.70, 127.70, 122.47, 121.52, 115.44, 111.09, 109.37, 74.98, 73.45, 56.03, 55.39, 48.02, 21.56, 20.41, 18.13, 14.89. 178 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.10 ([M + H].sup.+) calcd for (s, 1H), 8.43 (d, J = 7.8 Hz, 1H), C.sub.27H.sub.30FN.sub.2O.sub.7, 7.95 (d, J = 5.2 Hz, 1H), 7.47 (dd, J = 561.2032; found, 8.7, 6.5 Hz, 1H), 7.45-7.39 (m, 561.2030. 2H), 7.24-7.15 (m, 3H), 7.11-7.06 (m, 2H), 6.87 (ddd, J = 11.6, 9.4, 6.2 Hz, 4H), 6.71 (td, J = 8.3, 2.5 Hz, 1H), 6.48 (dd, J = 10.1, 2.5 Hz, 1H), 5.72 (d, J = 4.9 Hz, 1H), 5.54-5.47 (m, 1H), 4.70 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 1.44-1.38 (m, 6H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.54-−110.75 (m). 179 ESIMS m/z 595 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.08 ([M + H].sup.+) (s, 1H), 8.43 (d, J = 7.9 Hz, 1H), 7.96 (d, J = 5.2 Hz, 1H), 7.53 (dd, J = 8.7, 6.5 Hz, 1H), 7.45-7.38 (m, 2H), 7.31 (dd, J = 7.9, 1.6 Hz, 1H), 7.22 (dt, J = 8.4, 1.0 Hz, 1H), 7.09-7.00 (m, 3H), 6.87-6.81 (m, 2H), 6.79-6.71 (m, 2H), 6.49 (dd, J = 10.1, 2.5 Hz, 1H), 5.80 (d, J = 4.5 Hz, 1H), 5.59-5.52 (m, 1H), 4.71 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 1.45 (d, J = 6.5 Hz, 3H), 1.43 (d, J = 7.3 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.16 (s). 180 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 12.24 (s, 1H), 8.51 (d, J = 7.9 Hz, 1H), 7.98 (d, J = 5.2 Hz, 1H), 7.39-7.27 (m, 5H), 6.87 (d, J = 5.2 Hz, 1H), 5.07 (dd, J = 6.8, 4.8 Hz, 1H), 4.85-4.69 (m, 1H), 4.26 (d, J = 6.8 Hz, 1H), 3.95 (s, 3H), 3.19 (s, 3H), 1.83-1.66 (m, 1H), 1.56 (d, J = 7.1 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 171.86, 168.59, 155.30, 148.70, 140.42, 137.92, 130.58, 128.59, 128.30, 127.51, 109.37, 83.45, 81.46, 57.02, 48.05, 28.26, 19.78, 18.62, 16.72 181 ESIMS m/z 543 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.12 ([M + H].sup.+) (s, 1H), 8.46 (d, J = 7.9 Hz, 1H), 7.95 (d, J = 5.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 1H), 7.10 (d, J = 1.9 Hz, 1H), 6.84 (d, J = 5.2 Hz, 1H), 6.78 (dd, J = 8.4, 1.6 Hz, 1H), 6.73-6.68 (m, 2H), 6.55 (d, J = 8.4 Hz, 1H), 5.67 (d, J = 4.2 Hz, 1H), 5.43 (qd, J = 6.4, 4.3 Hz, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.93 (s, 3H), 3.88 (s, 3H), 2.31 (s, 3H), 2.18 (s, 3H), 1.39 (d, J = 7.2 Hz, 3H), 1.37 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.46, 168.66, 156.53, 155.31, 151.08, 148.72, 140.38, 139.44, 130.90, 130.55, 127.84, 127.71, 122.75, 121.72, 121.61, 114.28, 111.08, 109.36, 75.59, 73.42, 56.02, 55.41, 48.03, 21.58, 20.20, 18.10, 14.78. 182 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.31-8.22 [M].sup.+ calcd for (m, 2H), 7.36-7.20 (m, 5H), C.sub.26H.sub.32N.sub.2O.sub.8, 6.94 (d, J = 5.4 Hz, 1H), 5.78-5.68 500.2159; found, (m, 2H), 5.12 (h, J = 6.4 Hz, 1H), 500.2165 4.68-4.55 (m, 1H), 4.33 (d, J = 6.4 Hz, 1H), 3.90 (s, 3H), 3.19 (dd, J = 6.8, 2.4 Hz, 2H), 2.06 (s, 3H), 1.35 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 7.1 Hz, 3H), 1.01 (ttt, J = 8.0, 6.7, 4.9 Hz, 1H), 0.54-0.41 (m, 2H), 0.19-0.04 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.03, 170.27, 162.86, 160.26, 145.68, 143.97, 142.51, 138.81, 128.21, 127.95, 127.60, 109.52, 89.56, 83.08, 74.22, 73.75, 56.17, 48.08, 20.87, 18.13, 16.07, 10.59, 3.17, 2.71. 183 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.32-8.26 [M].sup.+ calcd for (m, 1H), 8.24 (d, J = 5.4 Hz, C.sub.28H.sub.30N.sub.2O.sub.8, 1H), 7.44-7.21 (m, 5H), 7.22-7.08 522.2002; found, (m, 2H), 6.94-6.89 (m, 1H), 522.2005 6.89-6.78 (m, 3H), 5.77-5.67 (m, 2H), 5.33-5.25 (m, 1H), 5.21 (d, J = 5.1 Hz, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.22, 170.27, 162.94, 160.26, 157.88, 145.68, 144.00, 142.41, 137.59, 129.33, 128.50, 128.14, 126.98, 121.15, 115.97, 109.55, 89.55, 81.23, 74.29, 56.17, 48.12, 20.87, 18.18, 15.10. 184 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.50-8.42 [M].sup.+ calcd for (m, 1H), 8.33-8.23 (m, 1H), C.sub.27H.sub.28N.sub.2O.sub.7, 7.42-7.35 (m, 2H), 7.34-7.20 (m, 492.1897; found, 3H), 7.20-7.11 (m, 2H), 7.01-6.92 492.1900 (m, 1H), 6.90-6.76 (m, 3H), 5.32-5.16 (m, 2H), 4.64 (tt, J = 10.1, 5.1 Hz, 1H), 3.86 (s, 3H), 2.38 (s, 3H), 1.38 (d, J = 6.3 Hz, 3H), 1.24 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.08, 168.87, 162.36, 159.40, 157.85, 146.63, 141.41, 137.54, 137.45, 129.32, 128.49, 128.13, 126.97, 121.15, 115.96, 109.76, 81.19, 74.29, 56.24, 47.89, 20.74, 18.32, 15.09. 185 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.31-8.26 3376.11, 2985.22, ([M + H].sup.+) calcd for (m, 2H), 7.43-7.36 (m, 2H), 1739.53, 1675.70, C.sub.28H.sub.31N.sub.2O.sub.8, 7.34-7.28 (m, 2H), 7.26-7.21 (m, 1493.93, 1200.10 523.2075; found, 1H), 7.20-7.13 (m, 2H), 6.95 (d, J = 523.2075 5.4 Hz, 1H), 6.91-6.80 (m, 3H), 5.75-5.71 (m, 2H), 5.32-5.18 (m, 2H), 4.74-4.60 (m, 1H), 3.91 (s, 3H), 2.05 (s, 3H), 1.43 (d, J = 7.1 Hz, 3H), 1.36 (d, J = 6.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.07, 170.27, 162.88, 160.30, 157.87, 145.67, 144.08, 142.45, 137.56, 129.33, 128.50, 128.06, 126.83, 121.16, 116.07, 109.55, 89.61, 81.11, 74.54, 56.19, 48.16, 20.87, 18.37, 14.52. 186 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 3378.15, 2984.35, ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 1740.49, 1674.69, C.sub.28H.sub.31N.sub.2O.sub.8, Hz, 1H), 7.43-7.37 (m, 2H), 7.36-7.21 1493.07, 1199.65 523.2075; found, (m, 3H), 7.20-7.13 (m, 2H), 523.2087 6.93 (d, J = 5.4 Hz, 1H), 6.90-6.79 (m, 3H), 5.74 (d, J = 6.4 Hz, 1H), 5.71 (d, J = 6.4 Hz, 1H), 5.33-5.18 (m, 2H), 4.67 (dq, J = 11.0, 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.22, 170.27, 162.95, 160.27, 157.90, 145.68, 144.01, 142.44, 137.61, 129.34, 128.51, 128.14, 126.99, 121.16, 115.99, 109.55, 89.57, 81.26, 74.31, 56.18, 48.14, 20.88, 18.20, 15.11. 187 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.30-8.22 3380, 2970, ([M + H].sup.+) calcd for (m, 2H), 7.41-7.24 (m, 5H), 1740, 1675, C.sub.28H.sub.30FN.sub.2O.sub.8, 7.10 (td, J = 8.3, 6.7 Hz, 1H), 6.93 1504, 1488, 541.1981; found, (d, J = 5.4 Hz, 1H), 6.64-6.50 (m, 1202, 1132 541.1990 3H), 5.76-5.68 (m, 2H), 5.32-5.21 (m, 1H), 5.19 (d, J = 4.9 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.19, 170.29, 163.36 (d, J = 245.4 Hz), 162.98, 160.27, 159.11 (d, J = 10.9 Hz), 145.68, 144.03, 142.37, 136.95, 130.10 (d, J = 10.0 Hz), 128.63, 128.35, 126.88, 111.55 (d, J = 3.0 Hz), 109.57, 108.03 (d, J = 21.3 Hz), 103.73 (d, J = 24.8 Hz), 89.56, 81.50, 74.07, 56.17, 48.15, 20.88, 18.16, 14.93. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-111.61 (dt, J = 10.9, 7.7 Hz). 188 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.45 3380, 2970, ([M + H].sup.+) calcd for (br s, 1H), 8.29 (d, J = 5.4 Hz, 1H), 2941, 1768, C.sub.27H.sub.28FN.sub.2O.sub.7, 7.40-7.26 (m, 5H), 7.10 (td, J = 1738, 1676, 511.1875; found, 8.3, 6.8 Hz, 1H), 6.99 (d, J = 5.5 Hz, 1507, 1488, 511.1883 1H), 6.63-6.50 (m, 3H), 5.26 (qd, J = 1199, 1132 6.4, 4.7 Hz, 1H), 5.18 (d, J = 4.9 Hz, 1H), 4.65 (p, J = 7.4 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.1 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.08, 168.91, 163.36 (d, J = 245.5 Hz), 162.41, 159.43, 159.10 (d, J = 11.0 Hz), 146.63, 141.41, 137.49, 136.92, 130.08 (d, J = 10.0 Hz), 128.62, 128.35, 126.89, 111.56 (d, J = 2.9 Hz), 109.76, 108.02 (d, J = 21.2 Hz), 103.73 (d, J = 24.9 Hz), 81.47, 74.09, 56.27, 47.93, 20.75, 18.31, 14.91. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-111.63 (dt, J = 10.9, 7.7 Hz). 189 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.29 3379, 2970, ([M + H].sup.+) calcd for (d, J = 8.3 Hz, 1H), 8.22 (d, J = 5.4 1740, 1676, C.sub.34H.sub.34FN.sub.2O.sub.8, Hz, 1H), 7.39-7.25 (m, 5H), 7.18-7.06 1488, 1200 617.2294; found, (m, 4H), 7.05-6.99 (m, 2H), 617.2304 6.92 (d, J = 5.4 Hz, 1H), 6.64-6.56 (m, 2H), 6.52 (dt, J = 10.8, 2.4 Hz, 1H), 5.71-5.64 (m, 2H), 5.21-5.10 (m, 2H), 4.99 (dt, J = 8.5, 5.9 Hz, 1H), 3.90 (s, 3H), 3.07 (qd, J = 13.9, 6.0 Hz, 2H), 2.04 (d, J = 2.0 Hz, 3H), 1.34 (d, J = 6.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 170.84, 170.27, 163.38 (d, J = 245.5 Hz), 163.01, 160.23, 158.97 (d, J = 10.9 Hz), 145.72, 144.01, 142.22, 136.91, 135.85, 130.10 (d, J = 10.0 Hz), 129.37, 128.70, 128.42, 128.37, 126.92, 126.77, 111.62 (d, J = 2.9 Hz), 109.56, 107.99 (d, J = 21.3 Hz), 103.75 (d, J = 24.9 Hz), 89.54, 81.19, 74.80, 56.16, 53.30, 37.83, 20.87, 14.34. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-111.61 (dt, J = 10.8, 7.6 Hz). 190 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.45 ([M + H].sup.+) calcd for (d, J = 8.4 Hz, 1H), 8.25 (d, J = 5.5 C.sub.33H.sub.32FN.sub.2O.sub.7, Hz, 1H), 7.39-7.24 (m, 5H), 7.17-7.03 587.2188; found, (m, 4H), 7.02-6.94 (m, 3H), 587.2184 6.65-6.55 (m, 2H), 6.52 (dt, J = 10.9, 2.4 Hz, 1H), 5.19-5.08 (m, 2H), 4.97 (dt, J = 8.5, 5.6 Hz, 1H), 3.89 (s, 3H), 3.09 (app d, J = 5.7 Hz, 2H), 2.39 (s, 3H), 1.32 (d, J = 6.3 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 170.67, 168.88, 163.40 (d, J = 245.3 Hz), 162.47, 159.39, 158.97 (d, J = 10.9 Hz), 146.72, 141.37, 137.49, 136.88, 135.69, 130.10 (d, J = 9.9 Hz), 129.43, 128.71, 128.42, 128.37, 126.95, 126.77, 111.64 (d, J = 2.9 Hz), 109.79, 107.98 (d, J = 21.3 Hz), 103.76 (d, J = 24.8 Hz), 81.14, 74.87, 56.27, 53.09, 37.85, 20.77, 14.26. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.61. 191 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.31-8.22 ([M + H].sup.+) calcd for (m, 2H), 7.44-7.27 (m, 5H), C.sub.28H.sub.29F.sub.2N.sub.2O.sub.8, 7.02-6.91 (m, 2H), 6.58-6.44 (m, 559.1886; found, 2H), 5.77-5.68 (m, 2H), 5.33 (qd, J = 559.1909 6.4, 5.0 Hz, 1H), 5.20 (d, J = 5.1 Hz, 1H), 4.73-4.60 (m, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.41 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.15, 170.28, 162.99, 160.27, 158.32 (dd, J = 242.3, 2.7 Hz), 149.47 (dd, J = 242.0, 3.2 Hz), 146.24 (dd, J = 12.5, 10.5 Hz), 145.69, 144.00, 142.41, 136.31, 128.68, 128.65, 127.01, 116.38 (dd, J = 21.0, 10.2 Hz), 109.58, 107.65 (dd, J = 23.8, 6.9 Hz), 105.13 (dd, J = 27.2, 1.4 Hz), 89.53, 83.05, 73.87, 56.18, 48.14, 20.86, 18.06, 15.10. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.68 (d, J = 15.0 Hz), −138.67 (d, J = 15.0 Hz). 192 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 ([M + H].sup.+) calcd for (d, J = 8.0 Hz, 1H), 8.29 (d, J = 5.4 C.sub.27H.sub.27F.sub.2N.sub.2O.sub.7, Hz, 1H), 7.43-7.25 (m, 5H), 7.04-6.91 529.1781; found, (m, 2H), 6.57-6.43 (m, 2H), 529.1784 5.31 (qd, J = 6.5, 5.1 Hz, 1H), 5.18 (d, J = 5.1 Hz, 1H), 4.65 (dq, J = 8.3, 7.2 Hz, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.04, 168.90, 162.43, 159.44, 158.32 (dd, J = 242.3, 2.5 Hz), 149.46 (dd, J = 242.1, 3.2 Hz), 146.63, 146.23 (dd, J = 12.3, 10.8 Hz), 141.42, 137.50, 136.28, 128.67, 128.65, 127.00, 116.35 (dd, J = 20.9, 10.1 Hz), 109.77, 107.62 (dd, J = 23.8, 7.0 Hz), 105.11 (dd, J = 27.3, 1.3 Hz), 82.99, 73.90, 56.27, 47.94, 20.75, 18.19, 15.03. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.69 (d, J = 15.0 Hz), −138.71 (d, J = 14.9 Hz). 193 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.35-8.22 ([M + H].sup.+) calcd for (m, 2H), 7.44-7.27 (m, 5H), C.sub.29H.sub.31F.sub.2N.sub.2O.sub.8, 7.02-6.91 (m, 2H), 6.58-6.42 (m, 573.2043; found, 2H), 5.78-5.68 (m, 2H), 5.32 (qd, J = 573.2058 6.4, 5.0 Hz, 1H), 5.19 (d, J = 5.0 Hz, 1H), 4.66 (ddd, J = 8.3, 6.6, 5.2 Hz, 1H), 3.91 (s, 3H), 2.06 (s, 3H), 1.87-1.75 (m, 1H), 1.69-1.57 (m, 1H), 1.41 (d, J = 6.4 Hz, 3H), 0.75 (t, J = 7.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.51, 170.28, 163.14, 160.30, 158.33 (dd, J = 239.9, 2.6 Hz), 149.43 (dd, J = 241.9, 3.2 Hz), 146.24 (dd, J = 12.4, 10.6 Hz), 145.69, 144.04, 142.42, 136.32, 128.71, 128.66, 126.98, 116.35 (dd, J = 21.0, 10.0 Hz), 109.55, 107.58 (dd, J = 23.9, 7.0 Hz), 105.00 (dd, J = 27.3, 1.4 Hz), 89.60, 82.99, 73.97, 56.18, 53.27, 25.41, 20.87, 15.09, 9.21. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.70 (d, J = 15.0 Hz), −138.70 (d, J = 14.9 Hz). 194 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.49 ([M + H].sup.+) calcd for (d, J = 8.6 Hz, 1H), 8.30 (d, J = 5.4 C.sub.28H.sub.29F.sub.2N.sub.2O.sub.7, Hz, 1H), 7.43-7.27 (m, 5H), 7.02-6.91 543.1937; found, (m, 2H), 6.57-6.42 (m, 2H), 543.1948 5.30 (qd, J = 6.4, 4.9 Hz, 1H), 5.19 (d, J = 5.0 Hz, 1H), 4.64 (ddd, J = 8.5, 6.5, 5.2 Hz, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.86-1.72 (m, 1H), 1.68-1.56 (m, 1H), 1.40 (d, J = 6.4 Hz, 3H), 0.74 (t, J = 7.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.38, 168.89, 162.60, 159.44, 158.31 (dd, J = 242.3, 2.6 Hz), 149.42 (dd, J = 242.0, 3.4 Hz), 146.65, 146.23 (dd, J = 12.4, 10.6 Hz), 141.47, 137.49, 136.29, 128.70, 128.65, 126.96, 116.32 (dd, J = 20.9, 10.2 Hz), 109.75, 107.54 (dd, J = 23.8, 6.8 Hz), 104.98 (dd, J = 27.2, 1.7 Hz), 82.92, 73.99, 56.27, 53.07, 25.48, 20.75, 15.02, 9.13. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-116.69 (d, J = 15.0 Hz), −138.73 (d, J = 15.0 Hz). 195 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.26 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.22 (d, J = 5.4 C.sub.29H.sub.30F.sub.3N.sub.2O.sub.8, Hz, 1H), 7.45-7.26 (m, 7H), 6.96-6.84 591.1949; found, (m, 3H), 5.76-5.67 (m, 2H), 591.1953 5.34-5.24 (m, 2H), 4.67 (p, J = 7.3 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.1 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.15, 170.28, 163.04, 160.28, 160.18, 145.66, 144.02, 142.32, 136.59, 128.72, 128.47, 126.82, 126.75 (q, J = 3.9 Hz), 124.33 (q, J = 259.5 Hz), 123.21 (q, J = 32.7 Hz), 115.78, 109.58, 89.54, 81.31, 73.99, 56.16, 48.23, 20.86, 18.09, 14.76. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-61.61. 196 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.44 ([M + H].sup.+) calcd for (d, J = 8.2 Hz, 1H), 8.25 (d, J = 5.4 C.sub.28H.sub.28F.sub.3N.sub.2O.sub.7, Hz, 1H), 7.43-7.28 (m, 7H), 6.97 561.1843; found, (d, J = 5.5 Hz, 1H), 6.90-6.86 (m, 561.1853 2H), 5.33-5.22 (m, 2H), 4.72-4.59 (m, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.37 (d, J = 6.0 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.03, 168.88, 162.48, 160.16, 159.43, 146.59, 141.35, 137.51, 136.57, 128.71, 128.46, 126.82, 126.77 (q, J = 4.2 Hz), 124.29 (q, J = 271.2 Hz), 123.19 (q, J = 32.6 Hz), 115.79, 109.77, 81.27, 74.04, 56.26, 48.02, 20.75, 18.24, 14.71. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-61.60. 197 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.34 ([M + H].sup.+) calcd for (d, J = 9.2 Hz, 1H), 8.21 (d, J = 5.3 C.sub.31H.sub.34F.sub.3N.sub.2O.sub.8, Hz, 1H), 7.44-7.27 (m, 7H), 6.93 619.2262; found, (d, J = 5.4 Hz, 1H), 6.90-6.83 (m, 619.2266 2H), 5.77-5.67 (m, 2H), 5.29 (q, J = 2.4, 1.9 Hz, 2H), 4.64 (dd, J = 9.1, 4.8 Hz, 1H), 3.90 (s, 3H), 2.20-2.08 (m, 1H), 2.06 (s, 3H), 1.40-1.34 (m, 3H), 0.90 (d, J = 6.8 Hz, 3H), 0.77 (d, J = 6.8 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.20, 170.26, 163.35, 160.36, 160.16, 145.63, 144.13, 142.28, 136.52, 128.74, 128.45, 126.77, 126.72 (q, J = 3.9 Hz), 124.28 (q, J = 271.3 Hz), 123.16 (q, J = 32.9 Hz), 115.72, 109.55, 89.64, 81.19, 74.05, 57.21, 56.16, 31.25, 20.86, 19.10, 17.46, 14.55. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-61.61. 198 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.48 ([M + H].sup.+) calcd for (d, J = 9.4 Hz, 1H), 8.24 (d, J = 5.4 C.sub.30H.sub.32F.sub.3N.sub.2O.sub.7, Hz, 1H), 7.43-7.29 (m, 7H), 6.97 589.2156; found, (d, J = 5.5 Hz, 1H), 6.89-6.82 (m, 589.2158 2H), 5.31-5.23 (m, 2H), 4.60 (dd, J = 9.4, 4.8 Hz, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 2.17-2.04 (m, 1H), 1.35 (d, J = 6.1 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H), 0.77 (d, J = 6.8 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.04, 168.87, 162.80, 160.15, 159.43, 146.60, 141.48, 137.50, 136.50, 128.73, 128.44, 126.76, 126.70 (q, J = 3.7 Hz), 124.30 (q, J = 269.7 Hz), 123.13 (q, J = 33.0 Hz), 115.73, 109.72, 81.14, 74.08, 57.04, 56.25, 31.31, 20.76, 19.00, 17.48, 14.46. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-61.60. 199 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.28-8.21 3382, 2987, ([M + H].sup.+) calcd for (m, 2H), 7.40-7.27 (m, 6H), 2941, 1742, C.sub.28H.sub.29Cl.sub.2N.sub.2O.sub.8, 6.97-6.91 (m, 2H), 6.57 (d, J = 8.9 1674, 1574, 591.1295; found, Hz, 1H), 5.75-5.67 (m, 2H), 5.32 1504, 1478, 591.1301 (qd, J = 6.4, 4.6 Hz, 1H), 5.24 (d, J = 1200, 729 4.6 Hz, 1H), 4.67 (p, J = 7.3 Hz, 1H), 3.91 (s, 3H), 2.07 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.32 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.17, 170.29, 163.04, 160.25, 152.05, 145.67, 144.00, 142.33, 136.30, 129.96, 128.71, 128.56, 127.34, 126.83, 126.04, 124.28, 115.75, 109.54, 89.55, 82.31, 74.15, 56.18, 48.24, 20.88, 18.08, 14.69. 200 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.43 ([M + H].sup.+) calcd for (s, 1H), 8.28 (d, J = 5.5 Hz, 1H), C.sub.27H.sub.27Cl.sub.2N.sub.2O.sub.7, 7.40-7.27 (m, 6H), 6.98 (d, J = 5.5 561.1190; found, Hz, 1H), 6.92 (dd, J = 8.9, 2.5 Hz, 561.1207 1H), 6.56 (d, J = 8.9 Hz, 1H), 5.33-5.25 (m, 1H), 5.23 (d, J = 4.5 Hz, 1H), 4.65 (p, J = 7.4 Hz, 1H), 3.91 (s, 3H), 2.38 (s, 3H), 1.40 (d, J = 6.5 Hz, 3H), 1.31 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.06, 168.90, 162.48, 159.40, 152.04, 146.60, 141.34, 137.47, 136.28, 129.92, 128.70, 128.55, 127.33, 126.80, 126.01, 124.26, 115.76, 109.73, 82.25, 74.19, 56.28, 48.03, 20.75, 18.20, 14.59. 201 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.28-8.21 ([M + H].sup.+) calcd for (m, 2H), 7.39-7.25 (m, 5H), C.sub.28H.sub.30ClN.sub.2O.sub.8, 7.12-7.07 (m, 2H), 6.93 (d, J = 5.4 557.1685; found, Hz, 1H), 6.77-6.71 (m, 2H), 5.72 557.1702 (app q, J = 6.5 Hz, 2H), 5.27 (qd, J = 6.5, 4.8 Hz, 1H), 5.16 (d, J = 4.9 Hz, 1H), 4.66 (p, J = 7.3 Hz, 1H), 3.91 (s, 3H), 2.06 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.17, 170.29, 163.00, 160.27, 156.41, 145.66, 144.03, 142.33, 137.00, 129.23, 128.62, 128.33, 126.88, 126.02, 117.21, 109.56, 89.56, 81.58, 74.11, 56.18, 48.20, 20.88, 18.13, 14.81. 202 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.30-8.22 3379, 2986, ([M + H].sup.+) calcd for (m, 2H), 7.41-7.26 (m, 5H), 2940, 1742, C.sub.28H.sub.30ClN.sub.2O.sub.8, 7.11-7.03 (m, 1H), 6.93 (d, J = 5.4 1675, 1593, 557.1685; found, Hz, 1H), 6.89-6.83 (m, 2H), 6.72-6.66 1578, 1504, 557.1688 (m, 1H), 5.76-5.68 (m, 2H), 1201, 1002 5.32-5.22 (m, 1H), 5.19 (d, J = 4.9 Hz, 1H), 4.66 (p, J = 7.4 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.18, 170.28, 162.98, 160.26, 158.52, 145.68, 144.02, 142.35, 136.86, 134.68, 130.13, 128.64, 128.37, 126.88, 121.41, 116.58, 114.03, 109.57, 89.56, 81.44, 74.08, 56.17, 48.16, 20.88, 18.16, 14.89. 203 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.45 3380, 2985, ([M + H].sup.+) calcd for (br s, 1H), 8.29 (d, J = 5.4 Hz, 1H), 2940, 1769, C.sub.27H.sub.28ClN.sub.2O.sub.7, 7.40-7.26 (m, 5H), 7.10-7.03 (m, 1737, 1676, 527.1580; found, 1H), 6.98 (d, J = 5.5 Hz, 1H), 6.88-6.82 1592, 1507, 527.1590 (m, 2H), 6.72-6.66 (m, 1H), 1197, 1174 5.30-5.22 (m, 1H), 5.18 (d, J = 4.9 Hz, 1H), 4.65 (p, J = 7.4 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.06, 168.90, 162.41, 159.42, 158.51, 146.63, 141.40, 137.48, 136.83, 134.68, 130.11, 128.64, 128.37, 126.88, 121.39, 116.58, 114.04, 109.76, 81.41, 74.10, 56.27, 47.93, 20.76, 18.31, 14.87. 204 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.30-8.22 ([M + H].sup.+) calcd for (m, 2H), 7.44-7.38 (m, 2H), C.sub.28H.sub.30ClN.sub.2O.sub.8, 7.37-7.26 (m, 4H), 6.99 (ddd, J = 557.1685; found, 8.2, 7.4, 1.7 Hz, 1H), 6.93 (d, J = 557.1691 5.4 Hz, 1H), 6.81 (td, J = 7.7, 1.5 Hz, 1H), 6.67 (dd, J = 8.4, 1.4 Hz, 1H), 5.76-5.69 (m, 2H), 5.37-5.26 (m, 2H), 4.67 (p, J = 7.3 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.44 (d, J = 6.4 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.24, 170.28, 162.97, 160.25, 153.29, 145.68, 144.00, 142.42, 136.85, 130.30, 128.60, 128.38, 127.42, 126.92, 123.50, 121.72, 115.11, 109.53, 89.56, 81.98, 74.35, 56.17, 48.15, 20.88, 18.14, 14.93. 205 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.46 3379, 2985, ([M + H].sup.+) calcd for (br s, 1H), 8.29 (d, J = 5.4 Hz, 1H), 2940, 1769, C.sub.27H.sub.28ClN.sub.2O.sub.7, 7.44-7.38 (m, 2H), 7.37-7.24 (m, 1739, 1674, 527.1580; found, 4H), 7.02-6.95 (m, 2H), 6.81 (td, J = 1589, 1507, 527.1585 7.7, 1.4 Hz, 1H), 6.66 (dd, J = 8.3, 1481, 1195, 1.5 Hz, 1H), 5.36-5.25 (m, 2H), 1174, 1059, 4.66 (p, J = 7.4 Hz, 1H), 3.90 (s, 729 3H), 2.38 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.13, 168.91, 162.39, 159.41, 153.29, 146.63, 141.46, 137.47, 136.82, 130.29, 128.59, 128.38, 127.41, 126.91, 123.50, 121.72, 115.11, 109.72, 81.96, 74.38, 56.27, 47.93, 20.76, 18.30, 14.90. 206 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.29-8.22 ([M + H].sup.+) calcd for (m, 2H), 7.38-7.27 (m, 5H), C.sub.28H.sub.29ClFN.sub.2O.sub.8, 6.94 (d, J = 5.4 Hz, 1H), 6.67-6.59 575.1591; found, (m, 2H), 6.43 (dt, J = 10.5, 2.3 Hz, 575.1597 1H), 5.72 (app q, J = 6.4 Hz, 2H), 5.30-5.22 (m, 1H), 5.17 (d, J = 4.8 Hz, 1H), 4.66 (p, J = 7.3 Hz, 1H), 3.91 (s, 3H), 2.07 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.14, 170.30, 163.09 (d, J = 248.2 Hz), 163.02, 160.28, 159.25 (d, J = 12.3 Hz), 145.67, 144.04, 142.31, 136.23, 135.22 (d, J = 13.4 Hz), 128.77, 128.60, 126.79, 112.53 (d, J = 3.3 Hz), 109.59, 109.18 (d, J = 25.2 Hz), 102.22 (d, J = 25.0 Hz), 89.54, 81.75, 73.84, 56.18, 48.18, 20.88, 18.13, 14.79. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.91 (dd, J = 10.3, 8.4 Hz). 207 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.44 ([M + H].sup.+) calcd for (br s, 1H), 8.29 (d, J = 5.4 Hz, 1H), C.sub.27H.sub.27ClFN.sub.2O.sub.7, 7.37-7.27 (m, 5H), 6.99 (d, J = 5.5 545.1485; found, Hz, 1H), 6.67-6.58 (m, 2H), 6.42 545.1485 (dt, J = 10.6, 2.3 Hz, 1H), 5.25 (qd, J = 6.4, 4.5 Hz, 1H), 5.15 (d, J = 4.7 Hz, 1H), 4.64 (p, J = 7.4 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.34 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 172.02, 168.92, 163.08 (d, J = 248.5 Hz), 162.47, 159.43, 159.23 (d, J = 12.3 Hz), 146.60, 141.33, 137.50, 136.19, 135.19 (d, J = 13.5 Hz), 128.76, 128.58, 126.79, 112.51 (d, J = 3.2 Hz), 109.79, 109.14 (d, J = 25.1 Hz), 102.20 (d, J = 25.1 Hz), 81.68, 73.86, 56.27, 48.01, 20.76, 18.23, 14.70. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.96 (dd, J = 10.3, 8.5 Hz). 208 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.31 ([M + H].sup.+) calcd for (d, J = 8.3 Hz, 1H), 8.25 (d, J = 5.4 C.sub.29H.sub.31ClFN.sub.2O.sub.8, Hz, 1H), 7.38-7.28 (m, 5H), 6.94 589.1747; found, (d, J = 5.4 Hz, 1H), 6.66-6.58 (m, 589.1752 2H), 6.42 (dt, J = 10.5, 2.2 Hz, 1H), 5.76-5.68 (m, 2H), 5.26 (td, J = 6.4, 4.7 Hz, 1H), 5.17 (d, J = 4.7 Hz, 1H), 4.66 (ddd, J = 8.3, 6.6, 5.2 Hz, 1H), 3.91 (s, 3H), 2.06 (s, 3H), 1.88-1.77 (m, 1H), 1.71-1.62 (m, 1H), 1.35 (d, J = 6.4 Hz, 3H), 0.79 (t, J = 7.5 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.51, 170.29, 163.08 (d, J = 248.3 Hz), 163.18, 160.31, 159.23 (d, J = 12.3 Hz), 145.68, 144.06, 142.33, 136.20, 135.22 (d, J = 13.4 Hz), 128.79, 128.60, 126.78, 112.51 (d, J = 3.2 Hz), 109.58, 109.16 (d, J = 25.2 Hz), 102.19 (d, J = 25.0 Hz), 89.59, 81.71, 73.89, 56.18, 53.34, 25.45, 20.88, 14.77, 9.34. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.92 (dd, J = 10.4, 8.3 Hz). 209 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.50-8.45 ([M + H].sup.+) calcd for (m, 1H), 8.30 (d, J = 5.4 Hz, C.sub.28H.sub.29ClFN.sub.2O.sub.7, 1H), 7.37-7.27 (m, 5H), 6.99 (d, J = 559.1642; found, 5.5 Hz, 1H), 6.65-6.58 (m, 2H), 559.1646 6.41 (dt, J = 10.6, 2.3 Hz, 1H), 5.25 (qd, J = 6.3, 4.4 Hz, 1H), 5.16 (d, J = 4.6 Hz, 1H), 4.67-4.59 (m, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.87-1.77 (m, 1H), 1.71-1.61 (m, 1H), 1.33 (d, J = 6.4 Hz, 3H), 0.78 (t, J = 7.4 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.38, 168.91, 163.07 (d, J = 248.1 Hz), 162.63, 159.43, 159.21 (d, J = 12.3 Hz), 146.62, 141.38, 137.49, 136.16, 135.18 (d, J = 13.5 Hz), 128.77, 128.58, 126.77, 112.49 (d, J = 3.2 Hz), 109.77, 109.12 (d, J = 25.3 Hz), 102.16 (d, J = 25.1 Hz), 81.65, 73.89, 56.27, 53.16, 25.51, 20.76, 14.69, 9.27. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-109.96 (dd, J = 10.3, 8.3 Hz). 210 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.54 ([M + Na].sup.+) calcd for (d, J = 8.1 Hz, 1H), 8.32 (d, J = 5.4 C.sub.25H.sub.26N.sub.2O.sub.7SNa, Hz, 1H), 7.30-7.23 (m, 1H), 7.24-7.16 521.1359; found, (m, 2H), 7.06 (dd, J = 3.7, 1.2 521.1354. Hz, 1H), 7.00 (d, J = 5.5 Hz, 1H), 6.95 (dd, J = 5.0, 3.5 Hz, 1H), 6.94-6.86 (m, 3H), 5.50-5.34 (m, 2H), 4.73 (dq, J = 8.2, 7.1 Hz, 1H), 3.91 (s, 3H), 2.40 (s, 3H), 1.42 (d, J = 7.1 Hz, 3H), 1.25 (d, J = 6.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.20, 168.92, 162.40, 159.44, 157.67, 146.65, 141.54, 140.20, 137.51, 129.39, 126.74, 126.26, 125.85, 121.54, 115.99, 109.74, 78.23, 73.49, 56.28, 48.03, 20.76, 18.70, 16.04. 211 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.66 3380, 2938, ([M + H].sup.+) calcd for (d, J = 2.2 Hz, 1H), 8.54 (dd, J = 1770, 1509 C.sub.26H.sub.28N.sub.3O.sub.7, 4.8, 1.7 Hz, 1H), 8.44 (d, J = 7.9 Hz, 494.1936; found, 1H), 8.30 (d, J = 5.5 Hz, 1H), 7.74 494.1931 (dt, J = 7.9, 2.0 Hz, 1H), 7.24 (dd, J = 4.9, 0.8 Hz, 1H), 7.22-7.13 (m, 2H), 6.99 (d, J = 5.5 Hz, 1H), 6.91 (tt, J = 7.2, 1.1 Hz, 1H), 6.82 (dt, J = 7.8, 1.1 Hz, 2H), 5.35-5.26 (m, 1H), 5.23 (d, J = 5.4 Hz, 1H), 4.72-4.61 (m, 1H), 3.91 (s, 3H), 2.39 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.99, 168.91, 162.41, 159.46, 157.31, 149.74, 148.94, 146.65, 141.39, 134.73, 133.23, 129.53, 123.58, 121.71, 116.04, 109.79, 79.29, 77.22, 73.70, 56.29, 47.86, 20.75, 18.29, 15.48. 212 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.52 3376, 2928, ([M + H].sup.+) calcd for (s, 1H), 8.36-8.29 (m, 1H), 7.84-7.74 1770, 1676 C.sub.24H.sub.26N.sub.3O.sub.7S, (m, 1H), 7.38-7.31 (m, 1H), 500.1483; found, 7.26-7.18 (m, 2H), 7.05-6.91 (m, 500.1478 4H), 5.67-5.56 (m, 1H), 5.58-5.47 (m, 1H), 4.78-4.67 (m, 1H), 3.91 (s, 3H), 1.44-1.34 (m, 6H). 213 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 8.40-8.24 3378, 2986, ([M + H].sup.+) calcd for (m, 2H), 7.80-7.77 (m, 1H), 1747, 1674 C.sub.25H.sub.28N.sub.3O.sub.8S, 7.39-7.31 (m, 1H), 7.25-7.18 (m, 530.1591; found, 2H), 7.00-6.87 (m, 4H), 5.73 (d, J = 530.1585 1.9 Hz, 2H), 5.66-5.46 (m, 2H), 4.79-4.65 (m, 1H), 3.91 (s, 3H), 2.07 (d, J = 1.8 Hz, 3H), 1.45-1.31 (m, 6H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 207.06, 170.35, 168.21, 163.00, 160.27, 157.52, 145.71, 142.76, 142.45, 129.59, 129.58, 122.13, 122.00, 120.25, 115.96, 115.60, 109.57, 89.54, 79.70, 72.94, 56.19, 53.77, 48.19, 20.88, 16.06. 214 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.53 ([M + H].sup.+) calcd for (d, J = 5.5 Hz, 1H), 8.29 (d, J = 5.4 C.sub.27H.sub.27Cl.sub.2N.sub.2O.sub.7, Hz, 1H), 7.43-7.23 (m, 6H), 7.05-6.87 561.1195; found, (m, 2H), 6.65 (d, J = 8.9 Hz, 561.1179 1H), 5.50-5.36 (m, 1H), 5.17 (d, J = 6.6 Hz, 1H), 4.79-4.65 (m, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.41 (d, J = 7.2 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.96, 168.90, 162.39, 159.45, 151.89, 146.64, 141.45, 137.51, 135.96, 130.00, 128.82, 128.75, 127.28, 127.21, 125.92, 124.14, 115.46, 109.80, 82.63, 73.24, 56.29, 48.04, 20.76, 18.53, 16.07. 215 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.47 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.29 (d, J = 5.4 C.sub.29H.sub.31Cl.sub.2N.sub.2O.sub.7, Hz, 1H), 7.45-7.27 (m, 6H), 7.05-6.91 589.1508; found, (m, H), 6.65 (d, J = 8.9 Hz, 589.1495 1H), 5.54-5.35 (m, 1H), 5.17 (d, J = 6.5 Hz, 1H), 4.81-4.62 (m, 1H), 3.88 (s, 3H), 3.03-2.87 (m, 1H), 1.40 (d, J = 7.2 Hz, 3H), 1.36 (d, J = 7.0 Hz, 6H), 1.21 (d, J = 6.6 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 174.71, 172.05, 162.37, 159.43, 151.90, 146.54, 141.84, 137.68, 135.96, 130.01, 128.79, 128.73, 127.28, 127.22, 125.92, 124.16, 115.46, 109.63, 82.58, 73.18, 56.30, 48.03, 33.96, 18.83, 18.57, 16.04. 216 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.24 (d, J = 5.4 C.sub.28H.sub.29Cl.sub.2N.sub.2O.sub.8, Hz, 1H), 7.40-7.27 (m, 6H), 7.02-6.90 591.1301; found, (m, 2H), 6.66 (d, J = 8.9 Hz, 591.1289 1H), 5.75 (s, 2H), 5.51-5.39 (m, 1H), 5.18 (d, J = 6.8 Hz, 1H), 4.84-4.63 (m, 1H), 3.91 (s, 3H), 2.07 (s, 3H), 1.44 (d, J = 7.2 Hz, 3H), 1.23 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.08, 170.26, 162.94, 160.28, 151.90, 145.67, 144.00, 142.38, 135.99, 129.99, 128.84, 128.77, 127.28, 127.20, 125.91, 124.11, 115.43, 109.59, 89.53, 82.75, 73.26, 56.19, 48.25, 20.87, 18.41, 16.13. 217 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.53 ([M + H].sup.+) calcd for (d, J = 7.0 Hz, 1H), 8.30 (d, J = 5.4 C.sub.27H.sub.29N.sub.2O.sub.7, Hz, 1H), 7.43-7.35 (m, 2H), 7.34-7.23 493.1975; found, (m, 3H), 7.21-7.08 (m, 2H), 493.1969 6.98 (d, J = 5.5 Hz, 1H), 6.91-6.74 (m, 3H), 5.50-5.32 (m, 1H), 5.12 (d, J = 6.4 Hz, 1H), 4.79-4.62 (m, 1H), 3.88 (s, 3H), 2.39 (s, 3H), 1.37 (d, J = 7.1 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.24, 168.92, 162.40, 159.45, 157.85, 146.69, 141.54, 137.50, 137.36, 129.35, 128.60, 128.36, 127.18, 121.05, 115.79, 109.78, 81.81, 73.75, 56.29, 48.03, 20.77, 18.71, 16.27. 218 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) 8.47 ([M + H].sup.+) calcd for (d, J = 6.6 Hz, 1H), 8.29 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.7, Hz, 1H), 7.41-7.35 (m, 2H), 7.35-7.21 521.2288; found, (m, 3H), 7.19-7.11 (m, 2H), 521.2285 6.96 (d, J = 5.5 Hz, 1H), 6.91-6.72 (m, 3H), 5.49-5.28 (m, 1H), 5.12 (d, J = 6.4 Hz, 1H), 4.80-4.60 (m, 1H), 3.86 (s, 3H), 3.09-2.82 (m, 1H), 1.41-1.32 (m, 9H), 1.21 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 174.72, 172.32, 162.39, 159.42, 157.86, 146.59, 141.93, 137.66, 137.37, 129.34, 128.59, 128.34, 127.18, 121.04, 115.79, 109.63, 81.78, 73.70, 56.29, 48.02, 33.96, 18.83, 18.74, 16.25. 219 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.35 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.26 (d, J = 5.4 C.sub.28H.sub.31N.sub.2O.sub.8, Hz, 1H), 7.45-7.36 (m, 2H), 7.36-7.22 523.2080; found, (m, 3H), 7.21-7.09 (m, 2H), 523.2081 6.94 (d, J = 5.4 Hz, 1H), 6.91-6.75 (m, 3H), 5.74 (s, 2H), 5.48-5.34 (m, 1H), 5.13 (d, J = 6.5 Hz, 1H), 4.82-4.64 (m, 1H), 3.89 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 7.2 Hz, 3H), 1.23 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.36, 170.28, 162.97, 160.27, 157.86, 145.72, 143.98, 142.50, 137.38, 129.34, 128.61, 128.36, 127.16, 121.04, 115.78, 109.59, 89.54, 81.87, 73.76, 56.19, 48.25, 20.88, 18.55, 16.32. 220 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.26 ([M + H].sup.+) calcd for (t, J = 7.2 Hz, 2H), 7.60-7.56 (m, C.sub.32H.sub.37N.sub.2O.sub.8, 3H), 7.52-7.49 (m, 1H), 7.46-7.31 577.2544; found, (m, 6H), 6.92 (d, J = 5.4 Hz, 1H), 577.2557. 5.72 (s, 2H), 5.18 (p, J = 6.4 Hz, 1H), 4.61 (p, J = 7.2 Hz, 1H), 4.42 (d, J = 6.4 Hz, 1H), 3.89 (s, 3H), 3.24 (d, J = 6.7 Hz, 2H), 2.05 (s, 3H), 1.38 (d, J = 6.3 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H), 1.08-1.00 (m, 1H), 0.55-0.43 (m, 2H), 0.19-0.08 (m, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.11, 170.26, 162.89, 160.25, 145.68, 143.97, 142.50, 141.19, 140.88, 139.47, 128.79, 128.72, 127.38, 127.11, 126.76, 126.50, 126.32, 109.51, 89.57, 83.15, 74.28, 73.90, 56.16, 48.09, 20.86, 18.09, 16.03, 10.63, 3.22, 2.75. 221 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 C.sub.34H.sub.34FN.sub.2O.sub.8, Hz, 1H), 7.60 (s, 1H), 7.57-7.51 617.2294; found, (m, 3H), 7.46-7.40 (m, 3H), 7.39-7.34 617.2312. (m, 2H), 7.11 (dd, J = 15.1, 8.2 Hz, 1H), 6.93 (d, J = 5.4 Hz, 1H), 6.66-6.56 (m, 3H), 5.74-5.69 (m, 2H), 5.32 (dd, J = 6.3, 5.0 Hz, 1H), 5.27 (d, J = 4.9 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.1 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.27, 170.27, 163.00, 160.27, 145.67, 144.03, 142.36, 141.66, 140.58, 137.63, 130.21, 130.11, 129.12, 128.83, 127.55, 127.14, 125.76, 125.51, 111.56, 109.56, 108.25, 108.04, 103.94, 103.69, 56.17, 48.16, 20.87, 18.11, 14.86. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.52. 222 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.45 ([M + H].sup.+) calcd for (s, 1H), 8.30 (d, J = 5.4 Hz, 1H), C.sub.31H.sub.35N.sub.2O.sub.7, 7.60-7.55 (m, 3H), 7.52-7.48 (m, 547.2439; found, 1H), 7.47-7.30 (m, 5H), 6.98 (d, J = 547.2447. 5.5 Hz, 1H), 5.17 (p, J = 6.4 Hz, 1H), 4.64-4.55 (m, 1H), 4.41 (d, J = 6.3 Hz, 1H), 3.89 (s, 3H), 3.24 (d, J = 6.8 Hz, 2H), 2.38 (s, 3H), 1.37 (d, J = 6.3 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H), 1.03 (tdd, J = 8.0, 7.4, 1.9 Hz, 1H), 0.55-0.43 (m, 2H), 0.19-0.07 (m, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.00, 168.89, 162.30, 159.41, 146.63, 141.53, 141.19, 140.88, 139.45, 128.79, 128.72, 127.37, 127.12, 126.75, 126.46, 126.31, 109.69, 83.11, 74.34, 73.91, 56.26, 47.88, 20.75, 18.27, 15.96, 10.63, 3.21, 2.75. 223 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.45 ([M + H].sup.+) calcd for (s, 1H), 8.28 (d, J = 5.4 Hz, 1H), C.sub.33H.sub.32FN.sub.2O.sub.7, 7.59 (s, 1H), 7.57-7.50 (m, 3H), 587.2188; found, 7.46-7.34 (m, 5H), 7.11 (dd, J = 587.2196. 15.2, 8.2 Hz, 1H), 6.98 (d, J = 5.5 Hz, 1H), 6.66-6.55 (m, 3H), 5.32 (dd, J = 8.8, 3.9 Hz, 1H), 5.26 (d, J = 4.8 Hz, 1H), 4.65 (p, J = 7.3 Hz, 1H), 3.90 (s, 3H), 2.38 (s, 3H), 1.40 (d, J = 6.3 Hz, 3H), 1.25 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.16, 168.90, 162.44, 159.43, 146.62, 141.65, 141.40, 140.58, 137.61, 130.19, 130.09, 129.12, 128.82, 127.54, 127.18, 127.15, 125.75, 125.51, 111.60, 111.57, 109.75, 108.23, 104.03, 103.93, 103.69, 81.59, 74.21, 56.27, 47.95, 20.75, 18.25, 14.83. 224 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.55 ([M + H].sup.+) calcd for (d, J = 5.9 Hz, 1H), 8.33 (d, J = 5.4 C.sub.25H.sub.33N.sub.2O.sub.7, Hz, 1H), 7.38-7.22 (m, 5H), 7.00 473.2288; found, (d, J = 5.5 Hz, 1H), 5.25-5.11 (m, 473.2290 1H), 4.82-4.63 (m, 1H), 4.24 (d, J = 6.7 Hz, 1H), 3.89 (s, 3H), 3.14-2.97 (m, 2H), 2.40 (s, 3H), 1.46 (d, J = 7.2 Hz, 3H), 1.07 (d, J = 6.5 Hz, 3H), 0.90-0.81 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.17, 168.89, 162.34, 159.44, 146.67, 146.65, 141.61, 138.52, 137.48, 128.27, 128.04, 127.66, 109.75, 83.96, 76.05, 74.13, 56.28, 48.06, 28.62, 20.76, 19.41, 19.36, 18.75, 16.27. 225 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.31 (d, J = 5.4 C.sub.25H.sub.33N.sub.2O.sub.7, Hz, 1H), 7.35-7.18 (m, 5H), 6.99 473.2288; found, (d, J = 5.4 Hz, 1H), 5.18-5.01 (m, 473.2288 1H), 4.70-4.52 (m, 1H), 4.35-4.14 (m, 1H), 3.88 (d, J = 1.6 Hz, 3H), 3.19-3.10 (m, 1H), 3.09-3.00 (m, 1H), 2.38 (d, J = 1.4 Hz, 3H), 1.30 (d, J = 6.5, 3H), 1.19 (d, J = 7.1 Hz, 3H), 0.93-0.80 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.96, 168.88, 162.31, 159.43, 146.65, 141.53, 138.89, 137.46, 128.18, 127.89, 127.53, 109.75, 83.70, 76.28, 74.48, 56.27, 47.89, 28.64, 20.74, 19.36, 19.34, 18.32, 15.79. 226 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.37 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.28 (d, J = 5.4 C.sub.26H.sub.35N.sub.2O.sub.8, Hz, 1H), 7.43-7.25 (m, 5H), 6.96 503.2393; found, (d, J = 5.4 Hz, 1H), 5.75 (s, 2H), 503.2401 5.19 (p, J = 6.5 Hz, 1H), 4.74 (p, J = 7.2 Hz, 1H), 4.25 (d, J = 6.7 Hz, 1H), 3.91 (s, 3H), 3.17-2.97 (m, 2H), 2.07 (s, 3H), 1.48 (d, J = 7.1 Hz, 3H), 1.09 (d, J = 6.5 Hz, 3H), 0.92-0.81 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.29, 170.26, 162.92, 160.26, 145.72, 143.94, 142.61, 138.53, 128.27, 128.05, 127.65, 109.55, 89.54, 84.01, 76.06, 74.13, 56.18, 48.27, 28.62, 20.86, 19.40, 19.36, 18.60, 16.32. 227 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.55 3381, 2963, ([M + H].sup.+) calcd for (d, J = 7.7 Hz, 1H), 8.34 (d, J = 5.5 2876, 1676 C.sub.24H.sub.31N.sub.2O.sub.7, Hz, 1H), 7.41-7.27 (m, 5H), 7.00 459.2131; found, (d, J = 5.5 Hz, 1H), 5.24-5.11 (m, 459.2124. 1H), 4.78-4.65 (m, 1H), 4.25 (d, J = 6.8 Hz, 1H), 3.91 (s, 3H), 3.29 (dt, J = 9.1, 6.8 Hz, 1H), 3.23 (dt, J = 9.1, 6.5 Hz, 1H), 2.40 (s, 3H), 1.59-1.49 (m, 2H), 1.46 (d, J = 7.2 Hz, 3H), 1.07 (d, J = 6.5 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H). 228 (Thin film) HRMS-FAB (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 3379, 2963, ([M + H].sup.+) calcd for (s, 1H), 8.32 (d, J = 5.4 Hz, 1H), 2937, 1771 C.sub.24H.sub.31N.sub.2O.sub.7, 7.36-7.27 (m, 5H), 6.99 (d, J = 5.5 459.2131; found, Hz, 1H), 5.10 (p, J = 6.3 Hz, 1H), 459.2125. 4.60 (dq, J = 8.2, 7.2 Hz, 1H), 4.27 (d, J = 6.1 Hz, 1H), 3.90 (s, 3H), 3.33 (dt, J = 9.1, 6.6 Hz, 1H), 3.25 (dt, J = 9.1, 6.5 Hz, 1H), 2.39 (s, 3H), 1.60-1.50 (m, 2H), 1.30 (d, J = 6.3 Hz, 3H), 1.18 (d, J = 7.1 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H). 229 (Thin film) HRMS-FAB (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.56 3379, 2984, ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.33 (d, J = 5.4 2939, 1770 C.sub.22H.sub.27N.sub.2O.sub.7, Hz, 1H), 7.40-7.26 (m, 5H), 7.00 431.1818; found, (d, J = 5.5 Hz, 1H), 5.27-5.14 (m, 431.1818. 1H), 4.83-4.66 (m, 1H), 4.14 (d, J = 6.9 Hz, 1H), 3.90 (s, 3H), 3.23 (s, 3H), 2.40 (s, 3H), 1.47 (d, J = 7.1 Hz, 3H), 1.08 (d, J = 6.5 Hz, 3H). 230 (Thin film) HRMS-FAB (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.37 3377, 2985, ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.28 (d, J = 5.3 2938, 1740 C.sub.23H.sub.29N.sub.2O.sub.8, Hz, 1H), 7.39-7.27 (m, 5H), 6.95 461.1924; found, (d, J = 5.4 Hz, 1H), 5.75 (s, 2H), 461.1922. 5.28-5.15 (m, 1H), 4.75 (p, J = 7.2 Hz, 1H), 4.14 (d, J = 6.9 Hz, 1H), 3.91 (s, 3H), 3.24 (s, 3H), 2.07 (s, 3H), 1.49 (d, J = 7.2 Hz, 3H), 1.10 (d, J = 6.5 Hz, 3H). 231 (Thin film) HRMS-FAB (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 3377, 2984, ([M + H].sup.+) calcd for (d, J = 7.1 Hz, 1H), 8.32 (d, J = 5.5 1770, 1675 C.sub.22H.sub.27N.sub.2O.sub.7, Hz, 1H), 7.39-7.26 (m, 5H), 6.99 431.1818; found, (d, J = 5.5 Hz, 1H), 5.17-4.99 (m, 431.1808. 1H), 4.60 (dq, J = 8.1, 7.1 Hz, 1H), 4.18 (d, J = 5.9 Hz, 1H), 3.90 (s, 3H), 3.26 (s, 3H), 2.39 (s, 3H), 1.29 (d, J = 6.4 Hz, 3H), 1.20 (d, J = 7.2 Hz, 3H). 232 (Thin film) HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.56 3378, 2986, ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.33 (d, J = 5.5 1771, 1676 C.sub.25H.sub.31N.sub.2O.sub.7, Hz, 1H), 7.37-7.28 (m, 5H), 7.00 471.2131; found, (d, J = 5.5 Hz, 1H), 5.25-5.13 (m, 471.2123. 1H), 4.80-4.67 (m, 1H), 4.32 (d, J = 6.8 Hz, 1H), 3.90 (s, 3H), 3.16 (dd, J = 6.8, 1.2 Hz, 2H), 2.40 (s, 3H), 1.48 (d, J = 7.2 Hz, 3H), 1.08 (d, J = 6.5 Hz, 3H), 1.04-0.94 (m, 1H), 0.53-0.39 (m, 2H), 0.17-0.02 (m, 2H). 233 (Thin film) HRMS-FAB (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.53-8.40 3385, 2986, ([M + H].sup.+) calcd for (m, 1H), 8.32 (d, J = 5.5 Hz, 1771, 1676 C.sub.25H.sub.31N.sub.2O.sub.7, 1H), 7.36-7.27 (m, 5H), 6.99 (d, J = 471.2131; found, 5.5 Hz, 1H), 5.20-5.05 (m, 1H), 471.2126. 4.71-4.48 (m, 1H), 4.33 (d, J = 6.3 Hz, 1H), 3.90 (s, 3H), 3.19 (dd, J = 6.8, 1.3 Hz, 2H), 2.39 (s, 3H), 1.33 (d, J = 6.3 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H), 1.06-0.90 (m, 1H), 0.53-0.38 (m, 2H), 0.22-0.04 (m, 2H). 234 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.26 ([M + H].sup.+) calcd for (t, J = 7.7 Hz, 2H), 7.59-7.51 (m, C.sub.32H.sub.37N.sub.2O.sub.8, 4H), 7.46-7.38 (m, 4H), 7.34 (dd, J = 577.2544; found, 8.3, 6.3 Hz, 1H), 6.92 (d, J = 5.5 577.2553. Hz, 1H), 5.73 (s, 2H), 5.17 (p, J = 6.3 Hz, 1H), 4.63 (dd, J = 14.8, 7.3 Hz, 1H), 4.39 (d, J = 6.2 Hz, 1H), 3.89 (s, 3H), 3.24 (d, J = 6.8 Hz, 2H), 2.06 (s, 3H), 1.37 (d, J = 6.3 Hz, 3H), 1.21 (d, J = 7.2 Hz, 3H), 1.04 (tdd, J = 8.0, 7.4, 2.5 Hz, 1H), 0.55-0.43 (m, 2H), 0.20-0.09 (m, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.08, 170.27, 162.89, 160.26, 145.68, 143.98, 142.53, 140.86, 140.76, 137.84, 128.75, 128.03, 127.31, 127.06, 126.95, 109.51, 89.57, 82.83, 74.25, 73.85, 56.16, 48.11, 20.87, 18.17, 16.03, 10.62, 3.21, 2.74. 235 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.45 ([M + H].sup.+) calcd for (d, J = 6.4 Hz, 1H), 8.29 (d, J = 5.4 C.sub.27H.sub.28FN.sub.2O.sub.7, Hz, 1H), 7.43-7.27 (m, 5H), 6.98 511.1880; found, (d, J = 5.5 Hz, 1H), 6.92-6.80 (m, 511.1879 2H), 6.81-6.66 (m, 2H), 5.26 (qd, J = 6.5, 5.0 Hz, 1H), 5.11 (d, J = 4.9 Hz, 1H), 4.65 (dq, J = 8.1, 7.2 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.24. 236 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.49 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.31 (d, J = 5.4 C.sub.27H.sub.27F.sub.2N.sub.2O.sub.7, Hz, 1H), 7.38-7.28 (m, 2H), 7.09-6.93 529.1786; found, (m, 3H), 6.92-6.79 (m, 2H), 529.1788 6.79-6.64 (m, 2H), 5.40-5.28 (m, 1H), 5.03 (d, J = 6.5 Hz, 1H), 4.72 (dq, J = 8.2, 7.2 Hz, 1H), 3.92 (s, 3H), 2.40 (s, 3H), 1.40 (d, J = 7.2 Hz, 3H), 1.19 (d, J = 6.5 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.21, −123.09. 237 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.27 ([M + H].sup.+) calcd for (d, J = 5.1 Hz, 1H), 8.25 (d, J = 5.5 C.sub.28H.sub.30FN.sub.2O.sub.8, Hz, 1H), 7.45-7.25 (m, 5H), 6.93 541.1986; found, (d, J = 5.5 Hz, 1H), 6.90-6.80 (m, 541.1992 2H), 6.80-6.68 (m, 2H), 5.78-5.61 (m, 2H), 5.27 (qd, J = 6.4, 4.9 Hz, 1H), 5.12 (d, J = 4.9 Hz, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.91 (s, 3H), 2.07 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.22. 238 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.32 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.26 (d, J = 4.9 C.sub.28H.sub.29F.sub.2N.sub.2O.sub.8, Hz, 1H), 7.40-7.30 (m, 2H), 7.04-6.98 559.1892; found, (m, 2H), 6.95 (d, J = 5.1 Hz, 559.1889 1H), 6.90-6.81 (m, 2H), 6.78-6.71 (m, 2H), 5.74 (s, 2H), 5.42-5.29 (m, 1H), 5.03 (d, J = 6.5 Hz, 1H), 4.82-4.70 (m, 1H), 3.92 (s, 3H), 2.07 (s, 3H), 1.42 (d, J = 7.2 Hz, 3H), 1.20 (d, J = 6.5 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.16, −123.06. double check 239 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 C.sub.34H.sub.35N.sub.2O.sub.8, Hz, 1H), 7.57-7.52 (m, 4H), 7.49-7.39 599.2388; found, (m, 4H), 7.34 (dd, J = 8.3, 6.3 599.2395. Hz, 1H), 7.19 (dd, J = 8.6, 7.4 Hz, 2H), 6.93-6.85 (m, 4H), 5.72 (t, J = 3.6 Hz, 2H), 5.35-5.29 (m, 1H), 5.26 (d, J = 5.0 Hz, 1H), 4.69 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). 240 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 C.sub.34H.sub.35N.sub.2O.sub.8, Hz, 1H), 7.63 (s, 1H), 7.56 (dd, J = 599.2388; found, 5.1, 3.4 Hz, 2H), 7.52-7.49 (m, 599.2393. 1H), 7.45-7.38 (m, 4H), 7.35 (ddd, J = 7.3, 3.8, 1.2 Hz, 1H), 7.21-7.15 (m, 2H), 6.93-6.86 (m, 4H), 5.74-5.70 (m, 2H), 5.37-5.30 (m, 1H), 5.29 (d, J = 1.8 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.43 (d, J = 6.3 Hz, 3H), 1.23 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.31, 170.28, 162.98, 160.27, 157.97, 145.69, 144.01, 142.43, 141.50, 140.69, 138.29, 129.39, 129.01, 128.80, 127.48, 127.14, 126.97, 125.88, 125.65, 121.26, 116.06, 109.54, 89.57, 81.39, 74.40, 56.17, 48.14, 20.87, 18.13, 15.05. 241 ESIMS m/z 541 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.26 ([M + H].sup.+) (t, J = 6.2 Hz, 2H), 7.40-7.35 (m, 2H), 7.17 (dd, J = 8.4, 7.6 Hz, 2H), 7.01 (t, J = 8.6 Hz, 2H), 6.94 (d, J = 5.4 Hz, 1H), 6.89 (t, J = 7.3 Hz, 1H), 6.83-6.79 (m, 2H), 5.74-5.70 (m, 2H), 5.29-5.22 (m, 1H), 5.18 (d, J = 5.3 Hz, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.91 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (151 MHz, CDCl.sub.3) δ 172.16, 170.29, 163.30, 162.97, 161.67, 160.29, 157.64, 145.70, 144.04, 142.39, 133.40, 133.38, 129.40, 128.76, 128.71, 121.37, 116.00, 115.59, 115.44, 109.59, 89.56, 80.67, 74.11, 56.19, 48.13, 20.88, 18.20, 15.23. 242 ESIMS m/z 511 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.45 ([M + H].sup.+) (d, J = 6.7 Hz, 1H), 8.29 (d, J = 5.4 Hz, 1H), 7.40-7.33 (m, 2H), 7.20-7.14 (m, 2H), 7.03-6.97 (m, 3H), 6.89 (t, J = 7.4 Hz, 1H), 6.83-6.78 (m, 2H), 5.28-5.21 (m, 1H), 5.17 (d, J = 5.2 Hz, 1H), 4.65 (dq, J = 14.5, 7.2 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (151 MHz, CDCl.sub.3) δ 172.04, 168.91, 163.30, 162.40, 161.67, 159.47, 157.64, 146.66, 141.43, 137.52, 133.36, 133.34, 129.40, 128.77, 128.72, 121.37, 116.01, 115.58, 115.44, 109.81, 80.64, 74.12, 56.30, 47.90, 20.76, 15.24. 243 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.47 ([M + H].sup.+) calcd for (d, J = 8.0 Hz, 1H), 8.29 (d, J = 5.4 C.sub.28H.sub.30ClN.sub.2O.sub.7, Hz, 1H), 7.43-7.36 (m, 2H), 7.36-7.22 541.1741; found, (m, 3H), 7.13 (dd, J = 2.2, 0.8 541.1733 Hz, 1H), 6.97 (d, J = 5.5 Hz, 1H), 6.77 (ddd, J = 8.4, 2.2, 0.9 Hz, 1H), 6.55 (d, J = 8.4 Hz, 1H), 5.41-5.24 (m, 1H), 5.22 (d, J = 4.8 Hz, 1H), 4.65 (dq, J = 8.3, 7.2 Hz, 1H), 3.88 (s, 3H), 2.38 (s, 3H), 2.18 (s, 3H), 1.42 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.15, 168.93, 162.40, 159.41, 151.06, 146.67, 141.44, 137.46, 137.01, 131.47, 130.71, 128.55, 128.33, 127.85, 126.99, 123.08, 115.10, 109.76, 82.07, 74.36, 56.30, 47.94, 20.77, 20.23, 18.32, 15.00. 244 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 8.8 Hz, 1H), 8.25 (d, J = 5.4 C.sub.29H.sub.32ClN.sub.2O.sub.8, Hz, 1H), 7.45-7.37 (m, 2H), 7.37-7.22 571.1847; found, (m, 3H), 7.13 (dd, J = 2.1, 0.8 571.1834 Hz, 1H), 6.93 (d, J = 5.4 Hz, 1H), 6.77 (ddd, J = 8.3, 2.2, 0.8 Hz, 1H), 6.56 (d, J = 8.3 Hz, 1H), 5.72 (d, J = 1.4 Hz, 2H), 5.33 (qd, J = 6.4, 4.0 Hz, 1H), 5.23 (d, J = 4.9 Hz, 1H), 4.78-4.58 (m, 1H), 3.90 (s, 3H), 2.18 (s, 3H), 2.06 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.24, 170.29, 162.97, 160.25, 151.05, 145.71, 143.97, 142.42, 137.03, 131.48, 130.71, 128.54, 128.32, 127.84, 127.00, 123.07, 115.09, 109.56, 89.54, 82.08, 74.32, 56.20, 48.16, 20.90, 20.23, 18.14, 15.02. 245 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.32-8.24 ([M + H].sup.+) calcd for (m, 2H), 7.48-7.34 (m, 2H), C.sub.29H.sub.31ClFN.sub.2O.sub.8, 7.13 (dd, J = 2.1, 0.8 Hz, 1H), 7.07-6.98 589.1753; found, (m, 2H), 6.94 (d, J = 5.4 Hz, 589.1746 1H), 6.79 (ddd, J = 8.4, 2.2, 0.9 Hz, 1H), 6.54 (d, J = 8.3 Hz, 1H), 5.72 (d, J = 0.9 Hz, 2H), 5.31 (qd, J = 6.4, 5.0 Hz, 1H), 5.21 (d, J = 5.0 Hz, 1H), 4.80-4.56 (m, 1H), 3.90 (s, 3H), 2.19 (s, 3H), 2.06 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.17, 170.29, 162.98, 162.56 (d, J = 247.0 Hz), 160.26, 150.79, 145.71, 143.98, 142.36, 132.80 (d, J = 3.2 Hz), 131.77, 130.79, 128.81 (d, J = 8.2 Hz), 127.86, 123.20, 115.53 (d, J = 21.6 Hz), 115.22, 109.59, 89.51, 81.53, 74.08, 56.18 (d, J = 3.1 Hz), 48.13, 20.87 (d, J = 2.1 Hz), 20.24 (d, J = 1.8 Hz), 18.14, 15.15. 246 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.48 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.27 (d, J = 5.4 C.sub.28H.sub.31N.sub.2O.sub.7, Hz, 1H), 7.44-7.35 (m, 2H), 7.35-7.18 507.2131; found, (m, 3H), 6.99-6.90 (m, 3H), 507.2120 6.79-6.68 (m, 2H), 5.27 (qd, J = 6.4, 5.0 Hz, 1H), 5.15 (d, J = 5.2 Hz, 1H), 4.65 (dq, J = 8.1, 7.1 Hz, 1H), 3.86 (s, 3H), 2.38 (s, 3H), 2.20 (s, 3H), 1.37 (d, J = 6.5 Hz, 3H), 1.24 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.13, 168.93, 162.40, 159.44, 155.77, 146.69, 141.44, 137.75, 137.48, 130.41, 129.80, 128.49, 128.12, 127.04, 115.88, 109.80, 81.40, 74.34, 56.29, 47.93, 20.78, 20.46, 18.38, 15.16. 247 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.46 ([M + H].sup.+) calcd for (d, J = 8.2 Hz, 1H), 8.28 (d, J = 5.4 C.sub.28H.sub.30FN.sub.2O.sub.7, Hz, 1H), 7.45-7.30 (m, 2H), 7.06-6.91 525.2037; found, (m, 5H), 6.76-6.63 (m, 2H), 525.2021 5.24 (qd, J = 6.4, 5.2 Hz, 1H), 5.12 (d, J = 5.3 Hz, 1H), 4.65 (dq, J = 8.3, 7.2 Hz, 1H), 3.88 (s, 3H), 2.39 (s, 3H), 2.21 (s, 3H), 1.37 (d, J = 6.3 Hz, 3H), 1.27 (d, J = 7.1 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.04, 168.93, 162.44 (d, J = 246.6 Hz), 162.40, 159.45, 155.49, 146.68, 141.39, 137.50, 133.52 (d, J = 3.2 Hz), 130.63, 129.84, 128.78 (d, J = 8.2 Hz), 115.88, 115.46 (d, J = 21.5 Hz), 109.82, 80.79, 74.12, 56.28 (d, J = 1.9 Hz), 47.89, 20.77 (d, J = 1.5 Hz), 20.45 (d, J = 1.8 Hz), 18.37, 15.29. 248 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.29 ([M + H].sup.+) calcd for (d, J = 8.5 Hz, 1H), 8.24 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.8, Hz, 1H), 7.46-7.35 (m, 2H), 7.35-7.18 537.2237; found, (m, 3H), 6.99-6.88 (m, 3H), 537.2229 6.80-6.66 (m, 2H), 5.72 (d, J = 1.6 Hz, 2H), 5.27 (qd, J = 6.4, 4.9 Hz, 1H), 5.16 (d, J = 5.1 Hz, 1H), 4.75-4.57 (m, 1H), 3.88 (s, 3H), 2.20 (s, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.26 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.23, 170.29, 162.97, 160.27, 155.76, 145.72, 143.97, 142.40, 137.77, 130.40, 129.79, 128.48, 128.09, 127.02, 115.85, 109.60, 89.52, 81.40, 74.30, 56.20, 56.17, 48.15, 20.88 (d, J = 2.0 Hz), 20.44 (d, J = 1.8 Hz), 18.18, 15.15.z 249 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.25 (d, J = 5.4 C.sub.29H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.45-7.31 (m, 2H), 7.08-6.86 555.2142; found, (m, 5H), 6.77-6.65 (m, 2H), 555.2133 5.73 (d, J = 1.0 Hz, 2H), 5.33-5.19 (m, 1H), 5.13 (d, J = 5.3 Hz, 1H), 4.76-4.51 (m, 1H), 3.90 (s, 3H), 2.21 (s, 3H), 2.06 (s, 3H), 1.38 (d, J = 6.3 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (75 MHz, CDCl.sub.3) δ 172.15, 170.29, 162.97, 162.43 (d, J = 246.6 Hz), 160.28, 155.49, 145.72, 143.99, 142.35, 133.54 (d, J = 3.2 Hz), 130.63, 129.83, 128.77 (d, J = 8.2 Hz), 115.86, 115.45 (d, J = 21.6 Hz), 109.62, 89.50, 80.80, 74.09, 56.19 (d, J = 2.6 Hz), 48.12, 20.87 (d, J = 2.2 Hz), 20.44 (d, J = 1.9 Hz), 18.19, 15.27. 250 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.25 (dd, J = C.sub.28H.sub.29F.sub.2N.sub.2O.sub.8, 5.4, 1.0 Hz, 1H), 7.44 (dt, J = 14.6, 559.1886; found, 7.3 Hz, 1H), 7.20 (t, J = 7.7 Hz, 559.1883. 2H), 6.96-6.88 (m, 2H), 6.86-6.77 (m, 4H), 5.77-5.69 (m, 2H), 5.49 (d, J = 5.7 Hz, 1H), 5.37 (p, J = 6.2 Hz, 1H), 4.69 (p, J = 7.3 Hz, 1H), 3.90 (d, J = 0.9 Hz, 3H), 2.06 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.31 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.94, 170.27, 162.93, 160.28, 157.09, 145.67, 144.03, 142.39, 129.68 (dd, J = 14.7, 10.2 Hz), 129.52, 121.60, 120.60 (d, J = 7.0 Hz), 115.58, 112.00 (d, J = 21.2 Hz), 109.58, 103.61 (t, J = 25.6 Hz), 89.54, 74.01, 72.91, 56.18, 48.10, 20.86, 18.17, 15.96. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-109.61 (d, J = 7.6 Hz), −113.91 (d, J = 7.6 Hz). 251 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 ([M + H].sup.+) calcd for (d, J = 6.2 Hz, 1H), 8.30 (d, J = 5.4 C.sub.27H.sub.27F.sub.2N.sub.2O.sub.7, Hz, 1H), 7.44 (dt, J = 14.6, 7.2 Hz, 529.1781; found, 1H), 7.23-7.16 (m, 2H), 6.99 (d, J = 529.1777. 5.5 Hz, 1H), 6.90 (dd, J = 9.7, 5.0 Hz, 1H), 6.83-6.77 (m, 4H), 5.48 (d, J = 5.7 Hz, 1H), 5.36 (p, J = 6.3 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.39 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (151 MHz, CDCl.sub.3) δ 171.83, 168.89, 162.35, 159.47, 157.08, 146.63, 141.44, 137.51, 129.87-129.60 (m), 129.52, 121.60, 121.01-120.03 (m), 115.60, 111.99 (d, J = 21.3 Hz), 109.78, 104.59-102.56 (m), 73.99, 72.93, 56.28, 47.88, 20.74, 18.36, 15.97. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-109.62 (d, J = 7.6 Hz), −113.92 (d, J = 7.5 Hz). 252 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.24 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.8, Hz, 1H), 7.28 (d, J = 8.0 Hz, 2H), 537.2231; found, 7.19-7.10 (m, 4H), 6.93 (d, J = 5.4 537.2235. Hz, 1H), 6.87 (t, J = 7.4 Hz, 1H), 6.84-6.80 (m, 2H), 5.75-5.70 (m, 2H), 5.26 (dt, J = 11.4, 5.7 Hz, 1H), 5.18 (d, J = 5.0 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.31 (s, 3H), 2.06 (s, 3H), 1.38 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.25, 170.27, 162.95, 160.27, 157.96, 145.68, 144.01, 142.49, 137.82, 134.51, 129.31, 129.19, 126.89, 121.06, 115.98, 109.53, 89.58, 81.10, 74.38, 56.17, 48.16, 21.14, 20.87, 18.23, 15.00. 253 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.30-8.21 ([M + H].sup.+) calcd for (m, 2H), 7.25 (d, J = 7.7 Hz, C.sub.29H.sub.32FN.sub.2O.sub.8, 2H), 7.12 (d, J = 7.8 Hz, 2H), 6.93 555.2142; found, (d, J = 5.4 Hz, 1H), 6.86-6.80 (m, 555.2138 2H), 6.80-6.66 (m, 2H), 5.77-5.68 (m, 2H), 5.32-5.18 (m, 1H), 5.09 (d, J = 4.8 Hz, 1H), 4.76-4.59 (m, 1H), 3.90 (s, 3H), 2.31 (s, 3H), 2.06 (s, 3H), 1.36 (d, J = 6.4 Hz, 3H), 1.29 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.17, 170.21, 162.97, 160.29, 157.37 (d, J = 238.8 Hz), 154.09 (d, J = 2.1 Hz), 145.64, 144.02, 142.48, 137.97, 134.24, 129.23, 126.87, 117.13 (d, J = 7.9 Hz), 115.66 (d, J = 23.1 Hz), 109.55, 89.56, 82.06, 74.25, 56.15, 48.20, 21.11, 20.83, 18.16, 14.83. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-123.35. 254 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.30-8.16 ([M + H].sup.+) calcd for (m, 2H), 7.41-7.30 (m, 2H), C.sub.28H.sub.29F.sub.2N.sub.2O.sub.8, 7.01 (t, J = 8.6 Hz, 2H), 6.94 (d, J = 559.1892; found, 5.4 Hz, 1H), 6.89-6.79 (m, 2H), 559.1891 6.81-6.69 (m, 2H), 5.81-5.64 (m, 2H), 5.32-5.18 (m, 1H), 5.10 (d, J = 5.1 Hz, 1H), 4.66 (p, J = 7.3 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-113.53, −122.83. 255 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.30 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.22 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.9, Hz, 1H), 7.39 (d, J = 7.6 Hz, 1H), 553.2181; found, 7.26-7.21 (m, 1H), 7.15 (t, J = 8.0 553.2183. Hz, 2H), 6.93-6.80 (m, 6H), 5.75-5.70 (m, 2H), 5.69 (d, J = 4.6 Hz, 1H), 5.43-5.36 (m, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.90 (d, J = 6.0 Hz, 6H), 2.06 (s, 3H), 1.34 (d, J = 6.5 Hz, 3H), 1.30 (d, J = 7.1 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.11, 170.21, 162.92, 160.25, 157.93, 156.67, 145.64, 143.96, 142.63, 129.26, 129.09, 127.86, 125.54, 120.84, 115.66, 110.20, 109.49, 89.59, 74.92, 73.12, 56.14, 55.47, 48.21, 20.84, 18.27, 15.04. 256 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.29 ([M + H].sup.+) calcd for (d, J = 7.7 Hz, 1H), 8.22 (d, J = 5.4 C.sub.29H.sub.32N.sub.2O.sub.9, Hz, 1H), 7.37-7.31 (m, 1H), 7.16 (t, 571.2086; found, J = 7.9 Hz, 2H), 6.92 (d, J = 5.4 Hz, 571.2095. 1H), 6.86 (t, J = 7.3 Hz, 1H), 6.80 (d, J = 8.1 Hz, 2H), 6.59 (ddd, J = 10.5, 9.5, 2.2 Hz, 2H), 5.75-5.71 (m, 2H), 5.61 (d, J = 4.7 Hz, 1H), 5.40-5.32 (m, 1H), 4.69 (p, J = 7.3 Hz, 1H), 3.90 (s, 6H), 2.06 (s, 3H), 1.35-1.28 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.06, 170.21, 163.39 (d, J = 246.1 Hz), 162.93, 160.27, 157.85 (d, J = 9.7 Hz), 157.69, 145.64, 143.99, 142.57, 129.31, 129.04 (d, J = 10.1 Hz), 121.30 (d, J = 3.2 Hz), 121.02, 115.62, 109.52, 107.37 (d, J = 21.2 Hz), 98.67 (d, J = 25.8 Hz), 89.58, 74.54, 72.98, 56.15, 55.78, 48.18, 20.83, 18.26, 15.11. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.31 (s, 1F). 257 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.27 ([M + H].sup.+) calcd for (d, J = 7.7 Hz, 1H), 8.24 (d, J = 5.4 C.sub.30H.sub.35N.sub.2O.sub.8, Hz, 1H), 7.27 (d, J = 7.6 Hz, 2H), 551.2388; found, 7.10 (d, J = 7.7 Hz, 2H), 6.97-6.91 551.2394 (m, 3H), 6.80-6.68 (m, 2H), 5.72 (d, J = 2.5 Hz, 2H), 5.30-5.21 (m, 1H), 5.13 (d, J = 5.1 Hz, 1H), 4.66 (p, J = 7.3 Hz, 1H), 3.89 (s, 3H), 2.30 (s, 3H), 2.20 (s, 3H), 1.37 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.3 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.19, 170.16, 162.94, 160.26, 155.85, 145.64, 143.96, 142.55, 137.69, 134.70, 130.26, 129.72, 129.11, 126.90, 115.86, 109.53, 89.52, 81.30, 74.34, 56.13, 48.16, 21.08, 20.80, 20.38, 18.19, 15.01. 258 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.24 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.9, Hz, 1H), 7.23 (t, J = 7.9 Hz, 1H), 553.2181; found, 7.20-7.14 (m, 2H), 6.99 (d, J = 7.7 553.2187. Hz, 1H), 6.95-6.91 (m, 2H), 6.90-6.78 (m, 4H), 5.75-5.70 (m, 2H), 5.26 (dt, J = 11.4, 5.7 Hz, 1H), 5.19 (d, J = 5.0 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 3.76 (d, J = 6.6 Hz, 3H), 2.06 (s, 3H), 1.39 (d, J = 6.4 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.24, 170.22, 162.97, 160.27, 159.78, 157.98, 145.67, 144.00, 142.50, 139.30, 129.54, 129.33, 121.19, 119.35, 115.99, 113.51, 112.48, 109.54, 89.56, 81.17, 74.33, 56.15, 55.20, 48.16, 20.84, 18.17, 14.96. 259 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.25 ([M + H].sup.+) calcd for (t, J = 7.0 Hz, 2H), 7.38 (dd, J = C.sub.29H.sub.32FN.sub.2O.sub.8, 8.5, 5.9 Hz, 1H), 7.21-7.13 (m, 555.2137; found, 2H), 6.93 (d, J = 5.4 Hz, 1H), 6.92-6.79 555.2146. (m, 3H), 6.77-6.71 (m, 2H), 5.76-5.68 (m, 2H), 5.39 (d, J = 5.0 Hz, 1H), 5.26-5.15 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.51 (s, 3H), 2.06 (s, 3H), 1.43 (d, J = 6.4 Hz, 3H), 1.23 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.31, 170.23, 162.98, 162.17 (d, J = 246.4 Hz), 160.29, 157.73, 145.65, 144.04, 142.39, 137.90 (d, J = 7.9 Hz), 131.54 (d, J = 3.0 Hz), 129.41, 128.68 (d, J = 8.5 Hz), 121.29, 117.15 (d, J = 21.2 Hz), 115.75, 113.22 (d, J = 21.2 Hz), 109.57, 89.56, 77.76, 73.35, 56.16, 48.11, 20.84, 19.29 (d, J = 1.1 Hz), 18.03, 14.86. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-114.90. 260 HRMS-ESI (m/z) .sup.1H NMR (300 MHz, CDCl.sub.3) δ 8.28 ([M + H].sup.+) calcd for (d, J = 7.9 Hz, 1H), 8.24 (d, J = 5.4 C.sub.28H.sub.29ClFN.sub.2O.sub.8, Hz, 1H), 7.49 (dd, J = 8.8, 6.1 Hz, 575.1591; found, 1H), 7.24-7.15 (m, 2H), 7.14-7.09 575.1596. (m, 1H), 6.97-6.87 (m, 3H), 6.82-6.76 (m, 2H), 5.76-5.70 (m, 2H), 5.63 (d, J = 5.4 Hz, 1H), 5.41-5.31 (m, 1H), 4.70 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.41 (d, J = 6.4 Hz, 3H), 1.31 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.96, 170.22, 162.94, 162.06 (d, J = 251.0 Hz), 160.29, 157.12, 145.64, 144.03, 142.45, 133.97 (d, J = 10.2 Hz), 131.24 (d, J = 3.5 Hz), 130.03 (d, J = 8.9 Hz), 129.52, 121.51, 116.69 (d, J = 24.7 Hz), 115.56, 114.80 (d, J = 21.2 Hz), 109.57, 89.55, 76.67, 72.95, 56.16, 48.13, 20.84, 18.16, 15.62. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.30. 261 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.29 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.25 (d, J = 5.4 C.sub.29H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.31 (t, J = 7.7 Hz, 1H), 555.2137; found, 7.22-7.15 (m, 2H), 6.93 (d, J = 5.4 555.2145. Hz, 1H), 6.87 (ddd, J = 17.3, 7.4, 4.4 Hz, 5H), 5.76-5.70 (m, 2H), 5.50 (d, J = 5.6 Hz, 1H), 5.38 (p, J = 6.2 Hz, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.30 (s, 3H), 2.06 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.01, 170.23, 162.91, 160.27, 160.25 (d, J = 245.8 Hz), 157.41, 145.65, 143.99, 142.56, 140.44 (d, J = 8.0 Hz), 129.41, 128.26 (d, J = 4.2 Hz), 125.32 (d, J = 3.0 Hz), 121.39 (d, J = 13.3 Hz), 121.29, 115.67 (d, J = 21.6 Hz), 115.61, 109.52, 89.57, 74.35, 73.10, 56.15, 48.14, 21.05 (d, J = 1.3 Hz), 20.84, 18.20, 15.84. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-119.14. 262 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.43 ([M + H].sup.+) calcd for (d, J = 8.5 Hz, 1H), 8.27 (d, J = 7.9 C.sub.32H.sub.33N.sub.2O.sub.8, Hz, 1H), 8.25 (d, J = 5.4 Hz, 1H), 573.2231; found, 7.89 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 573.2238. 8.2 Hz, 1H), 7.63 (dd, J = 11.1, 4.1 Hz, 2H), 7.53 (t, J = 7.1 Hz, 1H), 7.45-7.38 (m, 1H), 7.15-7.08 (m, 2H), 6.93 (d, J = 5.4 Hz, 1H), 6.84 (t, J = 7.4 Hz, 1H), 6.82-6.77 (m, 2H), 6.12 (d, J = 4.1 Hz, 1H), 5.75-5.69 (m, 2H), 5.49-5.41 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.06 (s, 3H), 1.42 (d, J = 6.5 Hz, 3H), 1.14 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.73, 170.24, 163.00, 160.30, 158.04, 145.66, 144.05, 142.46, 133.73, 133.05, 130.59, 129.36, 128.98, 128.64, 126.82, 125.84, 125.46, 124.71, 122.94, 121.09, 115.69, 109.56, 89.59, 77.50, 73.92, 56.16, 48.11, 20.85, 17.93, 14.33. 263 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.26 ([M + H].sup.+) calcd for (d, J = 7.8 Hz, 1H), 8.23 (d, J = 5.4 C.sub.32H.sub.33N.sub.2O.sub.8, Hz, 1H), 7.86 (s, 1H), 7.80 (dd, J = 573.2231; found, 8.5, 6.2 Hz, 3H), 7.54 (dd, J = 8.5, 573.2236. 1.6 Hz, 1H), 7.49-7.44 (m, 2H), 7.18-7.12 (m, 2H), 6.92 (d, J = 5.4 Hz, 1H), 6.86 (dd, J = 10.9, 4.3 Hz, 3H), 5.74-5.69 (m, 2H), 5.42-5.34 (m, 2H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.05 (s, 3H), 1.43 (d, J = 6.2 Hz, 3H), 1.23 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.27, 170.22, 162.96, 160.27, 157.99, 145.66, 144.01, 142.48, 135.18, 133.17, 133.10, 129.36, 128.44, 127.94, 127.72, 126.29, 126.17, 124.38, 121.24, 116.08, 109.54, 89.57, 81.46, 74.38, 56.16, 48.15, 20.85, 18.16, 14.98. 264 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 5.5 Hz, 1H), 8.27 (d, J = 5.4 C.sub.30H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.35 (t, J = 7.6 Hz, 1H), 567.2137; found, 7.19-7.13 (m, 2H), 6.98 (d, J = 5.5 567.2148. Hz, 1H), 6.87 (t, J = 7.3 Hz, 1H), 6.84-6.78 (m, 2H), 6.63-6.55 (m, 2H), 6.09 (ddt, J = 17.2, 10.4, 5.1 Hz, 1H), 5.65 (d, J = 4.6 Hz, 1H), 5.47 (ddd, J = 17.3, 3.0, 1.5 Hz, 1H), 5.42-5.32 (m, 2H), 4.72-4.63 (m, 1H), 4.61 (d, J = 5.0 Hz, 2H), 3.90 (s, 3H), 2.39 (s, 3H), 1.35-1.29 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.94, 168.86, 163.21 (d, J = 246.3 Hz), 162.34, 159.44, 157.65, 156.74 (d, J = 10.0 Hz), 146.62, 141.58, 137.49, 132.40, 129.31, 129.21 (d, J = 10.2 Hz), 121.48 (d, J = 3.2 Hz), 121.03, 117.97, 115.64, 109.71, 107.60 (d, J = 21.4 Hz), 99.80 (d, J = 25.8 Hz), 74.56, 73.01, 69.22, 56.26, 47.97, 20.73, 18.50, 15.24. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.31. 265 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 5.8 Hz, 1H), 8.28 (d, J = 5.1 C.sub.29H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.33 (dd, J = 8.3, 6.9 Hz, 555.2137; found, 1H), 7.17 (dd, J = 8.5, 7.5 Hz, 2H), 555.2143. 6.98 (d, J = 5.4 Hz, 1H), 6.87 (t, J = 7.3 Hz, 1H), 6.81 (d, J = 7.9 Hz, 2H), 6.62-6.53 (m, 2H), 5.61 (d, J = 4.5 Hz, 1H), 5.43-5.35 (m, 1H), 4.68 (p, J = 7.2 Hz, 1H), 4.09 (tt, J = 8.1, 4.1 Hz, 2H), 3.90 (s, 3H), 2.39 (s, 3H), 1.49 (t, J = 7.0 Hz, 3H), 1.32 (d, J = 6.8 Hz, 6H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.56. 266 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 6.6 Hz, 1H), 8.28 (d, J = 5.4 C.sub.29H.sub.31ClFN.sub.2O.sub.8, Hz, 1H), 7.38 (dd, J = 9.2, 6.7 Hz, 589.1747; found, 1H), 7.12 (d, J = 1.7 Hz, 1H), 6.98 589.1749. (d, J = 5.5 Hz, 1H), 6.81-6.76 (m, 1H), 6.61 (ddd, J = 10.8, 5.5, 2.3 Hz, 2H), 6.55 (d, J = 8.4 Hz, 1H), 5.63 (d, J = 4.4 Hz, 1H), 5.42-5.35 (m, 1H), 4.72-4.64 (m, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 2.39 (s, 3H), 2.19 (s, 3H), 1.35 (d, J = 6.5 Hz, 3H), 1.33 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.95, 168.85, 163.47 (d, J = 246.5 Hz), 159.42, 162.34, 157.82 (d, J = 9.7 Hz), 150.89, 146.60, 141.58, 137.48, 131.22, 130.67, 129.17 (d, J = 10.1 Hz), 127.84, 122.93, 120.74 (d, J = 3.4 Hz), 114.38, 109.67, 107.46 (d, J = 21.3 Hz), 98.64 (d, J = 25.9 Hz), 75.32, 73.02, 56.25, 55.78, 47.97, 20.71, 20.20, 18.44, 14.99. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.97 (d, J = 2.0 Hz). 267 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.41 ([M + H].sup.+) calcd for (d, J = 6.8 Hz, 1H), 8.29 (d, J = 5.4 C.sub.29H.sub.30FN.sub.2O.sub.9, Hz, 1H), 7.41 (dd, J = 9.4, 6.2 Hz, 569.1930; found, 1H), 7.17 (dd, J = 8.5, 7.5 Hz, 2H), 569.1951. 6.98 (d, J = 5.5 Hz, 1H), 6.90 (tt, J = 7.5, 3.9 Hz, 3H), 6.78 (d, J = 8.0 Hz, 2H), 5.43 (d, J = 3.9 Hz, 1H), 5.23 (qd, J = 6.5, 4.0 Hz, 1H), 4.65 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 2.44 (s, 3H), 2.38 (s, 3H), 1.32 (d, J = 6.6 Hz, 3H), 1.28 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.13, 169.16, 168.84, 162.39, 162.31 (d, J = 248.8 Hz), 159.45, 157.63, 148.71 (d, J = 10.9 Hz), 146.58, 141.52, 137.52, 129.46, 129.05 (d, J = 9.4 Hz), 125.46 (d, J = 3.6 Hz), 121.41, 115.63, 113.49 (d, J = 21.2 Hz), 110.65 (d, J = 24.6 Hz), 109.74, 75.35, 72.75, 56.26, 47.94, 21.01, 20.72, 18.26, 13.95. .sup.19F NMR (376 MHz, CDCl.sub.3) δ −111.42. 268 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 6.4 Hz, 1H), 8.28 (d, J = 5.4 C.sub.30H.sub.34FN.sub.2O.sub.8, Hz, 1H), 7.33 (dd, J = 8.3, 6.8 Hz, 569.2294; found, 1H), 7.20-7.13 (m, 2H), 6.98 (d, J = 569.2289. 5.5 Hz, 1H), 6.87 (t, J = 7.3 Hz, 1H), 6.83-6.79 (m, 2H), 6.62-6.53 (m, 2H), 5.62 (d, J = 4.6 Hz, 1H), 5.41-5.33 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.98 (t, J = 6.4 Hz, 2H), 3.90 (s, 3H), 2.39 (s, 3H), 1.95-1.85 (m, 2H), 1.32 (t, J = 7.0 Hz, 6H), 1.10 (t, J = 7.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.95, 168.86, 163.31 (d, J = 246.0 Hz), 162.33, 159.43, 157.73, 157.24 (d, J = 9.8 Hz), 146.62, 141.59, 137.48, 129.30, 129.00 (d, J = 10.2 Hz), 121.22 (d, J = 3.2 Hz), 120.97, 115.59, 109.69, 107.15 (d, J = 21.3 Hz), 99.21 (d, J = 25.7 Hz), 74.62, 73.06, 69.99, 56.25, 47.96, 22.49, 20.72, 18.51, 15.18, 10.68. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.49. 269 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.52 ([M + H].sup.+) calcd for (d, J = 5.5 Hz, 1H), 8.26 (d, J = 5.4 C.sub.29H.sub.33N.sub.2O.sub.8, Hz, 1H), 7.24 (s, 1H), 7.18-7.12 537.2231; found, (m, 2H), 6.97 (d, J = 5.5 Hz, 1H), 537.2220. 6.84 (dd, J = 14.9, 7.6 Hz, 3H), 6.70 (d, J = 6.4 Hz, 2H), 5.63 (d, J = 4.5 Hz, 1H), 5.40-5.33 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.89 (s, 3H), 3.89 (s, 3H), 2.39 (s, 3H), 2.31 (s, 3H), 1.32 (d, J = 6.5 Hz, 3H), 1.30 (d, J = 7.2 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.02, 168.85, 162.32, 159.41, 157.97, 156.57, 146.60, 141.65, 139.16, 137.46, 129.23, 127.70, 122.40, 121.51, 120.73, 115.65, 111.09, 109.64, 74.86, 73.22, 56.24, 55.40, 48.01, 21.56, 20.73, 18.47, 14.97. 270 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 5.6 Hz, 1H), 8.26 (d, J = 5.4 C.sub.28H.sub.30FN.sub.2O.sub.8, Hz, 1H), 7.34 (dd, J = 8.4, 6.8 Hz, 541.1981; found, 1H), 7.20-7.13 (m, 2H), 6.97 (d, J = 541.1987. 5.5 Hz, 1H), 6.87 (t, J = 7.3 Hz, 1H), 6.83-6.78 (m, 2H), 6.63-6.55 (m, 2H), 5.61 (d, J = 4.7 Hz, 1H), 5.39-5.31 (m, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.89 (s, 6H), 2.39 (s, 3H), 1.34-1.28 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.95, 168.85, 163.38 (d, J = 246.3 Hz), 162.34, 159.44, 157.84 (d, J = 9.8 Hz), 157.69, 146.61, 141.57, 137.49, 129.31, 129.05 (d, J = 10.1 Hz), 121.27 (d, J = 3.3 Hz), 121.02, 115.63, 109.70, 107.36 (d, J = 21.4 Hz), 98.66 (d, J = 25.8 Hz), 74.52, 73.01, 56.25, 55.77, 47.97, 20.72, 18.45, 15.10. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.28. 271 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 5.4 Hz, 1H), 8.27 (d, J = 5.4 C.sub.29H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.36-7.31 (m, 1H), 7.00-6.93 555.2137; found, (m, 3H), 6.70 (t, J = 5.7 Hz, 555.2136. 2H), 6.62-6.55 (m, 2H), 5.56 (d, J = 4.7 Hz, 1H), 5.37-5.30 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 3.88 (s, 3H), 2.39 (s, 3H), 2.21 (s, 3H), 1.33-1.28 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.97, 168.85, 163.34 (d, J = 246.0 Hz), 162.33, 159.44, 157.85 (d, J = 9.7 Hz), 155.58, 146.61, 141.59, 137.49, 130.22, 129.76, 129.07 (d, J = 10.1 Hz), 121.46 (d, J = 3.0 Hz), 115.48, 109.68, 107.33 (d, J = 21.4 Hz), 98.63 (d, J = 25.9 Hz), 74.66, 73.04, 56.25, 55.75, 47.96, 20.72, 20.42, 18.46, 15.11. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.44. 272 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 5.6 Hz, 1H), 8.28 (d, J = 5.4 C.sub.31H.sub.34FN.sub.2O.sub.8, Hz, 1H), 7.34 (dd, J = 9.2, 6.7 Hz, 581.2294; found, 1H), 7.17 (dd, J = 8.5, 7.5 Hz, 2H), 581.2296. 6.98 (d, J = 5.5 Hz, 1H), 6.90-6.81 (m, 3H), 6.59-6.53 (m, 2H), 5.66 (d, J = 4.6 Hz, 1H), 5.44-5.37 (m, 1H), 4.68 (p, J = 7.1 Hz, 1H), 3.90 (s, 3H), 3.88 (d, J = 7.0 Hz, 2H), 2.39 (s, 3H), 1.36-1.26 (m, 7H), 0.71-0.64 (m, 2H), 0.40 (q, J = 4.7 Hz, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.93, 168.85, 163.27 (d, J = 246.3 Hz), 162.33, 159.44, 157.71, 157.13 (d, J = 9.9 Hz), 146.62, 141.60, 137.49, 129.29, 129.13 (d, J = 10.2 Hz), 121.35 (d, J = 3.1 Hz), 120.95, 115.61, 109.69, 107.23 (d, J = 21.3 Hz), 99.37 (d, J = 25.8 Hz), 74.52, 73.11, 72.95, 56.25, 47.98, 20.72, 18.55, 15.31, 10.08, 3.26, 3.12. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.49. 273 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.46 ([M + H].sup.+) calcd for (d, J = 7.3 Hz, 1H), 8.29 (d, J = 5.4 C.sub.29H.sub.30F.sub.3N.sub.2O.sub.8, Hz, 1H), 7.38 (dd, J = 8.6, 6.6 Hz, 591.1949; found, 1H), 7.21-7.14 (m, 2H), 6.99 (d, J = 591.1943. 5.5 Hz, 1H), 6.88 (t, J = 7.4 Hz, 1H), 6.82-6.77 (m, 2H), 6.67 (td, J = 8.3, 2.3 Hz, 1H), 6.59 (dd, J = 10.2, 2.3 Hz, 1H), 6.23 (tt, J = 54.8, 4.0 Hz, 1H), 5.60 (d, J = 4.3 Hz, 1H), 5.40-5.32 (m, 1H), 4.66 (p, J = 7.2 Hz, 1H), 4.31-4.17 (m, 2H), 3.90 (s, 3H), 2.39 (s, 3H), 1.33 (d, J = 3.8 Hz, 3H), 1.31 (d, J = 4.4 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.96, 168.87, 163.12 (d, J = 247.7 Hz), 162.36, 159.46, 157.56, 155.60 (d, J = 9.7 Hz), 146.63, 141.54, 137.51, 129.58 (d, J = 9.9 Hz), 129.39, 121.84 (d, J = 3.5 Hz), 121.23, 115.62, 109.74, 108.83 (d, J = 21.1 Hz), 99.64 (d, J = 26.1 Hz), 74.60, 72.81, 68.12-66.92 (m), 56.27, 47.93, 20.71, 18.42, 14.85. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.59, −124.95 (d, J = 296.7 Hz), −125.92 (d, J = 296.7 Hz). 274 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.52 ([M + H].sup.+) calcd for (d, J = 4.2 Hz, 1H), 8.27 (d, J = 5.4 C.sub.30H.sub.35N.sub.2O.sub.8, Hz, 1H), 7.24 (d, J = 7.7 Hz, 1H), 551.2388; found, 6.96 (dd, J = 10.9, 7.0 Hz, 3H), 6.75-6.66 551.2384. (m, 4H), 5.58 (d, J = 4.5 Hz, 1H), 5.41-5.31 (m, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 3.87 (s, 3H), 2.39 (s, 3H), 2.30 (s, 3H), 2.20 (s, 3H), 1.34-1.27 (m, 6H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.04, 168.87, 162.32, 159.42, 156.59, 155.86, 146.60, 141.66, 139.07, 137.47, 129.89, 129.69, 127.72, 122.60, 121.50, 115.50, 111.07, 109.64, 74.99, 73.26, 56.24, 55.38, 48.02, 21.56, 20.72, 20.41, 18.48, 14.97. 275 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.49 ([M + H].sup.+) calcd for (d, J = 6.7 Hz, 1H), 8.27 (d, J = 5.4 C.sub.31H.sub.34FN.sub.2O.sub.8, Hz, 1H), 7.48 (dd, J = 8.7, 6.5 Hz, 603.2137; found, 1H), 7.44-7.38 (m, 2H), 7.24-7.15 603.2133. (m, 3H), 7.12-7.06 (m, 2H), 6.98 (d, J = 5.5 Hz, 1H), 6.93-6.84 (m, 3H), 6.71 (td, J = 8.3, 2.5 Hz, 1H), 6.48 (dd, J = 10.1, 2.5 Hz, 1H), 5.72 (d, J = 5.0 Hz, 1H), 5.52-5.44 (m, 1H), 4.71 (p, J = 7.2 Hz, 1H), 3.89 (s, 3H), 2.39 (s, 3H), 1.40 (d, J = 6.4 Hz, 3H), 1.34 (d, J = 7.2 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-110.73. 276 ESIMS m/z 336 ([M + H].sup.+) 277 ESIMS m/z 254 ([M − OCH.sub.2cPr].sup.+) 278 ESIMS m/z 356 ([M + H].sup.+) 279 ESIMS m/z 340 ([M + H].sup.+) 280 ESIMS m/z 312 ([M + H].sup.+) 281 ESIMS m/z 312 ([M + H].sup.+) 282 ESIMS m/z 458 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.31 ([M + Na].sup.+) (dd, J = 8.5, 6.7 Hz, 1H), 6.69 (td, J = 8.3, 2.4 Hz, 1H), 6.60 (dd, J = 10.8, 2.4 Hz, 1H), 5.85 (tt, J = 55.4, 4.1 Hz, 1H), 5.22-5.12 (m, 1H), 5.01 (d, J = 8.2 Hz, 1H), 4.84 (d, J = 5.0 Hz, 1H), 4.25 (t, J = 7.5 Hz, 1H), 3.82 (s, 3H), 3.64-3.50 (m, 2H), 1.44 (s, 9H), 1.24-1.17 (m, 6H). .sup.19F NMR (471 MHz, CDCl.sub.3) δ-111.01(dd, J = 16.7, 7.9 Hz), −124.47-125.21 (m), −125.21-125.96 (m). 283 ESIMS m/z 448 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.34 ([M + Na].sup.+) (dd, J = 8.3, 7.0 Hz, 1H), 6.66 (td, J = 8.3, 2.3 Hz, 1H), 6.57 (dd, J = 10.9, 2.3 Hz, 1H), 5.14 (p, J = 6.3 Hz, 1H), 5.04 (d, J = 6.4 Hz, 1H), 4.78 (d, J = 5.5 Hz, 1H), 4.29-4.17 (m, 1H), 3.81 (s, 3H), 3.18 (qd, J = 10.3, 6.8 Hz, 2H), 1.43 (s, 9H), 1.24 (d, J = 6.4 Hz, 3H), 1.18 (d, J = 7.2 Hz, 3H), 1.06-0.95 (m, 1H), 0.54-0.41 (m, 2H), 0.12 (dqd, J = 14.0, 9.3, 4.7 Hz, 2H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-112.12 (s). 284 ESIMS m/z 478 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.26-7.21 ([M + Na].sup.+) (m, 1H), 6.65 (td, J = 8.3, 2.4 Hz, 1H), 6.60 (dd, J = 10.8, 2.4 Hz, 1H), 6.23 (d, J = 4.2 Hz, 1H), 5.36-5.28 (m, 1H), 5.05 (d, J = 7.4 Hz, 1H), 4.33-4.20 (m, 1H), 3.84 (s, 3H), 1.44 (s, 9H), 1.29 (d, J = 7.2 Hz, 3H), 1.24 (s, 9H), 1.19 (d, J = 6.5 Hz, 3H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.22 (s). 285 ESIMS m/z 462 .sup.1H NMR (300 MHz, CDCl.sub.3) δ 7.31-7.27 ([M + Na].sup.+) (m, 1H), 6.66 (td, J = 8.3, 2.4 Hz, 1H), 6.59 (dd, J = 10.8, 2.4 Hz, 1H), 6.26 (d, J = 4.2 Hz, 1H), 5.37-5.27 (m, 1H), 5.04 (d, J = 7.7 Hz, 1H), 4.35-4.21 (m, 1H), 3.83 (s, 3H), 1.68 (ddd, J = 15.2, 7.9, 4.6 Hz, 1H), 1.44 (s, 9H), 1.28 (d, J = 7.2 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 1.08-0.84 (m, 4H). 286 ESIMS m/z 434 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.41-7.35 ([M + Na].sup.+) (m, 1H), 6.67 (td, J = 8.3, 2.4 Hz, 1H), 6.60 (dd, J = 10.9, 2.4 Hz, 1H), 5.20-5.12 (m, 1H), 5.02 (d, J = 6.6 Hz, 1H), 4.79 (d, J = 5.7 Hz, 1H), 4.31-4.19 (m, 1H), 3.83 (s, 3H), 3.19 (ddd, J = 8.8, 6.1, 3.0 Hz, 1H), 1.43 (s, 9H), 1.27-1.19 (m, 3H), 1.14 (dd, J = 12.7, 6.1 Hz, 3H), 0.69-0.62 (m, 1H), 0.56-0.42 (m, 2H), 0.36 (dt, J = 13.0, 5.6 Hz, 1H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.92 (s). 287 ESIMS m/z 434 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 7.36 ([M + Na].sup.+) (dd, J = 8.3, 7.0 Hz, 1H), 6.67 (td, J = 8.4, 2.3 Hz, 1H), 6.59 (dd, J = 10.9, 2.3 Hz, 1H), 5.13 (dt, J = 12.8, 6.4 Hz, 1H), 5.03 (d, J = 5.6 Hz, 1H), 4.84 (d, J = 5.0 Hz, 1H), 4.30-4.19 (m, 1H), 3.83 (s, 3H), 3.24 (ddd, J = 8.9, 6.0, 2.8 Hz, 1H), 1.44 (s, 9H), 1.21 (d, J = 7.2 Hz, 3H), 1.16 (d, J = 6.4 Hz, 3H), 0.67-0.60 (m, 1H), 0.57-0.50 (m, 1H), 0.47-0.34 (m, 2H). .sup.19F NMR (376 MHz, CDCl.sub.3) δ-112.09 (s). 288 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.12 ([M + H].sup.+) calcd for (s, 1H), 8.43 (d, J = 7.9 Hz, 1H), C.sub.22H.sub.26F.sub.3N.sub.2O.sub.7, 7.99 (d, J = 5.2 Hz, 1H), 7.31 (dd, J = 487.1687; found, 8.5, 6.8 Hz, 1H), 6.87 (d, J = 5.2 487.1690. Hz, 1H), 6.66 (td, J = 8.3, 2.4 Hz, 1H), 6.59 (dd, J = 10.8, 2.4 Hz, 1H), 5.83 (tt, J = 55.5, 4.1 Hz, 1H), 5.26-5.20 (m, 1H), 4.86 (d, J = 4.8 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.94 (s, 3H), 3.81 (s, 3H), 3.62-3.50 (m, 2H), 1.40 (d, J = 7.2 Hz, 3H), 1.24 (d, J = 6.5 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.24, 168.67, 163.50 (d, J = 246.6 Hz), 158.42 (d, J = 9.7 Hz), 155.40, 148.76, 140.49, 130.41, 128.90 (d, J = 10.1 Hz), 120.72 (d, J = 3.2 Hz), 114.27 (t, J = 241.2 Hz), 109.48, 107.23 (d, J = 21.3 Hz), 98.76 (d, J = 25.8 Hz), 77.76, 73.01, 68.71 (t, J = 28.1 Hz), 56.09, 55.68, 48.00, 18.04, 14.82. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-110.96 (dt, J = 10.7, 7.5 Hz), −124.47-125.22 (m), −125.22-125.96 (m). 289 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.15 ([M + H].sup.+) calcd for (s, 1H), 8.45 (d, J = 7.8 Hz, 1H), C.sub.24H.sub.30FN.sub.2O.sub.7, 7.98 (d, J = 5.2 Hz, 1H), 7.34 (dd, J = 477.2032; found, 8.4, 6.9 Hz, 1H), 6.87 (d, J = 5.2 477.2028. Hz, 1H), 6.64 (td, J = 8.3, 2.4 Hz, 1H), 6.56 (dd, J = 10.9, 2.4 Hz, 1H), 5.24-5.18 (m, 1H), 4.80 (d, J = 5.3 Hz, 1H), 4.65 (p, J = 7.2 Hz, 1H), 3.94 (s, 3H), 3.80 (s, 3H), 3.21 (dd, J = 10.3, 6.7 Hz, 1H), 3.15 (dd, J = 10.2, 6.9 Hz, 1H), 1.36 (d, J = 7.2 Hz, 3H), 1.26 (d, J = 6.4 Hz, 3H), 1.03-0.95 (m, 1H), 0.51-0.40 (m, 2H), 0.16-0.05 (m, 2H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 171.35, 168.62, 163.17 (d, J = 245.6 Hz), 158.46 (d, J = 9.7 Hz), 155.36, 148.73, 140.44, 130.50, 129.05 (d, J = 10.0 Hz), 122.41 (d, J = 3.2 Hz), 109.41, 106.95 (d, J = 21.1 Hz), 98.51 (d, J = 25.7 Hz), 75.99, 73.94, 73.55, 56.07, 55.61, 47.98, 18.09, 15.34, 10.63, 3.12, 2.72. .sup.19F NMR (471 MHz, CDCl.sub.3) δ-112.03 (dt, J = 10.8, 7.6 Hz). 290 HRMS-ESI (m/z) .sup.1H NMR (500 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.9 Hz, 1H), C.sub.25H.sub.32FN.sub.2O.sub.8, 7.99 (d, J = 5.2 Hz, 1H), 7.24 (dd, J = 507.2137; found, 8.7, 6.6 Hz, 1H), 6.88 (d, J = 5.2 507.2130. Hz, 1H), 6.62-6.55 (m, 2H), 6.25 (d, J = 4.1 Hz, 1H), 5.37 (qd, J = 6.5, 4.2 Hz, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.95 (s, 3H), 3.84 (s, 3H), 1.46 (d, J = 7.2 Hz, 3H), 1.23 (s, 9H), 1.21 (d, J = 6.6 Hz, 3H). .sup.13C NMR (126 MHz, CDCl.sub.3) δ 176.88, 171.22, 168.67, 163.44 (d, J = 246.4 Hz), 157.80 (d, J = 9.9 Hz), 155.39, 148.77, 140.48, 130.43, 128.41 (d, J = 10.1 Hz), 120.70 (d, J = 3.3 Hz), 109.48, 106.95 (d, J = 21.4 Hz), 98.89 (d, J = 25.8 Hz), 72.17, 70.06, 56.09, 55.79, 47.93, 38.91, 27.11, 18.17, 14.83. 291 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.13 ([M + H].sup.+) calcd for (s, 1H), 8.44 (d, J = 7.8 Hz, 1H), C.sub.24H.sub.28FN.sub.2O.sub.8, 8.00 (d, J = 5.2 Hz, 1H), 7.30-7.24 491.1824; found, (m, 1H), 6.88 (d, J = 5.2 Hz, 1H), 491.1820 6.59 (t, J = 8.0 Hz, 2H), 6.28 (d, J = 4.2 Hz, 1H), 5.42-5.34 (m, 1H), 4.69 (p, J = 7.3 Hz, 1H), 3.95 (s, 3H), 3.83 (s, 3H), 1.68 (ddd, J = 12.7, 8.2, 4.7 Hz, 1H), 1.46 (d, J = 7.2 Hz, 3H), 1.20 (d, J = 6.5 Hz, 3H), 1.06-0.95 (m, 2H), 0.95-0.83 (m, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 173.42, 171.27, 168.70, 163.47 (d, J = 246.5 Hz), 157.82 (d, J = 9.9 Hz), 155.41, 148.80, 140.46, 130.49, 128.77 (d, J = 10.1 Hz), 120.61 (d, J = 3.3 Hz), 109.49, 106.96 (d, J = 21.4 Hz), 98.88 (d, J = 25.8 Hz), 72.02, 70.17, 56.07, 55.79, 47.97, 18.11, 14.91, 12.97, 8.58. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.11 (s). 292 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.15 ([M + H].sup.+) calcd for (s, 1H), 8.43 (d, J = 7.7 Hz, 1H), C.sub.23H.sub.28FN.sub.2O.sub.7, 7.98 (d, J = 5.2 Hz, 1H), 7.39 (dd, J = 463.1875; found, 8.3, 7.0 Hz, 1H), 6.86 (d, J = 5.2 463.1873 Hz, 1H), 6.66-6.57 (m, 2H), 5.24-5.15 (m, 1H), 4.82 (d, J = 5.6 Hz, 1H), 4.70-4.61 (m, 1H), 3.94 (s, 3H), 3.83 (s, 3H), 3.20 (ddd, J = 9.1, 6.1, 3.0 Hz, 1H), 1.39 (d, J = 7.2 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 0.70-0.63 (m, 1H), 0.56-0.42 (m, 2H), 0.39-0.32 (m, 1H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.59, 168.55, 163.26 (d, J = 245.8 Hz), 158.24 (d, J = 9.6 Hz), 155.35, 148.75, 140.38, 130.58, 129.23 (d, J = 10.0 Hz), 122.42 (d, J = 3.2 Hz), 109.40, 106.86 (d, J = 21.1 Hz), 98.86 (d, J = 25.7 Hz), 77.62, 73.37, 56.04, 55.67, 52.37, 47.96, 18.40, 16.14, 6.27, 5.48. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.84 (s). 293 ESIMS m/z 485 .sup.1H NMR (400 MHz, CDCl.sub.3) δ 12.15 ([M + Na].sup.+) (s, 1H), 8.45 (d, J = 7.9 Hz, 1H), 7.99 (d, J = 5.1 Hz, 1H), 7.36 (dd, J = 8.3, 7.0 Hz, 1H), 6.87 (d, J = 5.2 Hz, 1H), 6.65 (td, J = 8.4, 2.4 Hz, 1H), 6.59 (dd, J = 10.9, 2.3 Hz, 1H), 5.23-5.15 (m, 1H), 4.86 (d, J = 4.8 Hz, 1H), 4.67 (p, J = 7.3 Hz, 1H), 3.94 (s, 3H), 3.83 (s, 3H), 3.24 (dq, J = 9.0, 3.0 Hz, 1H), 1.40 (d, J = 7.2 Hz, 3H), 1.18 (d, J = 6.4 Hz, 3H), 0.66-0.58 (m, 1H), 0.56-0.49 (m, 1H), 0.46-0.31 (m, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.26, 168.61, 163.26 (d, J = 245.7 Hz), 158.24 (d, J = 9.7 Hz), 155.39, 148.78, 140.40, 130.54, 129.24 (d, J = 10.1 Hz), 122.32 (d, J = 3.3 Hz), 109.44, 106.91 (d, J = 21.2 Hz), 98.67 (d, J = 25.7 Hz), 73.08, 56.06, 55.66, 52.43, 48.00, 18.19, 14.83, 6.10, 5.70. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-112.01 (s). 294 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.48 ([M + H].sup.+) calcd for (d, J = 6.8 Hz, 1H), 8.32 (d, J = 5.4 C.sub.24H.sub.28F.sub.3N.sub.2O.sub.8, Hz, 1H), 7.32 (dd, J = 8.5, 6.8 Hz, 529.1792; found, 1H), 7.00 (d, J = 5.5 Hz, 1H), 6.66 529.1788. (td, J = 8.3, 2.4 Hz, 1H), 6.59 (dd, J = 10.8, 2.4 Hz, 1H), 5.83 (tt, J = 55.5, 4.2 Hz, 1H), 5.24-5.16 (m, 1H), 4.85 (d, J = 4.7 Hz, 1H), 4.67 (p, J = 7.2 Hz, 1H), 3.91 (s, 3H), 3.81 (s, 3H), 3.57 (td, J = 13.8, 4.2 Hz, 2H), 2.39 (s, 3H), 1.34 (d, J = 7.2 Hz, 3H), 1.21 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.74, 168.86, 163.48 (d, J = 246.5 Hz), 162.35, 159.49, 158.38 (d, J = 9.8 Hz), 146.63, 141.53, 137.54, 128.91 (d, J = 10.0 Hz), 120.94 (d, J = 3.0 Hz), 114.30 (t, J = 241.1 Hz), 109.77, 107.18 (d, J = 21.3 Hz), 98.73 (d, J = 25.8 Hz), 77.81, 72.84, 68.83 (t, J = 28.1 Hz), 56.28, 55.65, 47.99, 20.71, 18.34, 14.74. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.16 (s), −124.83 (d, J = 293.2 Hz), −125.66 (d, J = 293.2 Hz). 295 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 6.2 Hz, 1H), 8.32 (d, J = 5.4 C.sub.26H.sub.32FN.sub.2O.sub.8, Hz, 1H), 7.35 (dd, J = 8.3, 7.1 Hz, 519.2137; found, 1H), 6.99 (d, J = 5.5 Hz, 1H), 6.64 519.2131. (td, J = 8.3, 2.3 Hz, 1H), 6.57 (dd, J = 10.9, 2.3 Hz, 1H), 5.18 (p, J = 6.3 Hz, 1H), 4.79 (d, J = 5.4 Hz, 1H), 4.65 (p, J = 7.2 Hz, 1H), 3.90 (s, 3H), 3.80 (s, 3H), 3.22 (dd, J = 10.2, 6.7 Hz, 1H), 3.15 (dd, J = 10.2, 6.9 Hz, 1H), 2.39 (s, 3H), 1.28 (d, J = 7.2 Hz, 3H), 1.25 (d, J = 6.4 Hz, 3H), 1.04-0.95 (m, 1H), 0.52-0.40 (m, 2H), 0.11 (dtt, J = 14.2, 9.5, 4.8 Hz, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.89, 168.88, 163.16 (d, J = 245.6 Hz), 162.30, 159.45, 158.48 (d, J = 9.7 Hz), 146.62, 141.64, 137.49, 129.07 (d, J = 10.0 Hz), 122.60 (d, J = 3.5 Hz), 109.70, 106.93 (d, J = 21.1 Hz), 98.49 (d, J = 25.7 Hz), 76.03, 73.93, 73.37, 56.26, 55.59, 47.97, 20.72, 18.42, 15.38, 10.64, 3.09, 2.70. 296 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.51 ([M + H].sup.+) calcd for (d, J = 6.7 Hz, 1H), 8.33 (d, J = 5.4 C.sub.27H.sub.34FN.sub.2O.sub.9, Hz, 1H), 7.26-7.22 (m, 1H), 7.01 549.2243; found, (d, J = 5.5 Hz, 1H), 6.62-6.56 (m, 549.2239 2H), 6.24 (d, J = 4.1 Hz, 1H), 5.39-5.31 (m, 1H), 4.68 (p, J = 7.2 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 2.39 (s, 3H), 1.41 (d, J = 7.2 Hz, 3H), 1.23 (s, 9H), 1.19 (d, J = 6.5 Hz, 3H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 176.86, 171.78, 168.86, 163.44 (d, J = 246.4 Hz), 162.35, 159.48, 157.82 (d, J = 10.1 Hz), 146.64, 141.55, 137.54, 128.46 (d, J = 10.2 Hz), 120.81 (d, J = 2.9 Hz), 109.76, 106.94 (d, J = 21.4 Hz), 98.87 (d, J = 25.8 Hz), 71.93, 70.12, 56.28, 55.77, 47.92, 38.90, 27.12, 20.72, 18.53, 14.86. 297 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.50 ([M + H].sup.+) calcd for (d, J = 6.4 Hz, 1H), 8.33 (d, J = 5.2 C.sub.26H.sub.30FN.sub.2O.sub.9, Hz, 1H), 7.29 (d, J = 7.4 Hz, 1H), 533.1930; found, 7.01 (d, J = 5.4 Hz, 1H), 6.60 (t, J = 533.1923. 9.5 Hz, 2H), 6.27 (d, J = 4.2 Hz, 1H), 5.39-5.31 (m, 1H), 4.70 (p, J = 7.3 Hz, 1H), 3.91 (s, 3H), 3.82 (s, 3H), 2.39 (s, 3H), 1.67 (ddd, J = 12.7, 8.1, 4.5 Hz, 1H), 1.40 (d, J = 7.2 Hz, 3H), 1.18 (d, J = 6.5 Hz, 3H), 1.04-0.95 (m, 2H), 0.89 (d, J = 2.7 Hz, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 173.42, 171.83, 168.85, 163.45 (d, J = 246.3 Hz), 162.36, 159.48, 157.82 (d, J = 9.8 Hz), 146.64, 141.55, 137.53, 128.82 (d, J = 10.1 Hz), 120.67 (d, J = 3.2 Hz), 109.77, 106.95 (d, J = 21.4 Hz), 98.84 (d, J = 25.9 Hz), 71.79, 70.18, 56.28, 55.78, 47.95, 20.72, 18.50, 14.95, 12.99, 8.57, 8.55. 298 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.48 ([M + H].sup.+) calcd for (s, 1H), 8.32 (d, J = 5.5 Hz, 1H), C.sub.25H.sub.30FN.sub.2O.sub.8, 7.39 (dd, J = 8.3, 7.0 Hz, 1H), 6.99 505.1981; found, (d, J = 5.5 Hz, 1H), 6.65 (td, J = 8.3, 505.1972 2.3 Hz, 1H), 6.59 (dd, J = 10.9, 2.4 Hz, 1H), 5.17 (p, J = 6.4 Hz, 1H), 4.82 (d, J = 5.9 Hz, 1H), 4.71-4.62 (m, 1H), 3.90 (s, 3H), 3.83 (s, 3H), 3.18 (dq, J = 9.1, 3.0 Hz, 1H), 2.39 (s, 3H), 1.35 (d, J = 7.1 Hz, 3H), 1.14 (d, J = 6.5 Hz, 3H), 0.69-0.62 (m, 1H), 0.56-0.47 (m, 1H), 0.47-0.40 (m, 1H), 0.35 (dt, J = 11.1, 5.8 Hz, 1H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 172.14, 168.87, 164.47, 164.18 (d, J = 228.4 Hz), 162.25, 162.03, 159.43, 158.30 (d, J = 9.8 Hz), 146.62, 141.70, 137.48, 129.32 (d, J = 9.8 Hz), 122.50 (d, J = 3.5 Hz), 109.68, 106.88 (d, J = 21.3 Hz), 98.83 (d, J = 25.8 Hz), 77.57, 73.17, 56.25, 55.66, 52.30, 47.98, 20.72, 18.72, 16.09, 6.26, 5.47. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-111.93 (s). 299 HRMS-ESI (m/z) .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.51 ([M + H].sup.+) calcd for (d, J = 6.2 Hz, 1H), 8.33 (d, J = 5.4 C.sub.25H.sub.30FN.sub.2O.sub.8, Hz, 1H), 7.36 (dd, J = 8.3, 7.0 Hz, 505.1981; found, 1H), 7.00 (d, J = 5.4 Hz, 1H), 6.65 505.1982 (td, J = 8.3, 2.4 Hz, 1H), 6.59 (dd, J = 10.9, 2.3 Hz, 1H), 5.20-5.12 (m, 1H), 4.86 (d, J = 4.8 Hz, 1H), 4.72-4.63 (m, 1H), 3.91 (s, 3H), 3.82 (s, 3H), 3.25 (ddd, J = 9.0, 6.0, 2.9 Hz, 1H), 2.40 (s, 3H), 1.33 (d, J = 7.1 Hz, 3H), 1.16 (d, J = 6.4 Hz, 3H), 0.66-0.59 (m, 1H), 0.54 (ddd, J = 14.0, 6.6, 4.2 Hz, 1H), 0.39 (dtd, J = 14.4, 10.1, 4.3 Hz, 2H). .sup.13C NMR (101 MHz, CDCl.sub.3) δ 171.83, 168.88, 163.24 (d, J = 245.4 Hz), 162.29, 159.47, 158.23 (d, J = 9.5 Hz), 146.61, 141.61, 137.51, 129.22 (d, J = 10.0 Hz), 122.44 (d, J = 3.5 Hz), 109.72, 106.88 (d, J = 21.2 Hz), 98.64 (d, J = 25.8 Hz), 72.88, 56.27, 55.65, 52.44, 47.98, 20.73, 18.55, 14.83, 6.11, 5.74. .sup.19F NMR (376 MHz, CDCl.sub.3) δ-112.15 (s). *Cmpd. No.—Compound Number

TABLE-US-00003 TABLE 3 Biological Testing Rating Scale Rating Table for Fungal Pathogens % Control Rating >80 A ≦80 B Not Tested C ≦0 D

TABLE-US-00004 TABLE 4 Biological Activity - High Volume Cereal Activity at 100 ppm *Cmpd. PUCCRT* SEPTTR* No. 1DP* 3DC* 1DP* 3DC* 113 A B A A 114 A A A A 115 D A D B 116 D D D B 117 A A A A 118 A A A A 119 A A B A 120 A B A B 121 A B B A 122 A A A A 123 A B B B 124 A A A A 125 B D B B 126 B D D B 127 A A A A 128 A B D B 129 B B A B 130 C C C C 131 B B D B 132 A B B D 133 B D D D 134 A A A B 135 A D A A 136 D B B D 137 A A A A 138 A A B B 139 C C C C 140 B A D B 141 C C C C 142 A A B B 143 C C C C 144 A B A B 145 A B A A 146 A A A A 147 A B A A 148 A B B A 149 A A A A 150 A A A B 151 A A A B 152 A A A A 153 C C C C 154 A A A A 162 A A A A 163 A A A A 164 A A A A 165 A A A A 166 A A A A 167 A A A A 168 A A A A 169 A B A A 172 A A A A 173 A A A A 175 A A A B 176 A A A A 177 B D A A 178 A B A A 288 A A B A 289 A A A A 290 A A A A 291 B B D A *Cmpd. No.—Compound Number *PUCCRT—Wheat Brown Rust (Puccinia triticina) *SEPTTR—Wheat Leaf Blotch (Zymoseptoria tritici) *1DP—1 Day Protectant *3DC—3 Day Curative *ppm—Parts Per Million

TABLE-US-00005 TABLE 5 Biological Activity - Low Volume Cereal Activity at 121.5 g/Ha *Cmpd. PUCCRT* SEPTTR* No. 1DP* 3DC* 1DP* 3DC* 182 A A A A 183 A A A A 184 A A A A 185 A A A A 186 D D B B 187 A A A A 188 A A A A 189 A B B D 190 A B B D 191 A A D B 192 A A A B 193 A A B D 194 A B B D 195 A B A A 196 A B A A 197 A B A D 198 A B A D 199 A B A A 200 A B A A 201 A A A A 202 A B A A 203 A B A A 204 A A B A 205 A A A A 206 A B A A 207 A B A A 208 A B A A 209 A B A A 210 B B B B 211 D B D B 212 B A D B 213 A A D B 214 A B A A 215 B B B B 216 A B A A 217 A B A A 218 D D A B 219 A A A A 220 A A B A 221 A B A B 222 A A A A 223 A B A A 224 A A B B 225 A A B A 226 A A B B 227 A A B A 228 A A B A 229 D A D B 230 A A D A 231 D A D A 232 A A D A 233 A A A A 234 A B A A 235 A A A A 236 A A A A 237 A A A A 238 A A A A 239 A B A A 240 A B A A 241 A A A A 242 A A A A 243 A B A A 244 A B A A 245 A B A A 246 A A A A 247 A A A A 248 A A A A 249 A A A A 250 A A A A 251 A A A A 252 A A A A 253 A A A A 254 A A A A 255 A A A A 256 A A A A 257 A A A A 258 A A A A 259 A A A A 260 A A A A 261 A A A A 262 A A A A 263 A A A A 264 A D A A 265 A A A A 266 A B A A 267 B D A B 268 A A A A 269 A A A A 270 A A A A 271 A D A A 272 A A A A 273 A A A A 274 A B A A 275 A A A B 294 B B A A 295 A B A A 296 A D A A 297 D D D B 298 B A B D 299 A B A A *Cmpd. No.—Compound Number *PUCCRT—Wheat Brown Rust (Puccinia triticina) *SEPTTR—Wheat Leaf Blotch (Zymoseptoria tritici) *1DP—1 Day Protectant *3DC—3 Day Curative *g/H—Grams Per Hectare

TABLE-US-00006 TABLE 6 Biological Activity - High Volume Disease Control at 25 ppm *Cmpd. PHAKPA* No. 1DP* 3DC* 182 A B 183 B B 184 B B 185 B D 186 D D 187 A B 188 A B 202 A B 203 C C 204 A B 205 B B 206 C C 207 B B 220 A B 225 A B 228 A D 230 B B 233 A B 235 B B 236 A D 237 B B 238 B B 241 A D 242 A B 250 A B 255 A D 256 A D 259 A D 260 A B 261 A D 262 A D 264 B B 265 B D 266 B D 267 B B 268 B B 269 A B 270 B D 271 B B 272 B D 273 B D 274 B D 275 B D 294 B B 295 A B 296 B B 297 B B 298 A B 299 A B *Cmpd. No.—Compound Number *PHAKPA—Asian Soybean Rust (Phakopsora pachyrhizi) *1DP—1 Day Protectant *3DC—3 Day Curative

TABLE-US-00007 TABLE 7 Biological Activity - 1DP High Volume Disease Control at 100 ppm *Cmpd. No. ALTESO* CERCBE* COLLLA* LEPTNO* PYRIOR* RHYNSE* VENTIN* 183 B A A A A A B 185 B B C C C C B 186 B B C C C C B 187 B A A A A A C 202 D B B B B D C 205 B A A A A B C 207 D A A A A A A 235 B A A A A A B 236 B A B A A A A 237 B A B A A A B 238 A A B A A A A 250 D B A D B B C 252 D A A A A A B 255 D A A A A B B 256 B A A A A A C 259 D A A A A A B 260 D A A A A A B 263 D A A A A A B *Cmpd. No.—Compound Number *ALTESO—Tomato Early Blight (Alternaria solani) *CERCBE—Leaf Spot of Sugar Beets (Cercospora beticola) *COLLLA—Cucumber Anthracnose (Colletotricum lagenarium) *LEPTNO—Wheat Glume Blotch (Leptosphaeria nodorum) *PYRIOR—Rice Blast (Pyricularia oryzae) *RHYNSE—Barley Scald (Rhyncosporium secalis) *VENTIN—Apple Scab (Venturia inaequalis) *1DP—1 Day Protectant